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Bovine tuberculosis is an infectious disease mainly in livestock caused by 
Mycobacterium bovis and has had substantial economic impacts in the UK and 
worldwide. Innate immunity against bovine tuberculosis in not fully understood, and 
some of the first host molecules to be involved are in innate immunity are collectins, 
which are soluble C-type lectins that play an important role in the targeting and 
clearance of microbes. Conglutinin is an important collectin, which is synthesized in 
the liver and is present in the serum and can be produced locally by neutrophil, 
dendritic and macrophage cells.  Conglutinin is a unique collectin found in cattle and 
other grazing animals. Its biological role is not fully understood. It is therefore 
interesting to study conglutinin’s role in the bovine infection and immunity. In this 
study, the aim was to investigate the role of conglutinin in bovine tuberculosis, by 
examining its influence in host-pathogen interactions between mycobacteria and 
macrophages.  
A recombinant fragment of conglutinin (rfBC) composed of α-helical neck region 
 and the C-terminal CRD region was successfully expressed in E. coli, purified and 
characterised. It was observed that rfBC binds to mycobacteria (M. bovis BCG and M. 
smegmatis) in the presence of Ca2+ in a dose-dependent manner. A direct 
bacteriostatic effect for conglutinin was also observed inhibiting mycobacterial 
growth in vitro. This is the first time a bacteriostatic effect for conglutinin has been 
observed against Gram-positive bacteria. 
It was also found that rfBC bound on the surface of mycobacteria (M. bovis BCG and 
M. smegmatis) also inhibited their phagocytosis by THP-1 macrophages cells. In this 
study we also observed that conglutinin led to dampening of cytokines and 
chemokines response in the THP-1 cells infected by M. bovis BCG and complement 
coated M. bovis BCG as compared to untreated M. bovis BCG. In vivo, macrophages 
phagocytose mycobacteria after entry in to the host but ultimately fail to destroy them 
and provide hostile environment for multiplication. Conglutinin inhibition of 
phagocytosis of these bacteria in to macrophages and dampening of pro-inflammatory 
response may be protective by keeping them extracellular where these can be easily 
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 1.1  Bovine tuberculosis 
Bovine tuberculosis (BTB) is a contagious disease that occurs in livestock due to 
Mycobacterium bovis, which belongs to the Mycobacterium tuberculosis complex 
(MTC) and has economic impacts worldwide (Michel et al., 2010; Muller et al., 
2013). Although a major host of M. bovis are cattle, the bacterium is not just restricted 
to bovidae species and can cause a disease in a wide variety of mammals including 
wild and domesticated animals such as cats, dogs, horses, sheep, goats, pigs etc, as 
well as humans due to its zoonotic potential (Barron et al., 2015).  
M. bovis infections occur in many countries across the globe. It is more commonly 
found in developing countries across the world specifically in Africa where a large 
number of cattle and wild mammal species (Fitzgerald and Kaneene, 2013). Due to 
the implementation of preventive and eradication programmes, the rate of BTB has 
greatly reduced in many developed countries including the United Kingdom, however 
a key problem identified in these countries is the presence of M. bovis in wild 
animals. The low-level prevalence of M. bovis in wild animals and its potential to 
spread to different mammalian species including domesticated and farm animals are 
some of the major challenges that are preventing the complete eradication of bovine 
tuberculosis (Schiller et al., 2010). 
An M. bovis infection in livestock primarily occurs due to the transmission of bacteria 
through the respiratory route, via inhalation of aerosol droplets containing the 
pathogen from an already infected host (Phillips et al., 2003). 
1.2  Epidemiology of bovine tuberculosis 
Although bovine tuberculosis is a disease with a substantial history, the epidemiology 
of this disease is still poorly understood. The occurrence of BTB incidences can vary 
between differing parts of the same country. Also, the difference in livestock 
management procedures in various parts of the world is another factor that may 
impact on the occurrence of BTB worldwide (Ayele et al., 2004). Across many 
developed countries, BTB has largely been eradicated from cattle populations due to 
effective control and containment programs. However, the continuous presence of 
BTB in different wild mammals (such as badgers, white-tailed possums, deer etc) is a 
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matter of great concern as these wild organisms can act as reservoir hosts and a 
persistent source of infection for cattle, thus making the complete eradication of the 
disease extremely difficult (Byrne et al., 2014; Kean et al., 1999).   
In most of the developing countries, BTB is still having a detrimental impact on the 
livestock sector with significant impacts on both cattle farming and public health due 
to the lack of implementation of proper control and eradication programs. During the 
last few decades the geographical distribution of BTB worldwide has changed 
significantly. Austria and North America have completely eradicated the disease or 
very close to achieving the free of the BTB. Still, a few developed countries such as 
New Zealand, parts of United States of America, Ireland and United Kingdom are 
facing challenges to control the M. bovis infection spread by wild life animals (Thoen 
et al., 2008). 
In developing countries BTB is still highly prevalent in herd populations, domestic 
animals and wildlife. The true epidemiological state of the disease is still not known 
since the majority of the cases of BTB remain unreported. Despite all of the above 
there is still enough evidence to indicate that BTB is on the rise in these countries 
particularly in Africa, Asia and Latin America (Cleaveland et al., 2007; Etter et al., 
2006). 
Worldwide Animal Health Information Database (WAHID) confirmed the M. bovis 
infection occurance in 45 countries in 2016. The map below shows the worldwide 
distribution of BTB from data present at WAHID. 
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Figure 1. 1: Worldwide incidence of M. bovis BCG infection.  
The data is for all the incidences of M. bovis infections recorded in the Worldwide Animal Health 
Information Database (WAHID) by World Organization for Animal Health (OIE) from January 2016 
to December 2016.	
1.3  Incidence of bovine tuberculosis (BTB) in the United Kingdom 
Bovine tuberculosis is one of the major disease effecting herd populations in the 
United Kingdom. Data shows that in 1979 only 0.01 percent of the total cattle 
population was positive when tested for BTB. However, the disease has spread 
significantly to all parts of the United Kingdom over the last three decades. According 
to the draft for the eradication strategy for England published in April 2014, it was 
proposed that the country aims to eradicate BTB completely from its cattle population 
by 2038. One of the main strategies is to divide the country in to three risk areas on 
the basis of  BTB prevalence; High Risk Area (HRA) with high levels of BTB 
infection present in cattle and also a significant reservoir of BTB in wild life 
(badgers); Low Risk Area (LRA) with low level of BTB infection and no significant 
reservoir of BTB in wild life ; Edge Area characteristics are variable levels of BTB 
infection, higher than LRA but lower than HRA and also the role of wild life in 
spreading diseases is uncertain (DEFRA, 2016). As a part of the surveillance and 
control program, almost 6.2 million BTB tests were performed in England in 2014 
and more than 26,000 cattle were slaughtered to control the spread across the herd 
population (DEFRA, 2016).  
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Data on BTB incidences in the United Kingdom released by DEFRA in September 
2017 shows that in 2016 there were 3753 new herds with BTB incidents in England 
which was relatively similar in 2015 cases. Since 2011, the total number of infected 
herds has stabilized in between 37,00 and 39,00 (DEFRA, 2017). In 2016 the total 
number of infected herds was slightly lower then 2015, HRA and LRA reported 3229 
and 137 respectively infected herds slightly less compared to 2015, in 2015 there 
were 3401 (HRA) and 156 (LRA). However, in edge areas which is the buffer zone in 
between HRA and LRA contains lower BTB than in the HRA but higher BTB as 
compared to LRA, the number of BTB incidents were reported in 387 herds in 2016, 
more than 2015, which had reported 339 infected herds (DEFRA, 2017). 
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Figure.1.2: Comparision of new incidences of M. bovis infection from 2016-17. The data shows all 
the new incidences of M. bovis in cattles in the UK, recorded by WAHID on behalf of the World 
Organization for Animal Health (OIE) from January-June 2016 and January -June 2017. 
The current surveillance and control system for BTB in United Kingdom uses the 
routine tuberculin skin test IFN-γ release assay to detect M. bovis infections in 
animals and culling of the infected populations accompanied by post-mortem 
surveillance. This strategy works well for the cattle herds and domesticated animals. 
Parts of the United Kingdom have been successful in reducing the level of BTB and 
preventing the establishment of the disease in their herd. Badgers have been identified 
as one of the most important wildlife reservoir hosts for BTB in the United Kingdom 
for transmission of BTB to cattle (Abernethy et al., 2013). A reservoir is usually an 
animal or a plant, inside of which a pathogen survives, often (though not always) 
without causing disease for the reservoir itself. Mycobacterium bovis can also infect 
and cause disease in badgers. 
1.4  The role of badgers in the epidemiology of bovine tuberculosis 
Although cattle are the most common hosts for M. bovis, other domestic and wild 
animals may act as a reservoir of infection (Corner, 2006). This causes difficulty in 
the eradication of BTB from cattle due to the continuous exposure/contact from these 
animals. There are several badgers species in different countries that act as reservoirs 
of M. bovis infection, those include European badgers (Meles meles) in the UK and 
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Zealand have the brush tail possum (Trichosurus vulperula), in north America the 
white tailed deer (Odocoileus virginianus), in South Africa buffalo (Syncerus caffer), 
and the lechwe antelope (Kobus leche) in Zambia (More and Good, 2006; Delahay et 
al., 2007; Fitzgerald and Kaneene, 2013).  
In 1971, the first badger reported with M. bovis infection was in the southwest region 
of England (Murhead and Burns, 1974), however these findings were controversial at 
that time. Most recently M. bovis infection has also been reported in badgers in Spain 
(Balseiro et al., 2013) and France (Payne et al., 2013). It has been reported that BTB 
is endemic in the badges across some parts of United Kingdom where they are 
actively contributing to the spread of infection in cattle (Eves, 1999; Donnelly et al., 
2006). This is now established in the United Kingdom that badgers can be infected by 
M. bovis According to the research study, badgers infected with M. bovis have been 
reported 1.6% to 37.2% in low prevalence of bovine BTB areas to high prevalence of 
bovine TB areas (Ni Bhuachalla et al., 2014). 
M. bovis infection can be transmitted to the cattle by infected badgers either by 
infectious aerosol routes or by swallowing of contaminated feed with badger feaces 
(Gallagher et al., 1976). The risk factors to transmit the disease from infected badgers 
to cattle includes the infection presence across the badger community, the phase of 
disease, the method of exposure in cattle and level of excretion from infected badgers 
(Gallagher and Clifton, 2000). 
In 1950, the eradication scheme for BTB from UK was introduced to make the 
country free of BTB (DEFRA, 2014). To achieve the goals of the eradication scheme, 
the regular testing of the cattle was implemented, and this resulted in reduced 
incidences of cattle to cattle transmission. Despite that, the complete eradication goals 
have not been attained and for that mainly the lack of available diagnostics tests were 
blamed. When badgers were established as the host of M. bovis, different options 
have been reviewed to control the BTB in badger populations (Cheeseman et al., 
1981). The main objective of this strategy was to minimize the transmission of M. 
bovis infection from badgers to cattle by implementing different strategies. The 
strategies comprised of culling of badgers, to keep two species (badgers and cattle) 
separate by improved biosecurity measures and vaccination. The badgers are listed as 
a legally protected species in the United Kingdom (Protection of Badgers Act, 1992). 
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However, there are exemptions in the law for culling of badgers in order to control the 
BTB infection in cattle (Roy and Milton, 2004). The main purpose of culling of the 
badger is to reduce the population of badgers so as to minimize the possibility of 
transference of M. bovis to the cattle. Culling can be selective or non-selective. In 
selective culling, infected populations or individuals can been culled and in non-
selective culling involves the infected badger population on the speculation basis with 
the thought to decrease in badger numbers will reduce the chances of infection to the 
cattle’s (Smith et al., 2016).  
The badger contribution in the transference of BTB in United Kingdom has been 
estimated from different research studies of culling and badger eradications 
operations performed over the previous 30 years. A non-specific badger culling trial 
was performed in between 1998 and 2005, which had a significant negative effect on 
the UK government stance on badger culling (Bourne et al., 2006). In 2011, farmers 
have been given permission to reduce the badger’s populations in highly affected 
areas in aiming to stop the disease transmission to cattle. Licenses were issued to 
farmer by Natural England under the Protection of Badgers Act 1992 for badger 
cullings (DEFRA, 2014). 
1.5  Characterestics of M. bovis  
 M. bovis causes tuberculosis in wild and domestic animals. M. bovis belongs to genus 
Mycobacterium and family Mycobacteriacae. Mycobacteria are non-motile, obligate 
aerobic and Gram-positive bacilli (Mostowy et al., 2005). M. bovis is part of the 
Mycobacterium tuberculosis complex (MTC) which includes; Mycobacterium 
tuberculosis, Mycobacterium bovis, Mycobacterium africanum, Mycobacterium 
lepra, Mycobacterium marinium, Mycobacterium ulcerans, Mycobacterium avium, 
Mycobacterium microti, Mycobacterium canetti and Mycobacterium smegmatis 
(Smith et al., 2006).   
M. bovis is a slow-growing (16-20 hours generation time), aerobic intracellular 
pathogen which commonly resides inside the phagocytic cells. M. bovis is a straight 
or slightly curved rod, Gram-positive acid-fast bacterium with dimensions of 1-4 µm 
in length and 0.3-0.6 µm wide (Barry et al., 1998). The genome of M. bovis is 
4,345,492 base pair long and is organized in a single circular chromosome. The 
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genome comprises of approximately of 3952 proteins encoded genes. The M. bovis 
genome has 99.52% similarity to Mycobacterium tuberculosis (Garnier et al., 2003). 
1.6  Transmission of M. bovis 
M. bovis infections can occur in a variety of animals resulting in BTB and the infected 
hosts can be categorized as reservoir hosts The reservoir hosts act as a stable host and 
can be a persistent presence of the tuberculosis within local populations. The reservoir 
hosts do not maintain a persistent M. bovis infection and need other species for 
persistent presence of disease with in a population and may transmit the infection 
between their members for a certain period of time. Wild mammals are believed to be 
the reservoir host for M. bovis in many countries of the world and are believed to be 
responsible for the continued presence of bovine tuberculosis in domestic animal and 
cattle herds (Baron et al., 2015; Humblet et al., 2009). 
There are several ways through which M. bovis can spread and cause BTB in cattle 
and other organisms. The primary route of infection of M. bovis infection is via the 
respiratory route, however, the bacteria can also cause infection via other routes 
including oral, congenital, breaks in the skin or wounds and occupational acquisition 
of the disease. The consumption of milk from an infected cow by calves is also a 
source of transmission of BTB (Skuce et al., 2012). 
The transmission of M. bovis among cattle rely on several aspects such as dose of 
infectious inoculum, route of infection, duration of contact and the immune status of 
the host. The transmission of bacteria by respiratory route between cattle may also 
require the production of very fine aerosol droplets for bacterial shedding which are 
only produced under certain conditions when the active disease is established in the 
primary host. As the disease becomes more established in the primary host the 
chances of transmission to other cattle enhances due to the large amount of pathogen 
shed (Skuce et al., 2011). 
1.7  Pathogenesis of bovine tuberculosis 
BTB presents mainly as lesions in the upper respiratory lymph nodes of the lung and 
thorax. Alveolar macrophages are the first to interact with the bacteria when infection 
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occurs through its main route via, the respiratory tract (Cassidy, 2006). Although the 
aetiology and immune response to M. bovis is similar to M. tuberculosis in humans, 
the pathology of the disease needs to be further investigated, in particular the 
molecular basis of the interaction Mycobacterium-macrophage, which could lead to 
selective and effective therapeutic development (Pollock and Neill, 2002). 
In BTB establishment of lesions depends on the route of transmission of the pathogen. 
The most common route of bacterial entry into the host is by inhalation that causes 
lesions of the upper respiratory tract mucosa, nasopharynx, retropharyngeal lymph 
nodes, lower respiratory tract and lungs (Neill et al., 2001) and ingestion of bacteria 
causes lesions of the mesenteric lymph nodes and gastrointestinal wall. Trans-
placental and genital transmission of mycobacterial infections is very rare due to the 
active eradication programs of bovine TB in most of countries (Menzies and Neill, 
2000).  
After entry into the host, macrophages, neutrophils and dendritic cells are recruited at 
the site of infection (Domingo et al, 2014). Macrophages may be able to destroy the 
mycobacteria if bacilli are lower in numbers. However, mycobacteria can evade 
immune responses and survive and replicate intracellularly (Dannenberg, 2001). The 
macrophages engulf the mycobacteria and migrate to regional lymph nodes, where the 
protective Th1 response is induced ending in the formation of granulomas (Pollock 
and Neill, 2002).  
In some animals, strong cell mediated immunity prevents the formation and 
extensions of the lesions to other organs, but the presence of the immune response in 
alveolar spaces and pulmonary airways is usually unable to control the spread of 
infection.  As a result, small lesions developed into the larger ones over time, causing 
chronic tuberculosis in the lungs. Chronic lesions in the lungs are identified as 
caseous necrosis and finally lesion formation occurring inside the affected lobe. 
Similarly, lymph nodes are chronically affected and become enlarged in size covered 
by granulomatous caseous material surrounded by fibrous tissues (Domingo et al., 
2014). 
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1.7.1  Granuloma structure and function 
Granuloma formation in the lungs is the result of mycobacterial infection. This is the 
main pathology of tuberculosis in humans and animals. Granulomas consists of 
different immune cells such as tissue lymphocytes, macrophages, natural killer cells 
and neutrophils, these cells contribute in the formation and function of the granuloma. 
In human tuberculosis alveolar macrophages induce the pro-inflammatory response 
after engulfing mycobacteria and this initiates a T-cell response by attracting CD4+ T-
cells, which lead to the recruitment of fibroblasts, CD8+ T-cells and B-cells attracting 
mononuclear cells from neighboring blood vessels. Different types of cytokines and 
chemokines such as TNF- α and INF-γ are released by infected macrophages that play 
a significant role in the formation of granuloma, where as IL-10 is a negative 
regulator of granuloma formation (Hogan et al., 2001). These immune cells form 
building blocks for the granuloma (or tubercle), which is a circumscribed yellowish 
granulomatous inflammatory nodule approximately 2–20 mm in diameter. The 
granuloma has a necrotic, caseous center surrounded by neutrophils, macrophages and 
langhans-type multinucleated giant cells (Neill et al., 2001). 
  




Figure. 1.3: The life cycle of Mycobacterium and granuloma formation. Infection starts after 
inhalation of droplets that contain bacilli and are phagocytized by macrophages. Pro-inflammatory 
responses promote recruitment of other immune cells; more macrophages, dendritic cells and 
lymphocytes towards the infected site and form the granuloma. The macrophages in the granuloma 
developed to form epithelial cells, multinucleate giant cells and cells filled with lipid droplets. The 
granuloma can be matured by the formation of the extracellular matrix material outside the 
macrophages layer (Russel et al., 2010).  
Granuloma formation helps in preventing the spread of mycobacteria to other organs 
of the host, and also granuloma represents a delicate host-pathogen stand-off that will 
not harm the host and does not kill the mycobacteria called latent tuberculosis 
infection (LTBI) (Sundaramurthy and Pieters, 2007).  
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1.8  Zoonotic impact of bovine Tuberculosis  
Bovine tuberculosis can infect humans through the inhalation of air droplets with 
bacteria after an infected animal or person coughs or sneezes, by consuming raw dairy 
products such as unpasteurised milk or uncooked meat from infected animals. Cattle 
owners, TB testers and dairy product handlers are those who have direct contact with 
infected animals, are at a higher risk of bovine TB (Cosivi et al., 1998). Zoonotic 
tuberculosis is a public health concern in developing countries. High similarities 
between Mycobacterium tuberculosis and Mycobacterium bovis infections can make 
it difficult to estimate how much of the population is infected with anything other 
than Mycobacterium tuberculosis (De la Rua-Domenech, 2006).  
Improved hygiene levels in the dairy industry and pasteurisation of milk in developed 
countries has drastically dropped down the cases of human infection by M. bovis. 
However, migration from developing countries with a less developed meat and dairy 
industry increases the level of BTB (Cotter et al., 1996). It is known that in 1980 and 
1991 the level of tuberculosis infection increased in San Diego, because of the 
migration of farmers from South America and Mexico having a higher rate of cattle 
infected by M. bovis (Dankner et al., 1993). 
M. bovis reportedly caused a significant number of tuberculosis cases in children and 
farmers in rural areas (Schmiedel, 1968). 5 to 20% of human TB was reported in 
developed countries before 1960s (Hardie and Watson, 1992). In countries where 
BTB is common, and milk is rarely pasteurized. This risk of acquiring BTB in 
humans is low in the UK (Torgerson and Torgerson, 2010).  
1.9  Symptoms of bovine tuberculosis 
The symptoms of BTB usually takes months to develop in cattle. Once the bacteria 
start actively dividing, the disease may develop rapidly and is accompanied by 
different symptoms that are commonly found across all species of host animals 
although there can be certain species variations. Some of the symptoms associated 
with BTB in animals include progressive weakness, anorexia, lack of appetite and 
fluctuating fever. Infection of the pulmonary system by the bacteria causes a moist 
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cough in the animals that is worse during in the morning or during cold weather 
conditions, causing difficulty in breathing (Menzies and Neill, 2000). 
 In some animals the lymph nodes in the retropharyngeal area may become enlarged 
during BTB. The enlarged lymph nodes can rupture and can also block blood vessels 
or airways. If the bacterial infection is obtained through oral route, diarrhea or 
constipation may be observed in the infected animal. Skin infections in certain 
domesticated animals like cats have also been observed in the form of soft swelling or 
flat ulcers mostly visible on the head, neck or shoulders. Some animals such as brush 
tailed possums, become disoriented during the final stages of the disease and appear 
to be extremely weak (Menzies and Neill, 2000). 
1.10  Diagnosis of bovine tuberculosis 
Diagnosis of BTB in cattle and other animals can be done either by direct detection of 
the bacterial presence inside the host or through indirect methods. The direct detection 
mainly involves a post-mortem examination of animals. This includes the use of 
microscopy to confirm the infection in animals previously testing positive for BTB by 
a pre-mortem test. Since most of the cattle and other infected hosts do not necessarily 
show the symptoms of the disease for a considerable period of time, the direct test is 
not very effective in controlling BTB.  
Indirect tests make use of the different indicators of M. bovis infection in live animals 
and are widely used for the diagnosis of BTB. Indirect diagnostic tests make use of 
immunological markers produced in response to M. bovis infection. These tests 
consist mainly of two types. First type of test includes intradermal tuberculin skin and 
INF-γ release assay (IGRA) test, which are established because of cell-mediated 
immunity to M. bovis. The second type of diagnostic test detects the antibodies 
responses in susceptible hosts (Wood et al., 1992).  
1.10.1  Tuberculin skin test (TST) 
Intradermal tuberculin test is the most common type of diagnostic test currently used 
and involves the injection of a small amount of PPD (purified protein derivatives of 
M. bovis) under the skin of the caudal fold (CFT) or neck (CIT) of an animal. The 
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skin on the neck is more sensitive to a tuberculin-related hypersensitivity reaction as 
compared to skin of caudal fold. The immune system reacts to the tuberculin resulting 
in a localized allergic reaction which is measured after 48 to 72 hours to predict the 
presence of M. bovis (Schiller et al., 2010).  
1.10.2  Interferon gamma (INF-γ) release assay (IGRA) test 
Interferon-γ (Interferon gamma) release is applied as an additional confirmatory test 
of cattle to the TST or alongside TST to increase diagnostic sensitivity. M. bovis 
antigens ESAT-6 and CFP-10 induces the secretion of INF-γ in host. M. bovis BCG 
vaccine strain does not contain these proteins, so the assay is more precise than the 
TST (Ramos et al., 2015).  
1.10.3  Post mortem diagnosis of Mycobacterium bovis infection 
Post-mortem diagnosis of BTB is another important cost-effective diagnostic 
technique, which observes lesions after slaughter of the animal. The identification of 
infection in post-mortem diagnosis, initiates the investigation of the disease in herds 
and the origin of infection (Whipple et al., 1996; Olea-Popelka et al., 2008).  
1.10.4  Histopathologic examination  
Diagnosis of BTB can be done by histopathology or microscopic confirmation of 
mycobacteria. Tissues or smears from the clinical samples can be directly stained with 
Ziehl/ Neelsen stain to diagnose the infection. Although pathological changes can be a 
good indication of M. bovis infection they are not always definitive. Different 
confirmatory tests including bacteriology and molecular methods such as PCR 
accompanied by histopathology can be used to establish the presence of an actual 
infection (Ramos et al., 2015).  
1.11  Treatment and prevention of BTB 
It is extremely difficult to treat tuberculosis infection in animals, so they are culled 
rather than treating them. In the United States and many other countries, it is not 
permitted to treat TB in animals (Thoen et al., 2008). If the infected animal is treated 
it can take as long as 9 months due to the resistant nature of M. bovis and a 
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combination of different antibiotics at different levels may be required. One of the 
main reasons for the lack of any treatment regimens is the expensive nature of M. 
bovis treatment which makes it economically unfeasible to treat the disease (DEFRA, 
2016). 
There is currently no effective vaccine available to prevent against BTB. The lack of 
effective vaccine makes the use of preventative measures extremely important for the 
prevention and transmission of disease (Waters et al., 2012). It is very difficult to 
distinguish between vaccinated cattle and infected cattle by performing tuberculin 
skin tests. United States and other countries with eradication programs have stopped 
the use of vaccines (Skinner et al., 2003). 
Pre-movement and post-movement testing for M. bovis, in herd populations is 
essential to decrease the transmission of M. bovis between herds and from one area to 
another. The herd animals should be screened on regular basis for the presence of M. 
bovis using the above diagnostic tests. Cattle who test positive for M. bovis are culled 
to prevent any further transmission. 
Furthermore, to minimize the risk of cattle-to-cattle spread of M. bovis, lower 
densities of cattle tend to be kept in herds. Double fencing is also necessary to stop 
the nose-to-nose spread of BTB to neighbouring farms. Double fencing also prevents 
the contact of herd animals with wildlife. Pasteurization of milk is also important to 
prevent the possible infection to humans, since M. bovis cannot survive at high 
temperatures (Tebug et al., 2014). 
Other control measures include basic herd hygiene, restricting movement of an 
infected animal and the maintenance of food and water hygiene has been found to 
reduce the risks of disease transmission (Phillips et al., 2003). In domestic herds, 
culling is a successful tool of controlling the infection in livestock operations. The 
effects of depopulation can be damaging both financially and emotionally to farmers. 
Countries using other strategies alternatively to the depopulation of herds, like in the 
United States, the U.S. Department of Agriculture asks regulatory authorities to 
perform herd-specific tests and slaughter programs for individual livestock operations 
(USDA, January 2005). In Europe and New Zealand, the regular testing and removal 
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of animals that have tested positive for BTB from the herd, results in no movement of 
animals other than to slaughter, until the herd has tested negative (Cousins, 2001). 
1.12  Biomarkers for Bovine tuberculosis 
The practice of “test and slaughter” programmes in most of developed countries 
seems to control bovine tuberculosis. In developing countries with a high number of 
BTB cases, it is not feasible to apply the “test and slaughter” policy due to economic 
limitations. In such circumstances, there is more need to improve the vaccination and 
diagnostic strategies to control the disease. Blood or serum based diagnostic 
techniques can be used to diagnose the infection at various stages in the host to 
prevent the spread of disease by isolating the infected animals from herds. 
Currently, the tuberculin skin test and IFN-γ tests are used as a diagnostic tool in BTB 
(Ramos et al., 2015; Gormley et al., 2006). IGRA in blood after specific antigen 
activation has been a helpful method for the diagnosis of infections in cattle 
(Vordermeier et al., 2011; Lim et al., 2012). 
BTB infection commonly occurs in macrophages, where the pathogen can survive, 
grow and spread to other sites of the body (Thacker et al., 2007). Cell-mediated 
immunity (CMI) plays a vital role in the host’s immune response. It has been shown 
that IFN-γ plays a vital role in CMI. Studies have shown that mice deficient in IFN-γ 
production failed to prevent the BTB infection in the mouse (Cooper et al., 1993; 
Flynn et al., 1993). 
Proteomics offer a new way of early detection of M. bovis infection by discovering 
novel biomarkers. Isobaric tag for relative and absolute quantification (iTRAQ) is a 
type of proteomics technique, a liquid chromatography and tandem mass spectrometry 
technique that permits diagnosis and quantification of peptides between multiple 
sample groups (Seth et al., 2009). It has been studied that vitamin DBP is up 
regulated during early bovine TB infection. There are six other proteins found in 
infected cattle are fetuin, serine proteinase inhibitor (alpha-1-antitrypsin, AAT), 
complement C3, alpha-1 acid glycoprotein and alpha-1 beta glycoprotein (Seth et al., 
2009).	
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To prevent the bovine TB in the United Kingdom involve statutory screening of the 
cattle herds using the single intradermal comparative tuberculin test (SICTT) and 
further culling and movement restrictions applied if test-positive cattle are detected. 
In addition, abattoir surveillance is carried out by specialist meat inspectors on all 
SICCT test reactor cattle looking for evidence of suspect tuberculous lesions in 
defined organs and body sites. Inspection should be carried out on all cattles those 
been slaughterd for human food chain (Bermingham et al., 2014).  
Although there are preventive measures in place to avoid the spreading of bovine TB, 
it is likely that control and eradication will require additional control strategies. A 
potentially powerful approach would be to study the genetic variation in host 
resistance to bovine TB. Previous studies suggested between-host genetic variation in 
resistance to TB exists in many species, including humans, mice, deer and cattle 
(Allen et al., 2010). Quantitative genetic studies in herds in United Kingdom and 
Republic of Ireland observed significant heritability for host resistance existance in 
dairy cattle herds (Bermingham et al., 2009, 2010; Brotherstone et al., 2010). 
Recently, several studies have begun to address the identification of genetic loci 
associated with bovine TB resistance. Polymorphisms in candidate genes, SLC11A1 
in African Zebu cattle (Kadarmideen et al., 2011) and (TLR1) in Chinese Holsteins 
(Sun et al., 2012) have been significantly associated with bovine TB infection. Two 
genomic regions identified by the microsatellite markers INRA111 and BMS2753 
were also linked with SICTT reactor status in United Kingdom cattle (Driscoll et al., 
2011). Finally, a recent genome-wide association study (GWAS) in Holsteins in 
Republic of Ireland identified a genomic region on Bos taurus chromosome 22 
containing the taurine transporter gene SLC6A6, which was suggestively associated 
with bTB resistance, although it only explained a small proportion of the total 
variance due to genetic factors  (Finlay et al., 2012). 
Thus, host genetic control of resistance to bTB in cattle is likely to be complex and 
involve many loci of varying effect. Furthermore, each study to date has had 
limitations in terms of the number of animals studied and the genomic tools deployed. 
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1.13 Innate immunity  
Host immunity is made up of the innate and adaptive immune response. The adaptive 
immune response is divided into humoral immunity and cellular immunity. Humoral 
immune response plays an important role in eliminating pathogens present in the body 
by producing specific antibodies by B-cells against pathogens (Akira, 2011). Cellular 
immunity takes part in the eradication of microbes and cancerous cells by the help of 
killer T cells and B cells. These cells have distinctive T-cell receptors (TCRs) and B-
cell receptors (BCRs), and identified a wide range of different antigens (Akira, 2011). 
 
.  
Figure. 1.4: Innate and adaptive immunity interaction: After entering of microbes in the host, 
innate immune system is initiated and plays a vital role as a first line of defence in the body against the 
pathogen. Dendritic cells act as antigen-presenting cells to T cells in lymph nodes from infected 
tissues. Adaptive immune system is activated after the innate immune response, antibody production 
and killer T cells activated to attack the pathogens directly (Akira, 2011). 
The innate immune response is the first line of defence against pathogens. Innate 
immunity is mediated by phagocytes those are leukocytes, dendritic cells, and 
macrophages engulf and kill the pathogens and take part in the presentation of 
antigenic peptides to T cells (Akira, 2011). 
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1.14 Immune response against M. bovis  
The activation of innate immune responses against pathogens is very critical at early 
stages of pathogen entry into the host, which is recognition of the microbes by 
macrophages (Pollock and Neill, 2002). Macrophages provide hostile environment to 
mycobacteria, but also contributes in the prevention and eradication of pathogens 
(Aldwell et al., 1996).  
Other immune cells may be involved in the response of initial tuberculosis infection. 
Natural killer (NK) cells play a major role in human tuberculosis. NK cells can 
produce IFN-γ and destroy mycobacteria-infected target cells (Yoneda & Ellner, 
1998). These cells are defined as large granular cytotoxic type of lymphocytes. Their 
unique role is to identify and destroy the harmful cells which do not have MHC I 
markers, as these harmful cells cannot be detected by any other immune cells. So they 
were named as NK cells due to the ability that NK cells do not require activation to 
kill cells those donot have MHC I markers. It has been studied that NK cells increase 
the synthesis of important cytokines such as IFN-γ, IL-12, IL-15 and IL-18 by 
macrophages in vitro (Kanakaraj et al., 1999). It has been shown that NK cells are 
activated in the early stages of tuberculosis. Higher number of NK cells found in the 
lungs of tuberculosis infected mice after 21 days of infection (Junqueria-Kipnis et al., 
2003).  
Neutrophils are known as the first leucocytes to respond in the host’s defence against 
invading pathogens, killing the pathogens by phagocytosis and intracellular killing via 
oxidative /non-oxidative. It has been reported that neutrophils are among the earliest 
immune cells helping in the formation of granuloma in BTB (Cassidy et al., 1998). A 
similar role in human tuberculosis has also been identified (Guirado and Schlesinger, 
2013). IL-17, IL-23 released by Th-17 cells and IL-18 by macrophages are important 
cytokines that attracts neutrophils in the tuberculosis infection and contribute to 
granuloma formation (Guglani and Khader, 2010).  
Despite mechanisms of the innate immune system, mycobacteria successfully infect 
and persist in the macrophage. In human tuberculosis, macrophages recognise the 
mycobacterium through the interaction of pathogen-associated molecular patterns 
(PAMPS) with cell surface pattern recognition receptor proteins (PRRs), such as the 
																																																																																																																																																					Chapter 1  
	 21 
Toll-like receptors (TLRs). These PAMPs include bacterial lipopolysaccharides, 
peptidoglycan, lipoprotein, nucleic acid and mycobacterial lipoarabinomannan and 
mannose-capped lipoarabinomannan.  
In the macrophages, mycobacteria produced either secreted antigens or break down 
components that are presented to T-cells. T- cells acts as antigen presenting cells to 
initiate the immune response. In adaptive immunity, after the antigen is processed and 
recognised by the antigen presenting cells (APCs), the adaptive immune system 
creates immune cells are designed to attack the antigen and effectively eliminate the 
pathogen from the host. It has been reported that cattle infected with M. bovis, have 
shown immune responses involved within this infection (Ritacco et al., 1991). This 
immune response in cattles against M. bovis is identical to the immune response 
identified for human tuberculosis (Lenzini et al., 1977).  
Adaptive immunity starts in the lymphoid organs. In the bloodstream, T-cells and B-
cells uniformly circulate to hunt for particular antigens. In tuberculosis infection, 
activation of the adaptive immune response is slow in comparison to other pathogens, 
this slower immune response helps bacterial multiplication inside the lungs. In mice 
the adaptive immune response activated after 10-12 days of tuberculosis infection 
(Wolf et al., 2008). In the early stages  of the tuberculosis infection, the mycobacteria 
hide inside the phagosome and stops dedritic cells and macrophages to present the 
antigen to T-cells. The prevention of presentation of antigen to T-cells provides 
enough time to bacilli for more multiplication in the lungs. This increase in bacterial 
population reduces the effects of an adaptive immune response (Wolf et al., 2008). In 
the result of tuberculosis infection, Th1 cells produced high level of CD4+, CD8+ and 
γ/δ T-cells. In the infected cattle, the changes in the circulating T-cells demonstrate 
the progression of infection with the time. It has been seen that γ/δ T-cells had 
involvement in the initial immune response followed by CD4 and then CD8 T-cells 
(Pollock et al., 1996).  
1.15  Role of complement system in bovine tuberculosis 
Complement system is comprised of 40 proteins, which are a major component of the 
innate immune system. Complement is activated by classical, alternative and lectin 
pathways (Gadjeva et al., 2001). The classical pathway is initiated when antibody 
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recognise antigens on the surface of pathogens and these antibody and antigen 
complexes binds to the C1q proteins, whilst mannose-binding lectin (MBL) or 
ficolins bound to the complement activator leads to the activation of lectin pathway 
(Matsushita et al., 2000; Matsushita and Fujita, 1992). A wide range of targets 
triggers the alternative pathway, it does not require specific initiator component such 
as C1q or MBL. Alternative pathway is usually triggered when C3b protein binds to 
the pathogen (Matsushita et al., 2000). 
Mycobacterium resides inside the macrophages and has ability to survive and 
multiply in the host immune cell. In BTB, M. bovis influence complement activation 
through its cell surface or secreted proteins (Carroll, 2009). M. bovis and M. 
tuberculosis have similar structure and M. tuberculosis invades and multiplies as an 
intracellular pathogen in the host immune cells therefore evading complement 
(Carroll et al., 2009).  
C3 convertase is the main product of any complement pathway, allowing the cleavage 
of C3 into C3a and C3b. C3b is deposited on microbial surfaces. Deposition of C3b 
can act as an opsonin on the surface of microbes and as well as other immune 
regulatory functions. The C3 convertase cleave the C3 protein into C3b and C3a 
components. C3a is an anaphylatoxin that activated the local inflammation where as 
C3b covalently bound non-selectively to surfaces of the pathogens. C3b acts as 
opsonin and enhance the clearance of the pathogens by immune cells and assists in 
cell lysis (Lachmann and Hughes, 1984; Pangburn and Muller, 1984). C3b also 
interacts with factor B and form C3bB complex. The reaction conducted by C4b2a in 
the classical and lectin pathways, is intensified by the alternative pathway, which 
generates more C3b and initiate the terminal sequence, common to all pathways. C3a 
and C5a-fluid phase anaphylatoxins, and iC3b and C3dg-cell-bound opsonins, 
facilitate phagocytosis (Pangburn and Muller, 1984). 
  




Figure 1.5: Schematic of complement pathways. In the early response of the immune system, 
classical, lectin or alternative pathways identify pathogens and activate complement reaction to destroy 
pathogens. After the activation of any complement pathways, this results in the synthesis of C3 
convertase that initiates cleavage of C3 into C3a and C3b, producing C5 convertase. C5 convertase 
further initiates cleavage of C5 into C5a and C5b. C3a and C5a recruits immune cells such as 
basophils, eosinophil, dendritic cells and macrophages to the infectious site. Formation of the 
membrane attack complex C5b-9 is responsible for lysis of bacterial cells (Lachmann and Hughes, 
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1.16  Collectins and their roles in innate immunity 
Collectins are soluble innate immune molecules, also called C-type lectins that play a 
vital role during the early stage of infection as well as other immune functions. 
Collectins prevent infection by various mechanisms, including opsonisation, growth 
inhibition, neutralization (Sano and Kuroki, 2005; Kishore et al., 2006; Haagsman et 
al., 2008). Well known members of the collectin family are surfactant protein A  (SP-
A) and D (SP-D), bovine conglutinin (Bc), mannan-binding lectin (MBL), collectin 
placenta 1 (CL-P1), collectin liver 1 (CL-L1), collectin of 43 kDa (CL-43) and 
collectin of 46 kDa (CL-46), all of which have a common structure. Their monomeric 
subunits are composed of N-terminal attached via α-helical neck regions to C-
terminal, also known as carbon recognition domains (CRD) (Wang et al., 1995; 
Hansen and Holmskov, 2002). These monomers are stabilised by covalent disulphide 
bridges as well as non-covalent interaction that form a trimer confirmation by binding 
cysteine residues in N-terminals or in collagen domains (van et al., 2004). 
Conglutinin has close structural similarities to SP-D, being able to form multivalent 
cruciform structures (tetramers of trimers) containing in total 12 CRD regions that can 
bind to microbial surfaces in the presence of Ca2+ (Hansen et al., 2002). Conglutinin 
is secreted largely by the liver and is found in bovine serum at a concentration of 12 
µg/ml (Holmskov et al., 1998). In contrast, SP-D is primarily found in the lungs at a 
concentration of 0.1–0.9 µg/ml and is secreted by alveolar type II cells and Clara cells 
(Kishore et al., 2006). Conglutinin is thought to have evolved in the Bovidae from a 
gene duplication event of an ancestral SP-D gene and is located on chromosome 28 in 
B. taurus (analogous to chromosome 10 in Homo sapiens), proximal to the bovine SP-
D gene (Gallagher et al., 1993). 
Collectins identify carbohydrates present on microbial surfaces and bind via the CRD 
in a calcium-ion-dependent manner (Dec et al., 2012). These interactions can induce 
agglutination or microbial neutralisation to prevent microbial spread. The interaction 
of collectin via CRD to the pathogenic microorganism, attract immune cells and this 
opsonisation may help in the phagocytosis of pathogenic microorganisms (Holmskov, 
2000). 
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Figure. 1.6. Structure of the collectins. Collectins are composed of CRD region attached with α-
helical neck, a collagen-like domain and an N-terminal cysteins rich domain. Three neck regions 
combines to form a triple coiled shape and collagen regions assembles in to a triple helix. Cystine 
residues in the N-terminal region bound the subunits to form oligomeric structure (van et al., 2004). 
Surfactant proteins A and D and mannose binding lectins demonstrated a vital role as 
a fungal and other pathogens opsonins helping in the identification of the pathogen to 
control infection (Willment and Brown, 2008). Collectins stimulate complement 
fixation, ingestion of pathogens and cytokines production to control fungal infection 
(Brummer and Stevens, 2010). 
1.16.1  Receptor for collectins on immune cells  
Collectins are important molecules play an important role in innate immunity. They 
bind to the carbohydrates (antigen) on the surface of microbes, inducing aggregation 
and mediating phagocytosis through specific receptors on phagocytes (Holmskov, 
2000). Collectins are involved in receptor-mediated phagocytosis of various 
microorganisms (Holmskov, 2000). There are various receptors that interact with 
collectins and are found on or are associated with the membranes of different cells 
responsible for stimulating phagocytes and promoting the phagocytosis, killing and 
clearance of microorganisms. SPA and SPD localization in endocytic vesicles and in 
lysosome granules of alveolar macrophages suggest that a receptor-mediated uptake 
of these two collectins occurs in these cells. Conglutinin has been found in the same 
																																																																																																																																																					Chapter 1  
	 26 
compartments of phagocytes and it has been speculated that this could result from an 
interaction mediated either by a receptors for conglutinin or indirectly via an iC3b 
receptor (Holmskov, 2000).  
The collectin receptor (C1qR or C1q receptor or CD93) is express by many immune 
cells such as neutrophils, monocytes and lymphocytes (Tenner, 1993). It is known 
that this receptor binds with the collagen part of C1q and was originally purified from 
Raji cells (Ghebrehiwet et al., 1984). Due to the binding of this receptor to MBL, 
SPA, conglutinin and CL-43, it is known as collectin receptor (Malhotra et al., 1990). 
The C1q receptor was also shown to bind MBL, SPA, conglutinin and CL-43. 
Conglutinin have capability of binding with N-acetyl glucosamine, mannose, fucose 
residues and zymosan (Holmskov, 2000).  
It has been found that cC1qR binds with in the N-terminal 54 amino acids of the 
bovine conglutinin. C1qR does not bind with the bovine conglutinin lacking of these 
residues (Malhotra et al., 1993). C1q receptors stimulates different cellular immune 
responses results in the increase of phagocytic activity by macrophages, enhancement 
of fibroblast adherence, developing of oxidative burst in neutrophils, and stimulating 
of ingestion by endothelial cells. The same cellular response can be produced in 
results after the collectins binds with immune cells. It has been reported that C1q and 
MBL can act as opsonins that induce phagocytosis of apoptotic host cells infected by 
E. histolytica (Teixeira et al., 2008).  
Calreticulin (CRT) is a 60-kDa protein found on leukocytes, platelets and 
endothelium cells. It has been reported that this receptor interacts with collagen region 
of C1q. It has been found that CRT binds with other member of collectin family such 
as MBL, SP- A and bovine (Malhotra et al., 1990). Glycoprotein-340 (gp-340) has 
been identified as a receptor for SPD, binds in the presence of calcium (Holmskov et 
al., 1997).  
1.16.2  Surfactant protein A and D 
SP-A and SP-D are pulmonary surfactants made of lipids (90%) and proteins (5-10%) 
produced by alveolar type II cells and non-ciliated bronchial epithelial cells (Clara 
cells) that cover the peripheral airways (Sano and Kuroki, 2004; Kishore et al., 2006). 
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Both are hydrophilic surfactant proteins, with SP-A being the most abundant 
glycoprotein in surfactant. The lung collectins regulate phagocytosis and have the 
capacity of inducing agglutination of microorganisms via opsonisation so that this 
facilitates microbial recognition by alveolar macrophages and neutrophils (Sano and 
Kuroki, 2005). 
SP-B and SP-C have a shown a mechanistic role in modulating the surface tension of 
the pulmonary surfactant. SP-B and SP-C are small hydrophobic molecules where as 
SP-A and SP-D are large hydrophilic in nature (Weaver and Whistsett, 1991; Kishore 
et al., 2006). Both proteins alongside of immune cells such as neutrophils and 
macrophages act as a first line of defence in the innate immunity. These proteins form 
a complex with lipids and proteins in the lungs, which reduces surface tension of 
alveoli and promote lungs expansions (Espitia et al., 2012). SP-A and SP-D identify 
particular carbohydrates present on microbes, which help in the elimination of the 
microbes from the host by opsonisation or agglutination mechanisms (Kishore et al., 
2005). These both have been shown to modulate the cytokines response such as 
enhancement of TNF-α, IL-1α, IL-1β, IL-6 and IFN-γ production by human PBMCs 
(Kishore et al., 2005).  
SP-A is a 630-kDa protein, composed of six subunits where as SP-D formed by four 
subunits and is a 520-kDa protein (Sano and Kuroki, 2005). SP-A and SP-D have 
similar overall structure composed of N-terminus, a triple-helical collagen region, an 
α-helical coiled neck region and a globular structure at the C-terminus composed of 
carbohydrate which acts as ligands to pathogens (Kishore et al., 2006). These proteins 
bind to pathogens and mediate the uptake of microbes by phagocytes (Espitia et al., 
2012). 
The CRD region of the SP-A and SP-D is crucial for binding to pathogens and results 
in their clearance (Kishore et al., 2006). Both SP-A and SP-D act as opsonins to 
present the pathogens to the dendritic cells and macrophages (Kishore et al., 2006). 
It has been known that SP-A binds with M. bovis BCG via CRD region and enhances 
the phagocytosis (Weikert et al., 1997). SP-D can also bind to M. tuberculosis and 
can inhibit its uptake by macrophages (Ferguson et al., 1999).  
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1.16.3  Conglutinin 
Ehrlich and Sach described conglutinin in 1902 first time as a heat-stable protein 
found in the bovine serum.  In 1909 Bordet and Streng named a component found in 
the bovine serum which initiate the agglutination of erythrocytes coated with antibody 
and complement and called it conglutinin (Ingram and Barnum., 1965). Conglutinin is 
described as a member of collectin family of high molecular weight (Holmskov, 
2000). Conglutinin also reported in mammals, chickens (Hogenkamp et al., 2006), 
fish (Nakao et al., 2006) and invertebrates (Nair et al., 2000). Conglutinin is the 
member of C-type (Ca++ dependent) group of collectin family and is produced in liver 
(Holmskov, 2000).  Collectin are playing an important role in innate immunity, they 
attached to carbohydrates of the microbial cell surface to induce aggregation in the 
presence of calcium to prevent the microbes growth (Holmskov, 2000). Collectin acts 
as secretory pattern opsonins to destroy the pathogens by activating phagocytic cells 
(Van et al., 2004). 
Conglutinin is a collectin detected in ruminant serum that participates in the 
agglutination of complement-coated erythrocytes. It has been demonstrated that 
conglutinin inhibits microbial and parasitic activity by its characteristics to bind with 
the saccharides present on microbial and parasitic surfaces (Lachmann, 1962). In 
ruminants, conglutinin is present in serum, neutrophils, follicular dendritic cells, 
macrophages those are generated from liver, lungs and spleen, thymus, lymph nodes 
and tonsils, which indicates conglutinin’s important role in the immune responses 
(Holmskov et al., 1992).  
1.16.3.1  Structure of bovine conglutinin 
The gene encoding conglutinin is present on bovidae chromosome 28 (Liou et al., 
1994). Collectins including bovine conglutinin are oligomeric in structure assemble 
from various monomers.  Conglutinin is a protein that forms a trimer that consists of 
monomers. These monomers are inter-connected and stabilised by covalent disulphide 
bridges (Hoppe and Reid, 1994). In electron microscope conglutinin revealed as an X-
shaped tetramer, build of four basic structural units (Figure 1.7). This tetramer 
structure of conglutinin consists of four globular heads, attached to central hub by 
four collagen arms (Andersen et al., 1992). Each monomer chain consists of 351 
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amino acid residues of N-terminal cysteine region, contains 25 residues followed by a 
171 -residue long collagenous region and a short 28 residues α-helical neck region 
which is attached to the C terminal (Lee et al., 1991). SP-D and conglutinin show 
78% residues resemblance (Lee et al., 1991).  
 
Figure.1.7. Structure of bovine conglutinin: Conglutinin is an oligomer of polypeptide. (A): 
conglutinin polypeptide consists of collagenous, neck and C-type lectin domain (CRD). (B): Three 
polypeptide chain of conglutinin combined to build a single subunit comprised of collagenous region 
and head comprised of three CRDs. (C): The subunits joined to form full size native bovine conglutinin 
(Hickling et al., 2004).  
1.16.3.2  Role of conglutinin in innate immunity 
Lachman and Muller showed the conglutinin interaction with erythrocytes those are 
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they named KAF (serine protease) (Lachman and Muller, 1968). In the presence of 
co-factors, it cleaves the α-chain of C3b at two sites forms inactivated form of C3 
known as iC3b (Laursen et al., 1994).  
It has been studied that this important molecule is synthesised by liver and secreted 
into the circulation where a wide range of its present in plasma, in female 1.25-35 
µg/ml, and in male 1.25-47 µg/ml and mean concentration is 12 µg/ml (Holmskov et 
al., 1998). It has been seen that conglutinin levels in the serum of cows mainly 
effected by season, breeding and phases of reproductive cycle (Dec and Wernicki, 
2006). Several studies reported that in abortion, calving and infection there was a 
decreased level of conglutinin in the serum. It has been reported that in a cow 
decrease in serum conglutinin started 4 week before calving and continue up to 2 
weeks after delivery (Laursen et al., 1994). The level started rising after delivery and 
reached up to its normal concentration in week 21 week after delivery (Ingram and 
Mitchell, 1970).  
Conglutinin shows antibacterial activity against Gram negative bacteria and antiviral 
effect against influenza a virus and human immunodeficiency virus (HIV) (Laursen et 
al., 1994). 
 Its function of agglutinating complement-coated erythrocytes is dependent on the 
presence of calcium and serum conglutinin activity factor (CAF), also termed as the 
factor I (Sliwa et al., 2010) that plays an important role in the splitting of C3b 
component of the complement into inactive iC3b molecules, that further opsonises 
erythrocytes. However, incubation of antibody-coated erythrocytes for a long period 
of time with serum, by coated with conglutinin results in the splitting of iC3b to C3d 
and C3c, what in turn interferes with the agglutination properties of conglutinin that 
has demonstrated to bind to iC3b in a calcium-dependent manner (Sliwa et al., 2010). 
It has been demonstrated that conglutinin binds with zymosan and complement 
component iC3b and has shown antimicrobial activity in vivo and vitro (Dec and 
Wernicki, 2006).  
Bovine conglutinin has also been reported to inhibit IAV hemagglutination and 
infection activities by causing aggregation of viral particles, and act as an opsonin that 
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enhances neutrophil respiratory bursts responses after exposure to IAV (Hartshorn et 
al., 1993). 
1.16.3.3  Role of conglutinin in haemagglutination inhibition and Virus 
neutralization 
Bovine conglutinin binds with viral glycoprotein through their lectin domain and 
demonstrated haemagglutination inhibition activity. It has been reported that 
conglutinin shows haemagglutination inhibition and neutralization against the 
Nebraska calf diarrhea virus (NCDV). This activity proposed conglutinin role against 
rotavirus infections in cows (Reading et al., 1998). Antiviral activities of conglutinin 
against influenza virus are well described although this virus is not involved in the 
infection of cattles. Conglutinin acts as β-inhibitors of influenza virus, which binds to 
viral carbohydrates and stimulate haemagglutination and neutralization. Conglutinin 
plays a significant role in neutralizing the virus, preventing viral growth and control 
the viral spreading to surrounding cells against influenza-A virus (Kawai et al., 2007).  
It has been studied that conglutinin binds to glycoprotein gp 160 present in the outer 
envelope of HIV-1 virus. The binding of bovine conglutinin to HIV-1 virus prevents 
binding with cell and stops infection (Andersen et al., 1991). 
1.16.3.4  Inhibition of bacterial growth by bovine conglutinin  
Conglutinin has been shown to increase mice survival from Salmonella tyohimurium 
when subcutaneously injected with conglutinin, with generation of reactive oxygen 
species (ROS) by granulocytes being one of the mechanisms by which conglutinin 
performs its antibacterial activity (Dec et al., 2012). 
It has also shown the protection against pathogen strains of Pasteurella septica, 
Klebsiella pneumoniae, Listeria monocytogenes and Streptococcus pyogenes in the 
mice (Ingram, 1959).  Conglutinin also exhibit the anti-bacterial behavior against 
Escherichia coli and Salmonella typhimurium in vitro (Friis  et al., 1990).  
The role of bovine conglutinin in bovine tuberculosis remains poorly understood. To 
characterise and understand the full role of conglutinin is key in order to understand 
the role that is plays in bovine tuberculosis. 
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1.17   Aims of study  
In this study, we have to investigate the effect of recombinent conglutinin on mycobacterial 
growth. Bovine conglutinin is the first animal collectin to be discovered, it is 
structurally similar to human surfactant Protein D. SPD is known to interact with 
Mycobacterium tuberculosis, which is closely related to Mycobacterium Bovis, 
causative agent of bovine tuberculosis. Conglutinin is synthesized in the liver and is 
present in the serum. It is hypothesized that during inflammation conglutinin leaks 
from the blood vessels at the site of infection due to changes in vascular permeability 
and is likely to come in direct contact with M. bovis and immune cells and therefore 
may modulate the outcome of the infection. Its biological role is not fully understood. 
It is therefore interesting to study conglutinin’s role in the bovine infection and 
immunity. The effects of these interactions were investigated using M. smegmatis and 
M. bovis BCG as model organism for M. bovis. The main aims of the study are: 
Aim 1: Expression, purification and characterisation of the rfBC (conglutinin neck-
CRD). 
Aim 2: To investigate the direct effect of rfBC on the growth of M. smegmatis and M. 
bovis BCG. 
Aim 3: To investigate the effect of rfBC on the uptake of M. smegmatis and M. bovis 
BCG by the THP-1 cells. 
Aim 4: To investigate the effect of rfBC on the growth of  M. smegmatis and M. bovis 
BCG by the THP-1 cells. 
Aim 5: To investigate the effect of rfBC on the uptake of complement deposited M. 





















2.1  Bacterial  cell culture media  
2.1.1  Luria broth (LB) media  
Liquid Luria broth (LB) media was prepared with 10g sodium chloride (NaCl), 10g 
tryptone and 5g-yeast extract dissolved in 1 litre distilled water. For solid agar media, 
15g/L of agar were added, prior to autoclaving. 
2.1.2  Mycobacteria growth 
Middlebrooks 7H9 media (Sigma-Aldrich) was prepared by adding 0.2% (v/v) 
glycerol, 0.05% (v/v) Tween-80, and 10% (v/v) albumin-dextrose-catalase (ADC) (BD 
BBL, Becton Dickinson). M. bovis BCG (Pasteur strain) were grown by inoculating in 
50ml Middlebrook 7H9 media contained all above supplements. GFP-expressing M. 
bovis BCG (Danish Strain 1331), containing the pGFPHYG2 plasmid (gift from Dr. B. 
Robertson, Imperial College, London), was grow in the above media but with the 
addition of 50 µg/ml of hygromycin to maintain the plasmid. Both were incubated in a 
shaking incubator (200 rpm) at 370C for approximate 20 days. M. smegmatis (gift from 
Dr.Ansar Pathan, Brunel University) were cultured in 30ml LB media have 0.0016% 
(v/v) glycerol, 0.001% (v/v) Tween 80 and 100 µg/ml carbencillin (Sigma-Aldrich) 
and was incubated shaking incubator at 200rpm, at 370C for 3-4 days till reach to 
exponential growth phase.  
Middlebrook 7H10 agar base media (Sigma-Aldrich), supplemented with 0.2% (v/v) 
glycerol and 10% (v/v) OADC (Sigma-Aldrich) is used for bacterial growth on solid 
media.  
2.2  Frozen storage of mycobacteria  
Mycobacterial cultures were grown and the optical density (OD) measured, 
OD600nm=0.6 to 1.00 to indicate the exponential phase of growth. For storage 30ml 
of culture of M. bovis BCG and M. smegmatis were centrifuged at 3000 rpm for 30 
minutes. The pellet was mixed by gentle vortexing and then frozen with an equal 
volume of 100% sterile glycerol. Vials were then stored at -800C. 
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2.3  Acid-Fast staining 
Acid fast staining was performed to confirm M. bovis BCG and M.smegmatis and also 
to establish the purity of the culture before storage or its use in experiments. Acid fast 
staining was performed by using 500µl of mycobacterial culture (OD600nm= 0.6-1.0),  
which was spun down at 7000rpm for 10 minutes. The pellet was mixed and added on 
the slide. After drying the slide at room temperature, mycobacteria were fixed by 
passing the slide a few times through the flame until it dried. Carbol Fuschin stain 
(PRO-LAB), was applied on the smear covered by filter paper while heated under the 
flame for 5 minutes to enhance dye penetration. After 5 minutes of heating process the 
slide was washed through once with tap water followed by decolorizing solution 
(PRO-LAB). The bacterial smear was then flooded with methylene blue (PRO-LAB) 
and counter stained for 40 seconds. Any bacterial contamination is in the 
mycobacterial suspension will be stained blue. Slide was then washed with tap water 
and left to air dry. Slides were then viewed using microscopy.  
2.4  Colony Forming Units (CFU) counts of mycobacteria 
CFU counts were performed to estimate the number of bacteria stored in vials at -800C 
for future experiments. One bacterial vial of each M. smegmatis and M. bovis BCG 
were, thawed on ice and sonication performed for 20 seconds using a CAMLAB, 
Transsonic T460 sonicator. We then added 10µl of sonicated sample into 990ml of LB 
for M. smegmatis or 7H9 for M. bovis BCG and diluted suspension to make a 1x10-2 
dilution. A 1x10-3 dilution was then made by adding 100µl of bacterial suspension in to 
the 900 µl of plain media. The serial dilutions were carried out using the same method 
by transferring 100µl to add in to 900µl media until 1x10-6 serial dilutions was reached. 
For bacterial counting, 250µl from dilutions 1x10-3, 1x10-4, 1x10-5 and 1x10-6 were 
platted on an LB agar plates for M. smegmatis and 7H10 media plates containing 10% 
ADC for M. bovis BCG. M. smegmatis plates were incubated at 370C for 3-4 days 
whilst M. bovis BCG plates were incubated for three weeks. Bacterial colonies were 
then counted by visual inspection. The following equation was used to count the 
bacteria in the original vial: 





                                        Average number of colonies on 3 plates 
  
                                       Volume plated (ml) x Dilution factor 
 
 
Figure 2.1: Preparation of 10-fold serial dilutions of bacteria. 
2.5 Thawing and culturing of THP-1 cells 
THP-1 cells (ATCC Catalog number TIB-202) were taken out from the liquid nitrogen 
containers and added into 10 ml of plain RPMI-1640 media (Gibco). The cells were 
centrifuged at 1500rpm for 10 minutes twice. THP-1 cells were cultured by adding 
10ml of complete RPMI-1640 (cRPMI) (Gibco) consisting of 10% (v/v) fetal bovine 
serum (FBS) (Sigma-Aldrich), 2 mM L-glutamine (Sigma-Aldrich), 100µg/ml 
penicillin (Sigma-Aldrich), 100µg/ml streptomycin (Sigma-Aldrich) and 1mM sodium 
pyruvate (Sigma-Aldrich) onto the cell pellet.  After mixing of the cell pellet by 
vortexing, the cell suspension was transferred into a 25ml culture flask. These cells 
were kept in the CO2 incubator at 37oC for 3 days to grow. 
2.6 Transformation of competent cells 
2.6.1 Preparation of competent cells  
The Escherichia coli BL21 (DE3) pLysS strain (NEB) were used for transformation. A 
single colony from strain was picked from LB agar cultures and inoculated into 5 ml of 
LB media overnight. Then, 500µl of the primary culture was inoculated into 10 ml of 
fresh LB media and the cells grown with shaking at 37oC to an absorbance of between 
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0.3-0.4 600nm. The culture was then centrifuged at 3000 rpm for 10 minutes and 1ml of 
ice-cold 0.1 M calcium chloride added to the pellet, mixed gently, and the volume 
made up to 12 ml with 0.1 M calcium chloride. The sample was left in ice for an hour 
and then centrifuged at 3000 rpm for 10min and the supernatant discarded. Pellets were 
again resuspended in 1 ml of ice-cold 0.1 M calcium chloride. These cells were stored 
on ice in a cold room. 
2.6.2 Transformation of competent cells  
An aliquot of 200 µl of competent cells was placed on ice and 2µl of the plasmid 
containing the conglutinin construct recombinant BK-neck-CRD in the pET vector  
(Wang et al., 1995) (gift from Dr Uday Kishore) was added into the competent cells. 
Samples were placed on ice for 1 hour. After an hour of incubation on ice, the cells 
were incubated for 2 minutes at 42oC in water bath and then placed on ice for 5 
minutes. 800µl of media was added into the sample and incubated the cell culture at 
37oC for 45 minutes in a shaking incubator. Cells were then plated out on LB agar 
media consisting of 100µg/ml ampicillin and 50 µg/ml chloramphenicol because the 
BL21 (DE3) pLysS strain of E. coli resistant to chloramphenicol and the conglutinin 
plasmid contains the ampicillin the resistance selective marker. Culture plates were 
incubated overnight at 37oC. The following day, colony growth was analysed.  
2.6.3 Isolation of plasmid DNA  
In order to maintain the conglutinin fragment plasmid, a single colony of E. coli 
TOP10 contains conglutinin fragment was inoculated from agar plates and in 5 ml of 
LB (containing 100 µg/ml ampicillin) and the cells grown on a shaking incubator 
overnight at 370C. Harvested 5ml of overnight bacterial culture by centrifugation. 
Resuspend the cell pellet in 250 µl of Lysis buffer. The mixture was thorugly mixed by 
inverting capped tube 6 times until the solution becomes viscous. Avoid doing vortex 
as this may result in shearing of the genomic DNA. Incubated the samples at room 
temperature for maximum 5 minutes. Then 250 µL of precipitation buffer been added 
to the samples and mixed the solution until cloudy white precipitate is formed. 
Centrifuge the solution for 10 minutes at maximum speed to form pellet. Supernatant 
was transferred to miniprep column, stored in collection tube. Centrifuged the solution 
at 13000 rpm for 60 seconds. Flow-through was discarded from the collection tube and 
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column been inserted in same tube. Centrifuged the column at 13000rpm for 60 
seconds after adding 750 µl of wash buffer 1. Flow- through been discarded from the 
collection tube and 250 µl of wash buffer 2 added in to the column. The samples were 
centrifuged at 13000 rpm for 60 seconds. Removed the column from the tube and the 
columns were then placed in fresh collection tubes and the DNA was eluted by adding 
50µl elution solution to each column and spinning them at 13000 rpm for 60 seconds. 
Eluted plasmid DNA was stored at 4°C for immediate use and at –20°C for long-term 
storage. 
2.7  Protein expression 
In order to check the successful transformation of the conglutinin plasmid in the BL21 
(DE3) pLysS strain of E. coli, pilot expression was performed. After confirming 
successful protein expression, large scale expression was then performed to purify the 
rfBC and maltose-binding protein (MBP).  
2.7.1 Pilot expression of recombinant conglutinin (BK-neck-CRD) and MBP 
(Maltose binding protein). 
 Colonies from transformed BL21 (DE3) pLysS strain of E. coli cell culture containing 
the rfBC and maltose-binding protein (MBP) on agar plates were cultured in 5 ml LB 
(containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol).  The cultures were 
then shaken overnight at 37oC and the following morning 500µl of each culture was 
grow in fresh 10 ml of LB containing 100 µg/ml ampicillin and 50 µg/ml 
chloramphenicol. The cells were grown on a shaking incubator at 37oC to an optical 
density (OD) of 600 nm of between 0.6 and 0.8. 
0.4 mM of Isopropyl β-D-thiogalactopyranoside (IPTG) (Sigma-Aldrich) was then 
added to the cells to induce protein expression. Additionally, 1 ml of culture, 
containing no IPTG was aliquoted and kept as an uninduced sample. Both induced and 
uninduced samples were shaken at 37oC for 3 hours. 1 ml from each induced sample 
was aliquoted into fresh microfuge tubes and together with the uninduced samples 
were centrifuged at 13000 rpm for 10 min. Pellets were then resuspended in 100 µl of 
2x treatment loading buffer (Table 2.1). The samples were then denatured at 100oC on 




Component Concentration  
     1MTris-HCL (pH 6.8)                                    1.25ml  
                    SDS (sodium dodecyl sulphate)                                    0.5g   
          2-ME (Mercaptoethanol)                                    1ml  
                          Glycerol 100%                                     2ml 
                          0.1% Bromophenol blue                                     0.4ml  
Adjust the final volume to 10ml with ddH20 
Table 2.1: Composition of SDS-PAGE loading sample buffer (2X Treatment buffer)  
 
2.7.2  Expression and purification of the recombinant conglutinin (rfBC) at large 
scale. 
BL21 (DE3) pLysS strain of E. coli (NEB) containing rfBC was was cultured into 
25ml of LB media added with 100 µg/ml ampicillin and 50 µg/ml chloramphenicol. 
The culture was shaken at 37oC, overnight. Then, 25ml of primary culture was added 
into 1 litre of LB with 100 µg/ml ampicillin and 50 µg/ml chloramphenicol. Bacterial 
cells were then grown at 37oC, while shaking to an OD 0.6-0.8600nm. Prior to the 
addition of IPTG to the culture, an uninduced sample was removed as a negative 
control for expression. To induce protein expression, 0.4mM of IPTG was added into 
the culture and incubated for a further 3 hours at 37oC in the incubator shaker at 200 
rpm. The culture was harvested by centrifugation at 5000 rpm for 10 minutes. The cell 
pellet was then incubated with 50 ml of ice-cold lysis buffer (20 mM Tris-HCI pH 8.0, 
200 mM NaC1, containing 0.25% (v/v) Tween 20, 2 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride (Sigma) and 200µg/ml of lysozyme (Sigma) for 1 hour. 
The cell suspension was then sonicated at 60 Hz for 2 minutes with an interval of 1 
minute on ice? (repeated 15 times). The sonicated sample was then spun down at 
16,000 rpm for 30 minutes. The sonicated samples from the cell pellet were then 
analysed on a 12% SDS-PAGE to confirm that the recombinant conglutinin is present 
in the sample pellets. Samples expressing conglutinin were then subjected to 
purification. The protein samples were denatured and refolded by treating the bacterial 
suspension with 6 M urea buffer and reducing the concentration of urea. The starting 
buffer contained 20 mM Tris-HCl pH 8.0, 100 mM NaCl, 5% (v/v) glycerol and 6 M 
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urea, which was used to mix the cell pellet and then dialysis performed against 1 litre 
of the same buffer but containing decreasing concentrations of urea to 4 M, 2M and 1 
M urea. The final solution contained the soluble recombinant conglutinin protein, 
which was dialysed against ion-exchange starting buffer (50 mM Tris-HC1, 100 mM 
NaC1, 5 mM CaCl2, pH 8). Additionally, this solution was loaded onto the maltose 
agarose column (20 ml) (Sigma) for binding of rfBC with column. The column used 
was pre-washed with 50 ml of autoclaved water, 50 ml of salt buffer (50mM Tris-
HCL, 1 M Nacl, 5mM CaCl2, pH 8) and 50 ml of affinity buffer (50 mM Tris-HC1, 
100 mM NaC1, 5 mM CaCl2, pH 8).   
After loading the protein sample, the column was treated with 30 ml of salt buffer and 
15 ml of affinity buffer. The proteins were eluted with the elution buffer containing 50 
mM Tris-HCL, 100 mM NaCl, 5mM EDTA, pH 8, NaN3 0.05%. The eluted 
conglutinin was collected into the 1.5ml fractions? in microfuge tubes and analysed on 
a 12% (w/v) SDS-PAGE to confirm the presence of conglutinin. The OD280 was 
determined for the concentration of the proteins before running the samples on SDS-
PAGE to confirm the protein. Recombinant conglutinin was characterised using 
Western blotting and ELISA and identified by rabbit anti-bovine conglutinin IgG (gift 
from Dr. Uday Kishore). 
2.7.3  Large scale expression and purification of maltose-binding protein (MBP)  
A single colony from of maltose binding protein (MBP)	was inoculated into 25 ml of 
LB containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol and was shaken at 
37oC overnight. The next day 25 ml of this culture was added into 1 litre LB 
(containing 100 µg/ml ampicillin and 50 µg/ml chloramphenicol) and grown in a 37oC 
shaking incubator until the OD reached between 0.6 to 0.8. To induce protein 
expression, 0.4 mM of IPTG was added to the sample. After 3 hours of incubation at 
37oC, shaking at 200 rpm speed, the cell pellet was collected by centrifugation at 5000 
rpm for 10 minutes. 
50 ml of lysis buffer (20 mM Tris-HCl, pH 8.0, 0.5 M NaCl, 1 mM EGTA pH 7.5, 1 
mM EDTA pH 7.5, 5% v/v glycerol, 0.2% v/v Tween 20, 0.1 mM PMSF and 
lysozyme (100 µg/ml)) was added to the cell pellet 4°C for 1 hour, in order to achieved 
lysis of the bacterial cell. The cell suspension was sonicated at 60 Hz for 2 minutes 
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with an interval of 1 minute (15 cycles). This sonicated sample was centrifuged at 
16,000 rpm for 30 mins. The cell supernatant was collected and diluted 5 times with 50 
ml of buffer I (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA PH 7.5, 0.2% 
v/v Tween 20 and 5% v/v glycerol). The diluted supernatant was then added to an 
amylose resin column (New England Bio labs). After passing through the MBP protein 
sample, the column was washed with 150 ml of buffer I (20 mM Tris-HCl, pH 8.0, 100 
mM NaCl, 1 mM EDTA PH 7.5, 0.2% v/v Tween 20 and 5% v/v glycerol) and then 
buffer II (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA PH 7.5, and 5% v/v 
glycerol). The MBP were eluted by elution buffer (100 mM maltose, 20 mM Tris-HCl, 
pH 8.0, 100 mM NaCl, 1 mM EDTA PH 7.5 and 5% v/v glycerol). The OD280 was 
determined for the concentration of the proteins before running the samples on SDS-
PAGE to confirm the protein.  
2.7.4  Removal of endotoxin from rfBC 
rfBC was further treated to make them free of lipopolysaccharides (LPS). Polymyxin B 
column (Sigma-Aldrich) was cleaned by passing through 50 ml of 1% sodium 
deoxycholate (Thermo scientific) and 50 ml of autoclaved water. rfBC was mixed with 
the polymyxin B column beats and kept at roller shaker for 1 hour. After an hour, 
proteins were eluted and concentration was checked by a Nano drop 
spectrophotometer. 
2.8 Protein characterization  
2.8.1 SDS-PAGE .  
The purified sample of rfBC was verified by running purified samples on a 12% SDS-
PAGE in order to determine the correct molecular weight. The molecular weight of the 







        Acrylamide Percentage 12%  
     H20                                    1.6ml  
                    Acrylamide/Bis-acrylamide                                     2ml   
      1.5M Tris (pH 8.8)                                    1.3ml  
                            10% (w/v) SDS                                     0.5ml 
                            10% (w/v) APS                                     0.5ml  
                          Temed 0.002ml 
 
Table 2.2: Components of resolving gel for SDS-PAGE 
        Acrylamide Percentage 12%  
     H20                                    0.68ml  
                    Acrylamide/Bis-acrylamide                                     0.17ml   
      1.5M Tris (pH 8.8)                                    0.13ml  
                            10% (w/v) SDS                                     0.01ml 
                            10% (w/v) APS                                     0.01ml  
                          Temed 0.001ml 
 
Table 2.3: Components of stacking gel for SDS-PAGE 
 
Proteins were diluted in 1:1 v/v ratio in 2x Laemmli buffer [4% (w/v) SDS, 20% 
glycerol, 10% 2-mercaptoethanol (v/v), 0.004% bromophenol blue (w/v), 0.125 M Tris 
HCL pH 6.8 (w/v)]. Samples were heated for 10 minutes at 100oC on heating block in 
to denature proteins. rfBC were loaded onto the wells. The gel was run at 120 volts for 
90 minutes. Following this, the gel was stained with staining solution (50% methanol, 
10% v/v acetic acid, 40% water with 0.1% coomassie blue) overnight on a rocking 
shaker. The next day, the gel was washed with distilled water and destained in destain 
solution (50% methanol, 10% acetic acid and 40% dH2O) for 2 hours. The gel image 
was captured using a Molecular Imager (Bio Rad). 
2.8.2 Western blot 
A western blot was used to detect the presence of the conglutinin proteins using a 
specific antibody. Onto 12 % SDS-PAGE gel 5, 10 and 20 µg/ml of recombinant 
conglutinin were loaded, together with the same concentration of MBP protein 
(negative control). A prestained protein ladder (Page RulerTM) with a mass range of 
10–250 kDa was used as a molecular weight standard.  
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Following SDS-PAGE, the gels were equilibrated in blotting buffer (12 mM Tris, 96 
mM glycine, 20% methanol, pH 8.3) and then the proteins were electro-blotted (Mini 
Trans-Blot Cell apparatus, Bio-Rad) onto polyvinylidene difluoride (PVD) 
membranes. Once the transfer was completed the PVD membrane was removed. 
Membrane was prepared for immunostaining by blocking with low-fat 5% milk (w/v) 
in PBS, overnight.  
The membrane was washed three times (5 minutes each time) with wash buffer 
(PBS/0.05% Tween 20) and then incubated for one hour at room temperature with 
rabbit anti-bovine conglutinin IgG antibody (diluted 1:1000 in PBS). The membrane 
was washed 3 times (5 minutes each) with the wash buffer and the membrane was 
incubated for an hour with Protein A? polyclonal goat anti-rabbit IgG (PA-HRP) 
(diluted 1:1000 in PBS). The membrane was washed a further 3 times with the wash 
buffer for 5 minutes each. Blots were developed using Clarity Western ECL (BioRad) 
according to the manufacturer’s instructions.  
2.8.3  Enzyme-linked immunosorbent assay (ELISA) 
A 96 well ELISA plate (Fisher Scientific) was coated with serial dilutions of 0.5, 0.25, 
1.25 and 0.65 µg/ml of rfBC in the presence of 5 mM calcium chloride and same 
concentrations of MBP (contro) incubated for two hours (one hour at 370C and one 
hour at 40C). After 2 hours of protein incubation, the plate was washed twice with 
200µl per well with PBS-tween (PBS/0.05% Tween 20). The plate was blocked with 
200µl per well of 1% w/v BSA in PBS for 2 hours at room temperature. After blocking 
the contents from plates were discarded and washed three times with PBS/Tween 20. 
100µl of the primary antibody: rabbit anti-bovine conglutinin IgG (diluted 1:1000 in 
PBS) was added to each well and the plate was incubated for an hour at room 
temperature. After the incubation contents from the plate were discarded and plate was 
washed 3 times with PBS/Tween 20. Protein A (1:1000) dilution was bind with rabbit 
anti-bovine conglutinin IgG, was added and incubated the sample at 370C for an hour 
then the wells emptied and washed for three times. Substrate TMB (3, 3’, 5,5’-
Tetramethylbenzidine) was prepared as recommended by manufacturer, and 100µl was 
added per well.The ELISA plate was incubated in dark for 1-5 minutes to allow colour 
to develop. As soon as colour developed, the reaction was stopped by adding 50µl of 
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H2SO4. The absorption was read at 450 nm using an ELISA reader (Bio-Rad micro 
plate reader). 
2.8.4  Cross linking 
In order to see whether rfBC forms dimer and trimer to stabilise the conglutinin 
structure as in native form. In order to do this, prepared cross linker BS3 (bis3 
sulfosuccinimidyl suberate) (Thermo fisher, cat no; 21580) immediately before use. To 
make working concentration 1mM BS3 from 1g powders, first 25mM BS3 stock been 
made by dissolving 2mg BS3 in to 140µl of DMSO (Dimethyl sulfoxide) according to 
manufacturer guideline. To make the final concentration of 1mM, added 1µl from 
25mM stock to 24µl of DMSO (Dimethyl sulfoxide).  
Seven aliquots of proteins were made in 1.5ml micro centrifuge tubes by adding 45µl 
of recombinant conglutinin (0.52µg/ml) for 7-time points reaction, 0,1,2,4,8,16 and 32 
minutes. Added 5µl of 1mM of BS3 in all micro centrifuge tubes except 0 time point. 
Incubate the reaction mixture at room temperature for different time points. After 
incubation for each time point, 20mM Tris-HCl (pH 7.5) were added to stop the 
reaction. To visualize the crosslinking of recombinant bovine conglutinin, the samples 
were ran on 12% SDS-PAGE.  
2.9  Preparation of M.smegmatis and M. bovis BCG bacteria for  Enzyme-linked 
immunosorbent assay (ELISA) for binding assays 
M. smegmatis (gifted by Dr Ansar Pathan) was inoculated in a 50 ml tube containing 
30 ml of LB, 50µl glycerol, 30 µl Tween 80 and 1.5ml carbenciline (Sigma-Aldrich 
C1613) to avoid the contamination of fungus or non-specific bacterial cells. The cells 
were grown on a shaking incubator at 37oC to an OD of between 0.8 and 0.9 to reach 
its exponential phase. It took an average of 72 hours to reach at required OD. The 
culture was then centrifuged at 5000 rpm for 30 min and the supernatant discarded and 
the collected pellet stored at -80oC in glycerol solution (glycerol and LB 1:1 (v/v)).  
M. bovis BCG (Pasteur strain) were grown as described in the method section 2.1.2. 
The bacteria were grown until they reached exponential phase, an OD600nm = 0.60-1.00, 
which is equivalent to 1 x 109 bacteria/ml (Abdul-Aziz et al., 2016). The bacteria were 
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spun down at 4500 rpm for 10 minutes and washed three times in 0.15 mM PBS. The 
mycobacterial pellet was re-suspended in the 7H9 growth medium (with 10% ADC, 
0.05% (v/v) Tween 80 and 0.2% (v/v) glycerol).  
2.9.1 rfBc binding with M. bovis BCG and M. smegmatis cells by ELISA 
Microtitre wells were coated overnight with 107 M. Bovis BCG cells (50µl per well) 
and 107 M. smegmatis cells in 0.1 M carbonate /bicarbonate buffer, pH 9.6 and left at 
40C. The wells were blocked for 2 hours at 37oC with BSA then the plate washed twice 
with 200 µl phosphate-buffered saline (PBS). Different concentrations of rfBC	40, 20, 
10, 5, 2.5, 1.25 and 0.625 µg) were set up as serial doubling dilutions in calcium buffer 
(40mM Tris, 200mM NaCl, 5mM CaCl2), and EDTA buffer (40mM Tris, 200mM 
NaCl, 5mM EDTA). Identical serial dilutions of MBP protein (40, 20, 10, 5, 2.5, 1.25 
and 0.625 µg) were used as a negative control protein to be used with bacterial cells.  
rfBC was incubated with M. bovis BCG and M. smegmatis for 1 hours at 370 C and 1 
hour at 40C, then washed the plate with 200µl of washing buffer (PBS Tween 0.05%) 
for four times. The primary antibody, rabbit anti-bovine conglutinin IgG, (diluted in to 
PBS 1:1000) (100 µl/well) was incubated with the bacterial sample at 37oC for 1 hour. 
Again, the sample was washed with 200 µl per well of washing buffer (PBS/0.05% 
Tween 80) three times. Protein A diluted into PBS (1:1000) was added and incubated 
the sample at 370C for 1 hour then the wells emptied and washed for three times. 
Development of the assay was completed by adding 100µl of 3, 3’, 5,5’-
Tetramethylbenzidine or TMB substrate in to the well. The sample was kept in dark for 
1-5 minutes to allow colour to develop. The reaction was stopped by adding 50µl of 
H2SO4 after the colour development. The absorption was read at 450 nm using a micro 
plate reader reader (Bio-Rad). 
2.10 rfBC binding with M. bovis BCG cells microscopy 
This method was used to examine the binding of recombinant bovine conglutinin to the 
M. bovis BCG cells. 2x109 M. bovis BCG cells were harvested at exponential phase, at 
an OD600nm =1. Dissolved bacterial cell pellets in to the 500µl 5mM calcium chloride 
(CaCl2) buffers contains 20µg/ml rfBC and 20µg/ml of MBP. Proteins were incubated 
with M. bovis BCG cells for 1 hour at 370C in a shaker and 1 hour at 40C. After 2 hours 
incubation samples were centrifudged at 7000 rpm for 10 minutes. Washed the 
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samples twise with 500µl/ml PBS (each time centrifudged  at 7000 rpm for 5 minutes). 
The primary anti-body Rabbit anti-bovine conglutinin IgG diluted in to PBS (1:200) 
was added to conglutinin bound M. bovis BCG and incubated for 1 hour at 370C. The 
samples were washed 3 times (500µl/ml PBS, each time centrifudged  at 7000 rpm for 
5 minutes). Protein A conjugated to FITC (Sigma) (1:1000) was treated to the complex 
in both samples. The samples were incubated for 30 minutes in the dark at room 
temperature. The cells were harvested after washing 3 times with PBS. Cell suspension 
(20µl) was added on a clean glass slides and covered with a coverslip. Leica 
microscope (Leica DM4000) was used to visulaised the slides.  
2.11 Direct effect of rfBC to M. smegmatis and M. bovis BCG growth 
M. bovis BCG and M.smegmatis were grown in 7H9 and LB media respectively as 
describe above. At OD600nm=1.00, which is equivalent to 1x109 bacteria/ml. Taken 1ml 
of M. bovis BCG and M. smegmatis in 2ml centrifudge tube and centrifuged at 
10,000rpm for 10 minutes. Cell pellets were suspended into 1ml of LB media for M.  
smegmatis and 1ml of 7H9 for M. bovis BCG. To break the clumps in the cultures, 
passed through 12–15 times from 1ml syringe with 25 gauge needle. After vortexing 
the samples, 100µl of bacterial culture was diluted in 900µl of LB or 7H9. A bacterial 
dilution of 1x10-5 and 1x10-3 in total volume of 1ml of LB or 7H9 medium was used 
for M. smegmatis and M. bovis BCG respectively, in the experiment. 
Three different concentrations of conglutinin: 10, 20 and 40µg/ml and one control 
sample without protein, were incubated with M. smegmatis and M. bovis BCG cells for 
1 hour at 370C and 1 hour at 40C in the shaker. After 2 hours of incubation, 200µl 
bacterial culture was plated on each plate. LB agar plates were used for M. smegmatis 
and 7H10 plates (with 10% OADC) were used for M. bovis BCG cultures. M. 
smegmatis were kept in 370C incubator for three days and M. bovis BCG plates were 
kept on same conditions, but for approximately 2-3 weeks for growth. After the 
appearance of bacterial colonies, they were counted and analysed. 
2.12 Measuring M. bovis BCG cell lysis by propidium iodide uptake  
For this study, we took 1 ml of M. bovis BCG culture at OD600nm=1.0 and centrifuged  
at 7000 rpm for 10 mins. The M. bovis BCG pellet was resuspended in 200µl of 5 mM 
																																																																																																																																																					Chapter 2 
	 47 
CaCl2. Three different concentration (10, 20 and 40µg/ml) of rfBC  added in three 
microfuge tubes and two were left untreated with protein. All samples were incubated 
1 hour at 370C in the shaker and one hour at 4oC. After two hours incubation, the 
sample was centrifuged at 7000 rpm for 10 minutes. Bacterial pellets were then 
suspended in to 1 ml of PBS. One of untreated sample of M. bovis BCG was heated on 
hot plate at 100oC for 10 minutes to lyse the cell membrane as a positive control for the 
assay.  
Propedium iodide (Sigma-Aldrich) (1:1000) was added to the bacterial suspension. 
Cells were incubated with propedium iodide for 20 minutes at room temperature in the 
dark. After incubation, samples were washed with 500 µl of PBS three times by 
centrifugation at 7000 rpm for 10 minutes. 
A small amount of the cell suspension (20µl) was added on a clean glass slide and 
covered with a coverslip. Slides were visualised using a fluorescence microscope 
(Leica DM4000). 
2.13 Infection Assays 
2.13.1 Infection Assay by Colony forming Units (CFU) 
THP-1 macrophage cells were grown in complete RPMI media as described in method 
section 2.5. After the growth, cells were adjusted to 7x105cells/well and were 
differentiated into macrophages by adding 100 ng/ml of phorbol 12-myristate 13-
acetate (PMA) (Sigma-Aldrich) and then incubated for 48 hours in 12-well plates. 
After 48 hours, cells were washed once with plain RPMI and media replaced with 
fresh complete RPMI (cRPMI) for overnight. Cells were then washed once with plain 
RPMI and then left in 400 µl of plain RPMI (serum free, antibiotic free) at least an 
hour before adding bacteria.  
M. bovis BCG were grown to OD600=0.6-1.0 at log phase (stationary culture) as 
described above.  2 ml of culture was centrifuged with an OD600nm = 0.6 in 2 ml 
microfuge tube at 3300 x g for 10 minutes (The following formula was used for 
consistancy, if culture has an OD600 of 0.5, then need to spin down 2.4 ml (0.6 × 2 
ml/0.5 = 2.4 ml). After harvesting bacteria, the bacterial pellet was resuspended in 200 
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µl of plain RPMI with no supplements. To ensure a single-cell suspension, the bacteria 
were passed through from 1ml syringe with 25-gauge needle, 12–15 times. 
Tubes were set up with 10, 20 and 40 µg/ml of conglutinin added to bacteria, together 
with 5mM of CaCl2 (10µl of 0.1 M CaCl2). Samples were incubated on a shaking 
incubator at 37oC for 1 hour followed by 1 hour at 4oC with shaking to allow 
conglutinin to bind. After 2 hours incubation with conglutinin, bacterial cells were 
centrifuged at 3300 x g for 10 minutes and then gently resuspended in 2 ml of plain 
RPMI. 
70µl of the bacterial suspension with and without conglutinin was added to the THP-1 
cells giving a muliticity of infection (MOI) of 10:1, (bacteria:cells). Bacteria were then 
mixed with THP-1 cells by gentle pipetting in the wells. Assays were then incubated at 
37°C and 5% CO2 for 3 hour, 6 hour, 24 hour and 48 hour time-points. 
After each time-point of incubation, the supernatant was collected for cytokine protein 
analysis. THP-1 cells were then washed 3 times with plain RPMI and removed using 
0.25% of trypsin and incubated at 37oC for 10 minutes. Then 500µl of RPMI with 
serum was added to neutralize the effect of trypsin. Cells were then centrifuged at 1400 
rpm for 10 minutes and the supernatant discarded. At the 3- and 6-hour time-points, 
THP-1 cells were lysed and colony-forming unit assay performed to investigate the 
number of intracellular bacteria (see below). For the remaining time-points, 
supernatants and pellets were collected and stored at -80oC for further experiments. 
For the 3- and 6-hours timepoints, cell pellets were harvested and resuspended in 1ml 
0.1% saponin to lyse the THP-1 cells. The cells were vortex for 10 minutes. Ten-fold 
Serial dilutions were then made by adding 100µl of the suspension into 900µl of 7H9 
to give a 1x10-1 dilution. Two further 10-fold dilution were carried out to give a 1x10-2 
and 1x10-3 dilutions. 200µl was plated on 7H10 plates supplemented with 10% OADC 
at each dilution. Assays were conducted in triplicate. 7H10 plates were incubated for 2-
3 weeks at 37oC and then bacterial colonies counted and analysed. 
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2.13.2  Infection assay by microscopy 
THP-1 cells were grown in cRPMI as described in method section 2.5. After growth, 
THP-1 cells were re-suspended in cRPMI seeded at 1 x 105cells/well on sterile 
coverslips (Sigma-Aldrich) and were induced to adhere with by adding 100 ng/ml of 
PMA. Cells were incubated for 48 hours in 12-well plates. After 48 hours, cells were 
washed three times with plain RPMI and media replaced with 1 ml of cRPMI 
overnight. Cells were then washed with plain RPMI and replaced and left in 400 µl of 
plain RPMI (serum-free, antibiotic-free) for 1 hour before the addition of bacteria. 
M. bovis BCG-GFP (strain expressing GFP plasmid pGFPHYG2; gift from Dr B. 
Robertson, Imperial College London) was grown in Middlebrook 7H9 media (Sigma 
Aldrich) as described above. M. bovis BCG-GFP were grown to OD600=0.6-1.0 at log 
phase (stationary culture) as described above.  2 ml of culture was centrifuged with an 
OD600nm = 0.6 in 2 ml microfuge tube at 3300 x g for 10 minutes (The following 
formula was used for consistancy, if culture has an OD600 of 0.5, then need to spin 
down 2.4 ml (0.6 × 2 ml/0.5 = 2.4 ml). After harvesting bacteria, the bacterial pellet 
was resuspended in 200 µl of plain RPMI with no supplements. To ensure a single-cell 
suspension, the bacteria were passed through from 1ml syringe with 25-gauge needle, 
12–15 times 
Tubes were set up with 10, 20 and 40 µg/ml of conglutinin added to bacteria, together 
with 5mM of CaCl2 (10µl of 0.1 M CaCl2). Samples were incubated on a shaking 
incubator at 37oC for 1 hour followed by 1 hour at 4oC with shaking to allow 
conglutinin to bind. After 2 hours incubation with conglutinin, bacterial cells were 
centrifuged at 3300 x g for 10 minutes and then gently resuspended in 2 ml of plain 
RPMI. 
70µl of the bacterial suspension with and without conglutinin was added to the THP-1 
cells giving a muliticity of infection (MOI) of 10:1, (bacteria: cells). Bacteria were 
then mixed with THP-1 cells by gentle pipetting in the wells. Assays were then 
incubated at 37°C and 5% CO2 for 3 hour and 6 hour. 
After 3 hours of incubation, the supernatants were discarded from the wells. Coverslips 
were then washed 3 times with 500 µl PBS in wells. Coverslips were then fixed with 
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300 µl of 4% paraformaldehyde (PFA for 10 minutes at room temperature. After 
fixing, cells were then washed 3 times with 500 µl of PBS.  
A master mix containing PBS, Hoechst (1:10000) and wheat germ agglutinin (WGA) 
(Thermo Scientific) (1:500) was prepared. 50µl of the master mix was added to each 
coverslip and incubated for 10 minutes at room temperature in the dark. Coverslips 
were then washed 5 times with 1ml of PBS and placed on the glass microscope slides 
for visulalisation using a fluorescent micropose (Leica DM4000 microscope).  Few 
drops of antifade (Citifluor AF3) were added on each coverslips and slides covers were 
used on top of cover slips. 
2.14  Nuclear Factor Kappa B (NF-κB) Translocation Assay 
To examine the translocation of NF-κB, THP-1 cells were grown in cRPMI as 
described in method section 2.5. After growth, THP-1 cells were re-suspended in 
cRPMI seeded at 1 x 105cells/well on sterile coverslips (Sigma-Aldrich?) and were 
induced to adhere with by adding 100 ng/ml of PMA. Cells were incubated for 48 
hours in 12-well plates. After 48 hours, cells were washed three times with plain RPMI 
and media replaced with 1 ml of cRPMI overnight. Cells were then washed with plain 
RPMI and replaced and left in 400 µl of plain RPMI (serum-free, antibiotic-free) for 1 
hour before the addition of bacteria. 
1.2 ml of M. bovis BCG-GFP culture with OD600 = 1.0 was centrifuged in six 
different 2 ml microfuge tubes at 3300 g for 10 minutes. Six conditions were studied: 
1: M. bovis BCG only, 2: M. bovis BCG+complement activated, 3: M. bovis BCG+ 
conglutinin 20 µg, 4: M. bovis BCG+40 µg conglutinin, 5: M. bovis BCG+ 
complement activated+20 µg conglutinin and M. bovis BCG+complement 
activated+40 µg conglutinin.  
For complement activation (sample tubes 2, 5 and 6) bacterial pellets were dissolved in 
1:5 serum dilution and 160µl DGVB++Mg EGTA buffer). They were incubated for 45 
min at 37°C on a shaker to activate alternative complement pathway and deposited 
complement protein on M. bovis BCG. After the deposition of complement proteins on 
the M. bovis BCG surface, all the samples were spun at 3300xg for 10 minutes. 
Bacterial cell pellets were then resuspended in 200 µl of 7H9 media containing 5mM 
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CaCl2. 20 and 40 µg/ml of conglutinin were then added in to the bacterial suspensions 
of complement deposited bacteria (5 and 6 sample tubes respectively) and no 
complement deposited (3 and 4 sample tubes). All samples were incubated in a shaking 
incubator at 37oC for 1 hour followed by 1 hour at 4oC with shaking. After 2 hours 
samples were centrifuged at 3300 x g for 10 minutes. 2 ml of plain RPMI was added to 
the pellet and gently resuspended the bacteria into a single-cell suspension using a 1ml 
syringe with 25-gauge needle.  
70µl of the bacterial suspension with and without rfBC was added to the THP-1 cells 
giving a muliticity of infection (MOI) of 10:1, (bacteria:cells). Bacteria were then 
mixed with THP-1 cells by gentle pipetting in the wells. Assays were then incubated at 
37°C and 5% CO2 for 6 hour. 
After 6 hours of treatment, cells were washed 3 times with 500 µl PBS inside the 
wells. Cover slips were fixed by adding 500 µl of 100% Methanol and incubated at -
200C for 10 minutes. The coverslips were washed three times after fixation of cells 
with 500 µl of PBS buffer. NF-κB primary antibodies (1:200) was added to each 
coverslip and left for 1 hour at RT. 500 µl of PBS was used to wash the coverslips, 3 
times after primary antibody treatment. 
A master mix containing Hoechst (1:10000) and Cy3 secondary antibody for NF-kB 
(1:500) in PBS was prepared. 50 µl of master mix of both was added to each coverslip 
and left for 1 hour at RT. Then the coverslips were washed four times with 1 ml of 
PBS. Slides were prepared to view under the Leica DM4000 Fluorescence microscope 
by adding antifade (Citifluor AF3) and placing covers on the top of slides.  
2.15 Complement activation assay  
2.15.1 Serum adsorption  
Normal Human Serum (TCS Biosciences Ltd) was incubated with Sheep Blood in 
Alsever’s Solution (Thermo scientific) to reduce Anti-Forssman antibody activity. 
Sheep Erythrocytes were washed with PBS and centrifuged at 3,000 rpm for 5 min 
until no spontaneous lysis of erythrocytes occurred. 2.6 ml of washed red blood cells 
(RBC) were centrifuged and suspended in 13 ml of normal human serum. The 
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suspension was incubated overnight at 4ºC on a slow rotator. After overnight 
incubation, the serum was collected by centrifuged at 3000 rpm at 4oC for 5 minutes 
and serum supernatant was collected. Serum was tested for the presence of anti-
Forssman antibodies by incubating 500 µl of erythrocytes (E cells) in 1:5 diluted sera 
(20 µl serum + 80 µl DGVB++) and 1:10 diluted sera (10 µl serum + 90µl DGVB++), 
and incubated for 1 hour at 37°C.  
2.16 Haemolytic assay  
2.16.1 Preparation of neuraminidase-treated sheep erythrocytes (NE)  
For the haemolytic assay and preparation of neuraminidase-treated E cells, we 
followed same protocle as mentioned by Carroll, washed E cells were dissolved in 
incubation buffer containing 10mM sodium phosphate, 140 mM NaCl, 0.1 mM PMSF, 
pH 5.0 and the cells concentration standardised to 1x109 cells/ml. For every 2x1010 
cells,5 units of neuraminidase from Clostridium perfringens (Sigma-Aldrich) were 
added and incubated cells for 1 hour at 37oC in a shaking incubator . After 1 hour the 
cells were spun at 3000 rpm for 10 minutes and washed with PBS contains 0.5 mM 
EDTA. Cells were again washed with DGVB-Mg EGTA buffer. Neuraminidase-
treated erythrocytes were finally dissolved into DGVB-Mg EGTA buffer and 
concentration adjusted to109 cells/ml (Carroll et al, 2009).  
2.16.2 Alternative pathway complement consumption assay  
The experiment was performed with the serum sample kept at 4ºC on ice until the 
haemolytic incubation. The experiments were performed in duplicates for each sample: 
150 µl of diluted serum to suspended 100 µl, 200 µl, 400µl and 800µl of M. bovis BCG 
OD600nm = 1 and 150 µl of DGVB-MgEGTA (control) to monitor spontaneous 
haemolysis. They were incubated for one hour at 37°C on a shaker. After treatment, 
spun down (10,000 rpm, 5 min), 100 µl of the supernatant was added with 100µl of 109 
cells/ml NE in DGVB-MgEGTA and the tubes were kept for 1 hour at 37° C. This 
stage of the haemolytic assay was performed to measure the total complement activity. 
After incubation, they were spun down at 2,500 rpm for 15 minutes. Absorbance of the 
supernatant was read at OD 541 nm.  
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2.17 Complement dependent interactions of M bovis BCG coated with rfBC with 
THP-1 cells and phagocytosis by CFU (Colony forming Units). 
THP-1 macrophage cells were grown in complete RPMI media as described in method 
section 2.5. The same numbers of THP-1 cells were grown, differentiated and seeded 
into the 12 well plates as mentioned in method section 2.13.1.  
M. bovis BCG were grow to OD600=0.6-1.0 at log phase (stationary culture). This M. 
bovis BCG solution was separated into eppendorf tubes; 1: M. bovis BCG, 2: M. bovis 
BCG+Complemnt activated, 3: M. bovis BCG+Complemnt activated+conglutinin 
10µg 4: M. bovis BCG=Complemnt activated+conglutinin 20µg and M. bovis 
BCG+Conglutinnin 40µg. Spun down 1.2 ml of culture with OD600 = 1.00 in 2 ml 
microfuge tube of all conditions at 3300 × RCF for 10 minutes. After harvesting cells, 
resuspended bacterial pelle + in to 200µl 1:5 serum dilution  (40µl adsorbed serum and 
160µl DGVB++MgEGTA buffer) except first condition without complement. They 
were incubated for 45 min at 37°C on a shaker to activate alternative complement 
pathway and deposited complement protein on M. bovis BCG. After incubation spun 
down samples at 3300xg for 10 minutes. 
After harvesting bacteria, the bacterial pellet was resuspended in 200 µl of plain RPMI 
with no supplements. To ensure a single-cell suspension, the bacteria were passed 
through from 1ml syringe with 25-gauge needle, 12–15 timesTubes were set up with 
10, 20 and 40 µg/ml of conglutinin added to bacteria, together with 5mM of CaCl2 
(10µl of 0.1 M CaCl2). Samples were incubated on a shaking incubator at 37oC for 1 
hour followed by 1 hour at 4oC with shaking to allow conglutinin to bind. After 2 
hours incubation with rfBC, bacterial cells were centrifuged at 3300g for 10 minutes 
and then gently resuspended in 2 ml of plain RPMI. 
70µl of the bacterial suspension with and without rfBC was added to the THP-1 cells 
giving a muliticity of infection (MOI) of 10:1, (bacteria:cells). Bacteria were then 
mixed with THP-1 cells by gentle pipetting in the wells. Assays were then incubated at 
37°C and 5% CO2 for 3 hour, 6 hour, 24 hour and 48 hour time-points. 
After each time-point of incubation, the supernatant was collected for cytokine protein 
analysis. THP-1 cells were then washed 3 times with plain RPMI and removed using 
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0.25% of trypsin and incubated at 37oC for 10 minutes. Then 500µl of RPMI with 
serum was added to neutralize the effect of trypsin. Cells were then centrifuged at 1400 
rpm for 10 minutes and the supernatant discarded. At the 3- and 6-hour time-points, 
THP-1 cells were lysed and colony-forming unit assay performed to investigate the 
number of intracellular bacteria (see below). For the remaining time-points, 
supernatants and pellets were collected and stored at -80oC for further experiments. 
For the 3- and 6-hours timepoints, cell pellets were harvested and resuspended in 1ml 
0.1% saponin to lyse the THP-1 cells. The cells were vortex for 10 minutes. Ten-fold 
Serial dilutions were then made by same way as mentioned in method section 2.13.1. 
200µl was plated on 7H10 plates supplemented with 10% OADC at each dilution. 
Assays were conducted in triplicate. 7H10 plates were incubated for 2-3 weeks at 37oC 
and then bacterial colonies counted and analysed. 
2.18 Complement dependent interactions of M. bovis BCG coated with rfBC with 
THP-1 cells and phagocytosis by microscope. 
1 x 105cells/well of THP-1 were seeded, grown and differentiated on sterile coverslips 
same as mentioned in method section 2.13.2. M. bovis BCG GFP (strain producing 
GFP harbors plasmid pGFPHYG2) culture with OD600 = 0.8 is separated into five 
microfuge tubes; 1: M. bovis BCG, 2: M. bovis BCG+Complemnt activated, 3: M. 
bovis BCG+Complemnt activated+rfBC 10µg, 4: M. bovis BCG+Complemnt 
activated+rfBC 20µg and 5: M. bovis BCG+Conglutinnin 40µg. All tubes were spun at 
3300 × RCF for 10 minutes to collect the bacterial pellet. After harvesting cells, 
resuspended bacterial pellet in to 200µl 1:5 serum dilution (40µl adsorbed serum and 
160µl DGVB++MgEGTA buffer) except first condition without complement. They 
were incubated for 45 min at 37°C on a shaker to activate alternative complement 
pathway. After incubation spun down samples at 3300xg for 10 minutes.  
After harvesting bacteria, the bacterial pellet was resuspended in 200 µl of plain RPMI 
with no supplements. To ensure a single-cell suspension, the bacteria were passed 
through from 1ml syringe with 25-gauge needle, 12–15 times 
Tubes were set up with 10, 20 and 40 µg/ml of rfBC added to bacteria, together with 
5mM of CaCl2 (10µl of 0.1 M CaCl2). Samples were incubated on a shaking incubator 
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at 37oC for 1 hour followed by 1 hour at 4oC with shaking to allow rfBC to bind. After 
2 hours incubation with rfBC, bacterial cells were centrifuged at 3300x g for 10 
minutes and then gently resuspended in 2 ml of plain RPMI. 
70µl of the bacterial suspension with and without rfBC was added to the THP-1 cells 
giving a muliticity of infection (MOI) of 10:1, (bacteria:cells). Bacteria were then 
mixed with THP-1 cells by gentle pipetting in the wells. Assays were then incubated at 
37°C and 5% CO2 for 3 hour and 6 hour. 
After 3 hours of incubation, the supernatants were discarded from the wells. Coverslips 
were then washed 3 times with 500 µl PBS in wells. Coverslips were then fixed with 
300 µl of 4% paraformaldehyde (PFA for 10 minutes at room temperature. After 
fixing, cells were then washed 3 times with 500 µl of PBS.  
A master mix containing PBS, Hoechst (1:10000) and wheat germ agglutinin (WGA) 
(Thermo Scientific) (1:500) was prepared. 50µl of the master mix was added to each 
coverslip and incubated for 10 minutes at room temperature in the dark. Coverslips 
were then washed 5 times with 1ml of PBS and placed on the glass microscope slides 
for visulalisation using a fluorescent micropose (Leica DM4000 microscope). Few 
drops of antifade (Citifluor AF3) were added on each coverslips and slides covers were 
used on top of cover slips. 
2.19 Quantitative real-time polymerase chain reaction (q-PCR) to determine gene 
expression 
2.19.1 rfBC treatment of THP-1 cells with or without intracellular M. bovis BCG 
Inhibition assay were performed for intracellular M. bovis BCG according to the 
protocol mentioned in section 2.13.1 and 2.17. The experiment included THP-1 cells as 
a control, THP-1 cells with intracellular M. bovis BCG treated with 10µg/ml, 20µg/ml 




2.19.2 Designing Primers for target genes 
Forward and Reverse Primers for various target genes were designed using Basic Local 
Alignment Search Tool (BLAST) and Primer-BLAST utility available at NCBI. 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The sequences for the forward and reverse 
primers used for target genes are shown in Table 2.4. These primers were used in the 
previous studies in the lab (Kouser, L et al, 2018; Abdul-Aziz, M et al, 2016) 
 
Table 2.4: DNA Sequence for forward and reverse primers used for amplification of different 
target genes in THP-1 cells. All sequences are 5’ to 3’. 
2.19.3 RNA extraction from THP-1 cells 
Total RNA extraction from THP-1 cells was performed using the GenElute™ 
Mammalian Total RNA Purification Kit (Sigma-Aldrich) according to the 
manufacturer’s protocol. THP-1 cells were first thawed on ice and 250 µl of lysis 
solution containing 2.5 µl 2-mercaptoethanol (2-ME) to the cell pellets. The mixture 
was thoroughly vortexed until all the clumps dissolved. To each cell lysate, 250 µl of 
Target 
gene 

























70% ethanol was added and was vortexed briefly before loading onto RNA binding 
columns. The samples were centrifuged at 13000 rpm for 15 seconds. The column was 
the washed once with 500µl of Wash Solution 1 at 13000 rpm for 15 seconds followed 
by washing twice with 500 µl Wash solution 2 for 15 seconds each. To remove any 
excess ethanol left from washing, the columns were spun for another 2 minutes at 
13000 rpm. The columns were then placed in fresh collection tubes and the total RNA 
was eluted by adding 50µl elution solution to each column and spinning them at 13000 
rpm for 1 minute. Eluted RNA was kept in a -80°C freezer until further use.  
2.19.4 DNase treatment 
The eluted RNA was made free of any contaminating DNA by using DNase I kit 
(Sigma-Aldrich). 50 µl of eluted RNA was treated with 5 µl of 10X buffer and 5µl of 
DNase I enzyme for 15 minutes at room temperature to allow digestion of any DNA 
present in the sample RNA. The reaction was stopped by adding 5µl of stop solution 
and transferring the samples to a heat block at 70°C for 10 minutes to inactivate the 
DNase I enzyme.  
At this point the concentration eluted RNA was estimated by	measuring the absorbance 
at 260 nm and the quality of eluted RNA was determined from the ratio of absorbance 
at 260:280nm using NanoDrop 2000/2000c (Thermo Fisher Scientific, UK). 
2.19.5 Synthesis of cDNA from total RNA 
High Capacity RNA to cDNA Kit (Applied Biosystems, USA) was used for the 
synthesis of cDNA from the purified eluted RNA by reverse transcription. A master 
mix consisting of 2X RT buffer (10 µl/sample) and 20X enzyme mix (1 µl/sample) 
was prepared. 11 µl of the master mix was added to each tube containing 9 µl of eluted 
RNA in PCR tubes on ice. Finally, the eluted RNA was converted into cDNA by 
placing the tubes in a thermal cycler (Peqlab). The samples were incubated at 37°C for 
60 minutes and the reaction was terminated by heating the samples to 95°C for 5 
minutes. The synthesized cDNA samples were stored at -20°C. 
2.19.6 Quantitative real time PCR (qPCR)  
The level of mRNA expression for various target genes were analsysed using qPCR. 
The reactions were carried out in triplicate for each target gene in a MicroAmp™ Fast 
Optical 96-Well Reaction Plate (Applied Biosystems). For each well the reaction 
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mixture consisted of 5 µl of iTaq™ Universal SYBR® Green Supermix (Bio-Rad, 
USA), 0.15 µl of 5 µM gene specific forward and reverse primers respectively and 1 µl 
(500ng) of relevant cDNA. The final concentration in each well was made 10µl by 
adding ultra-pure water (Sigma-Aldrich, UK). The plates were sealed using transparent 
adhesive sealing films and centrifuged at 1000rpm for 1 minute to settle the contents in 
the wells. Finally, the q-PCR plate was placed in a Step One Plus™ qPCR machine 
(Applied Biosystems). Initially the samples were incubated 2 min at 500C followed by 
incubation at 950C for 10 min. The template was amplified for 40 cycles under 
temperature conditions; 15s incubation at 950C and 1 min at 600C.  
2.19.7  Data analysis 
Human 18S rRNA gene was included as an endogenous control in all the qPCR 
experiments.  18S rRNA was used to normalize the mRNA levels of genes of interest 
before the comparison between different samples by the real time PCR.  Housekeeping 
genes are stable, expressed in the cells and tissues of interest that do not show changes 
under the experimental conditions. Data was analysed by using the RQ Manager 
Version 1.2.1 (Applied Biosystems). Cycle threshold (CT) values were obtained at the 
end of qPCR for target genes from different experimental conditions. Mean CT values 
were calculated from the obtained CT values for triplicates. The relative expression for 
target genes was calculated by Relative quantification (RQ) using the equation RQ=2-
∆∆Ct 
2.19.8  Multiplex analysis  
Multiplex assay was performed to determine the expression of multiple proteins with 
in a sample. As described above in the experiment of 2.13.1 and 2.17 (material and 
method section), the samples supernatants were collected from the phagocytosis assays 
after 24 hour  and 48 hour of treatments to THP1-cells to determine secreted cytokines 
(IL-6, IL-10, IL12p40, IL12p70, IL-1α, IL-1β,   TNF-α, IL-17A, IL-4, TNF-β), 
chemokines (MCP-3, MDC, Eotaxin,   Fractalkine, GRO, MCP-1), growth factors (IL-
2, FGF, G-  CSF, GM-CSF, IL-4, VEGF) and other ligands and receptors ( IFN-Υ, 
FLT-3L, IL-1RA). MagPix Milliplex kit (EMD Millipore) was used to   measure 
cytokine response following the manufacturers protocol. 25 µL of assay buffer   was 
added to each well of a 96-well plate, followed by the addition of 25 µL of standard, 
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  controls or supernatants of cells treated with M. bovis BCG in the presence or absence 
of rfBC and complement. 25 µL of magnetic beads coupled to analytes of interest were 
added in each well, and incubated for 18 hours at 40C the 96-well plate was  washed 
with the assay buffer and 25 µL of detection antibodies were incubated with the  beads 
for 1 hour at room temperature. 25 µL of Streptavidin-Phycoerythrin was then added 
  to each well and incubated for 30 mins at room temperature shaking at 750 rpm. 
Following  a washing step, 150 µL of sheath fluid was added to each well and the plate 
was read using   the Luminex Magpix instrument. Assays were conducted in duplicate.  
 2.20  Statistical analysis  
Analysis of data for statistical significance was conducted using GraphPad Prism 5 for 
Windows (GraphPad Software, Inc). Statistical analyses were made using 2-way 
ANOVA   for mRNA expression data and a 1-way ANOVA for the multiplexdata. p-
value of less than or equal to 0.05 was consisderd to be significant and. P values <0.05 
were considered statistically significant representewith an asterisk (*) on the graphs, 








Chapter 3: Purification and characterization of recombinant 
fragment of bovine conglutinin (rfBC) expressed in 




 3.1 Introduction 
Conglutinin synthesised in the liver (Holmsky et al., 1992) and is a calcium dependent 
lectin, which occurs frequently in animals yet also found in chickens (Hogenkamp et 
al., 2006) and fish (Nakao et al., 2006).  
The first aim was to express, purify and characterized the rfBC. This chapter describes 
the expression of the rfBC in E.coli, BL21 (DE3) pLysS  (prokaryotic expression 
system). rfBC consist of neck and CRD region (conglutinin-neck-CRD) has been 
expressed and purified successfully. The recombinant protein denatured and purified 
using maltose-agarose affinity chromatography. Protein purification was confirmed by 
SDS-PAGE analysis. ELISA and western blot were performed to detect the rfBC 
presence in the purified samples. This recombinant protein, which is formed of neck 
and CRD region, was found to form trimers. Binding of rfBC was observed on M. 
smegmatis  (non-pathogenic model of mycobacteria).  
The second aim in this study was to investigate the following roles of rfBC on M. 
smegmatis: 1. Binding of rfBC with M. smegmatis  (non-pathogenic model of 
mycobacteria). 2. Direct effect of rfBC on the growth of M. smegmatis. 3. Effect of 
rfBC on the phagocytosis of M. smegmatis by the THP-1 cells. 
In this chapter MBP (Maltose binding protein) was expressed in E.coli, BL21 (DE3) 
pLysS and purified by affinity chromatography. The purpose of MBP production was 





3.2 Results  
3.2.1  Expression and purification rfBC in E. coli (BL21 (DE3) pLysS strain) 
rfBC was expressed in E. coli and purified by using affinity chromatography. Pilot 
expression was performed to check the expression of different clones after 
transformation. Visible protein bands at 23kDa showed that transformation was 
successful (Figure 3.1). Three transformed random colonies were picked up for further 
expression analysis. Colony number one (lane 3) showed higher yield of rfBC 
expression as compared to the other expressed clones analysed. 
 
 
Figure 3.1: Pilot expression of rfBC in E. coli BL21 (DE3) pLysS. Lane 1 is the protein marker, Lane 
2 is uninduced sample, and Lane 3,4 and 5 are IPTG induced cultures from colony 1, 2 and 3 
respectively. Protein bands appear in all of the induced cultures at 23 kDa. rfBC expression is more 
prominent in colony 1 (Lane 3). Samples were run on a SDS-PAGE (12% w/v gel) followed by 
Coomassie staining. 
  











3.2.2  Large scale expression of rfBC 
Large-scale expression was performed to produce a high yield of rfBC in order to 
perform the further experiments in this thesis. Colony 1 from pilot expression (Figure 
3.1) was selected to inoculate in large-scale volume of the media and induced with 
IPTG to induced expression of rfBC (Figure 3.2).  
 
Figure 3.2: Large-scale expression of rfBC. rfBC expression is analysed from the BL21 (DE3) pLysS 
colony 1. The samples were run on 12% SDS-PAGE (12% w/v gel). Lane 1 contained protein marker, 
Lane 2: un-induced sample, Lane 3: un-induced sample incubated 3 hours and Lane 4: Induced sample. 
The protein band appeared in lane 4 at molecular weight 23 kDa is the result of expression induction 
using IPTG and all the  other bands are non interested proteins.   
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3.2.3  Purification of rfBC 
The rfBC was purified from large-scale expressed cell lysate. SDS-PAGE showed that 
protein is present in the inclusion bodies in the cell pellet (Figure 3.3, lane 2). The cell 
lysate was lysed and sonicated. rfBC was recovered from inclusion bodies after 
denaturing and refolded by dialysis against decreasing concentrations of urea-TBS 
buffer. Protein was purified by ion exchange and affinity chromatography (Figure 3.3, 
lane 3 and 4). 
 
Figure 3.3: rfBC purified fractions. Lane 1 contains the protein marker, Lane 2: Sample after lysis and 
sonication from cell pellet showing presence of rfBC in inclusion bodies, Lane 3 and 4 are purified rfBC 
(loaded in duplicate) at 23kDa expected band. The rfBC purified by ion exchange and affinity 
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3.2.4  Western blot and ELISA analysis of rfBC for confirmation of protein by 
anti-conglutinin. 
Western blotting was used to identify the rfBC. Purified rfBC is separated by SDS-
PAGE and then transferred electrophoretically onto a nitrocellulose membrane. rfBC 
was identified by probing with rabbit anti bovine conglutinin.  
ELISA was also carried out to confirm the presence of rfBC in purified fractions. The 
results identified that rabbit anti bovine conglutinin monoclonal antibody bound with 
rfBC. There was no binding observed with the negative control protein (mannose 
binding protein) both in Western blot analysis (Figure 3.4B) and very little in ELISA 




3.2.4.1  Western blot analysis 
rfBC is separated on SDS-PAGE for western blot analysis. Maltose binding protein 
(MBP) was used as a control protein. Three concentrations 5µg/ml, 10µg/ml and 
20µg/ml of rfBC and MBP were loaded on to the gel to confirm the presence of rfBC 
in the purified samples (Figure 3.5 A). Following SDS-PAGE, primary and secondary 
antibodies applied to the samples. Western blot analysis confirms the identity and 
purity of rfBC using rabbit anti-bovine conglutinin. Western blotting with anti-MBP 
(not shown) confirmed no reaction with rfBC and reaction with 42.5 kDa MBP  
 
 
Figure 3.4 A: SDS-PAGE gel of rfBC and MBP for western blot analysis. Lane 1 contains the 
molecular mass standards (protein marker), lane 2 rfBC 5µg, lane 3 rfBC 10µg, lane 4 rfBC 20 µg, lane 
5,6 and 7 loaded with MBP 5µg, 10 µg and 20 µg respectively. Samples were run on 12% SDS-PAGE 
gel. MBP used as a negative control. 
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Figure 3.4 B: Western blot analysis of rfBC for confirmation of proteins by anti- conglutinin. The 
immunoblot shows three different concentration of rfBC that have been loaded. Lane 1 contains rainbow 
protein marker, lane 2, 3 and 4 with rfBC 5µg, 10µg and 20 µg, lane 5,6 and 7 are loaded with MBP 
5µg, 10 µg and 20 µg. MBP was used as a negative control. The gel was immunostained rabbit anti-
bovine conglutinin antibody that identified rfBC at 23kDa.  
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3.2.4.2 ELISA to confirm the rfBC presence in purified fractions 
ELISA was performed to detect the rfBC presence in the purified fraction. ELISA plate 
was coated with different dilutions 0.65 µg, 1.25 µg ,2.5 µg and 5 µg of rfBC and then 
rabbit anti-bovine conglutinin was added to the rfBC and secondary antibody used to 
detect the complex. MBP used as a control. We found the binding with anti-rfBC in all 
the concentrations but we could not find significant binding at any concentration of 
MBP (Figure 3.5).This shows us rfBC is present in the purified samples. 
 
Figure 3.5: ELISA data confirmed presence of rfBC in the purified fractions. Different  serial 
dilutions  of rfBC and MBP (0.65 µg, 1.25 µg ,2.5 µg and 5 µg) were treated with monoclonal anti-
rfBC. Samples were read at 450nm. Each histogram represents the average of 3 independent 
experiments. Error bars represent the SEM. There is a significance difference established MBP and rfBC 





























3.2.5  Endotoxin level measurment (LAL assay) of rfBC 
The Limulus amebocyte lysate (LAL) assay was performed to measure the endotoxin 
level in the purified rfBC. Chromogenic LAL endotoxin assay kit (Genscript) was used 
to carry out the test. The endotoxins activate Factor C proteolytic activity present in 
LAL, which is photometrical, measured using chromogenic substrate at optical density 
(OD405). The endotoxin level in rfBC was 0.23 EU/ml and assay results were linear 
(Figure 3.6). One EU is equal to 100pg of E. coli lipopolysaccharide. 
	
Figure 3.6: LAL assay to measure endotoxin levels in the purified rfBC. Each data point shows the 
optical density for triplicate data from different concentrations of endotoxin solution. The endotoxin 
level in purified rfBC were found to be ~0.23 pg/mg. 
  


















3.2.6   Cross-linking of rfBC 
To verify that rfBC was correctly folded and formed a homotrimer in solution, 
chemical cross-linking using BS3 was performed on the purified protein. rfBC formed 
trimers in a time and BS3 concentration-dependant manner. It has been confirmed that 
rfBC formed the dimers and trimers same way as in native form (Figure 3.7). 
 
 
Figure 3.7: Chemical cross-linking of purified rfBC to show that it could form dimeric and 
trimeric structures. 20 µg/ml of rfBC were incubated with 1mM BS3 (bis(sulfosuccinimidyl)suberate) 
for 0 min (lane 1), 1 min (lane 2), 2 min (lane 3), 4 min (lane 4), 8 min (Lane 5), 16 min (Lane 6), 32 
min (lane 7), 64 min (lane 8). Protein marker (lane 9). Samples were resolved on a SDS-PAGE (12% 
w/v gel) followed by Coomassie staining and show dimers at 46 kDa and trimers at 69 kDa. 
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3.2.7  Expression and purification of maltose binding protein (MBP) in E. coli 
(BL21 (DE3) pLysS strain) 
Maltose binding protein was expressed in E. coli and purified by using amylose resin 
column. Pilot expression confirmed the successful transformation of MBP plasmid in 
to the E. coli (Figure 3.8A). One of the colonies from pilot expression was selected to 
produced MBP at large scale. In large scale clone expressed the MBP protein very well 
(Figure 3.8B). MBP was purified from the cell lysates by passing through amylose 
resin column. The eluted fraction was characterised on 12% SDS-PAGE, shown the 
expected band at 42.5 kDa (Figure 3.8C). 
 
	
Figure 3.8A: Characterisation of MBP produced during pilot expression. Clear MBP band shown in 
both clones of the MBP and there is no band in the uninduced sample. Lane 1 contains protein marker. 
Lane 2 and 3 were loaded with induced clones of MBP and bands appeared at 42.5 kDa in both clones. 
Lane 4 comprised of an un-induced sample Samples were run on a SDS-PAGE (12% w/v gel) followed 
by Coomassie staining. 
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Figure 3.8 B: Characterisation of MBP produced during large-scale expression. MBP band shown 
in the induced sample and there is no band in the uninduced sample. Lane 1 contains protein marker. 
Lane 2 with un-induced sample and Lane 3 loaded with induced sample. MBP appeared at 42.5 kDa in 
induced colony. Samples were run on a 12% SDS-PAGE (12% w/v gel) followed by Coomassie 
staining.  
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Figure 3.8 C: Purified fraction of maltose binding protein (MBP). Purified fraction of MBP 
characterised on 12% SDS-PAGE. Purified MBP migrated at a molecular weight of 42.5 kDa. Lane 1 
contains protein marker and lane 2 with MBP purified fraction. Samples were run on a 12% SDS-PAGE 
(12% w/v gel) followed by Coomassie staining.  
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3.2.8 Binding of rfBC to M. smegmatis in the presence of calcium and EDTA  
This study was performed to investigate the binding of rfBC to M. smegmatis and also 
to see either this binding is calcium dependent. Higher binding observed at higher 
concentration of rfBC and also it was confirmed that strong binding observed in the 
presence of calcium components. There was less binding observed in the presence of 
EDTA (Figure 3.9). 
 
 
Figure 3.9: Binding of rfBC to M. smegmatis. No rfBC and MBP (Maltose binding protein) were used 
as a negative control and triplicate the condition to calculated the average for more accuracy. Data 
showed us that the binding was calcium dependent and maximum binding observed with 20µg rfBC 
concentration. Each histogram represents the average of 3 independent experiments. Error bars represent 
the SEM. There is a significance difference established between M. smegmatis binding with rfBC in 
EDTA buffer and M. smegmatis binding with rfBC in Ca2+ buffer. Error bars represent the standard error 
of the mean (SEM). P value analyse by applying unpaired one-way ANOVA test (*p<0.05). 
 
  























3.2.9 Direct effect of rfBC on M. smegmatis growth 
In this study, we found that rfBC directly inhibited the growth of M. smegmatis. Three 
concentrations  10 µg, 20 µg and 40 µg of rfBC incubated with mycobacteria for 2 
hours (1 hour at 370C and 1 hour at 40C) and 0 µg rfBC was used as a control (Figure 
3.10). rfBC inhibited the grwoth of M. smegmatis. Growth was inhibited 13% with 10 
µg /ml rfBC, 24 %  with 20 µg /ml rfBC and  40 µg/ml of rfBC inhibited the growth of 
M. smegmatis  directly by 44% and the results are statistically significant.Three 
independent experiments shown the same trend of growth inhibition (Figure 3.10). 
 
Figure 3.10 : Direct Effect of rfBC on M. smegmatis growth. Different  concentration of rfBC 10 µg, 
20 µg and 40 µg were added  to M. smegmatis. M. smegmatis were incubated with and without rfBC for 
2 hours . Bacterial colony forming units were obtained and counted. The percentage difference in 
growth for each rfBC concentration was calculated with respect to untreated M. bovis BCG as 100% 
(corresponding to 6 x 104 cells). The experiment was performed in triplicate for each rfBC concentration 
and was repeated 3 times. There is a significance difference established between un-treated samples (M. 
smegmatis only) and M. smegmatis treated with 40 µg rfBC. Error bars represent the standard error of 
the mean (SEM). P value analyse by applying unpaired one-way ANOVA test (*p<0.05, **p<0.01). 
  
























3.2.10 Effect of rfBC on uptake of M. smegmatis by THP-1 cells 
The effect of rfBC on uptake of M. smegmatis by THP-1 cells was studied after 3 and 6 
hours treatment. In this study results shown that rfBC reduced the uptake with a M. 
smegmatis, reduction of uptake  was observed 9 % with 10 µg /ml rfBC, 17 %  with 20 
µg /ml rfBC and 27% reduction of uptake of M. smegmatis treated with 40µg rfBC by 
THP-1 cells as compared to untreated mycobacteria for 3 hours.  
While after 6 hours incubation of M. smegmatic with THP-1 cells, reduction in uptake  
was observed 11 % with 10 µg /ml rfBC, 17 %  with 20 µg /ml rfBC and 26% 
reduction of uptake of M. smegmatis treated with 40µg rfBC by THP-1 cells as 
compared to untreated mycobacteria which is nearly similar to the 3 hours results 
(27%). The results are statistically significant (p=0.05) with only 40µg/ml rfBC for 3 
and 6 hours. 
 
Figure 3.11: Effect of rfBC on the uptake of M. smegmatis by THP-1 cells. Three concentration 
(10µg, 20µg, 40µg) of rfBC were incubated with M. smegmatis for two hours. rfBC coated M. 
smegmatis were treated to THP-1 cells for 3 and 6 hours to study the effect of rfBC. Bacterial colony 
forming units were obtained and counted. The percentage difference in growth for each rfBC 
concentration was calculated with respect to untreated M. bovis BCG as 100% (corresponding to 6 x 104 
cells). The experiment was performed in triplicate for each rfBC concentration and was repeated 3 
times. There is a significance difference established between un-treated samples (M. smegmatis only) 
and M. smegmatis treated with 40 µg rfBC for 3 and 6 hours. Error bars represent the standard error of 
the mean (SEM). P value analyse by applying unpaired one-way ANOVA test (*p<0.05, **p<0.01).  


























3.3  Discussion 
In this study, rfBC protein consisting of residues 197-351 of the native protein was 
successfully expressed (Figure 3.1, lane 3-5 and Figure 3.2, lane 4). The residues 197-
224  (28 amino acids) represent α-helical neck region and residues 225-351  (127 
amino acids) make the long C-terminal CRD region of the naturally produced bovine 
conglutinin (Wang et al., 1995). The rfBC was expressed by using the T7 promoter 
expression system E.coli, BL21 (DE3) pLysS that produced a large amount of protein. 
It has been observed that rfBC formed inclusion bodies (Figure 3.3, lane 2). In order to 
denature and refolding of insoluble form of rfBC it was dialysed against different 
concentration of urea buffer. The expressed rfBC protein consisting of neck-CRD was 
purified by ion exchange and affinity chromatography and gave a major band of 23 
kDa on SDS-PAGE (Figure 3.3, lane 3), which is similar in molecular size to that of 
rfBC (Wang et al., 1995).  
The rfBC protein was made free of endotoxin before use in further experiments, as 
endotoxin can interfere in the experiments by causing the activation of macrophages 
(Martinez et al, 2008). LAL assay was used to measure the concentration of endotoxin 
in the expressed rfBC. The endotoxin level was found to be less than 1EU/ml (Figure 
3.6). The purified rfBC protein was characterised by performing western blot and 
ELISA by using rabbit anti-rfBC IgG as a probe, MBP used as a control and the rfBC 
specific antibody showed no binding to this protein. 
Native bovine conglutinin monomers can combine to form a trimeric structure that is 
stabilised by inter-monomer covalent disulphide bridges, binding cysteine residues in 
N-terminals or in collagen domain (Hoppe and Reid, 1994). rfBC has been expressed 
as a neck-CRD region, in order to investigate weather this protein can also form dimer 
and trimer to stabilise the rfBC structure. Cross linking of the rfBC protein via BS3 
linker showed its ability to form dimers and trimers (Figure 3.7), suggesting that 
conglutinin-neck-CRD have potential to form oligomers. Dimers and trimers increase 
the affinity of conglutinin protein to bind to its receptors. As natural bonds between the 
polypeptide chains are weaker and while running the sample on SDS-PAGE treated 
with buffers and heat treatment can easily break week bonds so BS3 cross linker used 
to strength the bond to easily visible to characterise the rfBC presence in the solution.  
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In this study, recombinant fusion mannose binding protein (MBP) was expressed and 
purified. MBP was produced using E.coli, BL21 (DE3) pLysS expression system. The 
MBP was purified by affinity chromatography using amylose resin column and a major 
band appeared at 42.5 kDa on SDS-PAGE (Figure 3.8 C, lane 2). MBP was produced 
to be used as a negative control for rfBC protein in this study.  
Conglutinin is structurally similar to another important member of collectin family 
lung surfactant protein D (SP-D) (Lu et al., 1993) and SP-D is able to target glycol 
conjugates on pathogens, preventing infection by stimulating phagocytes to eliminates 
pathogens and also by regulating immune responses (Ferguson et al., 1999). It is 
thought that the additional bovine collectin is derived from gene duplication events an 
ancestral bovine SP-D gene. However, unlike other members of collectin family 
conglutinin is exclusively found in cattle (Holmskov, 2000). Unlike SP-D, the 
biological function of conglutinin is not well understood. Conglutinin is synthesised in 
the liver and found in serum at approximate concentrations of 12 µg/ml  (Holmskov et 
al., 1998). Conglutinin has also been found in the spleen, tonsils and lymph nodes 
(Holmskov et al., 1992). It is currently not known whether conglutinin is synthesised 
locally e.g. lungs as a result of respiratory infection. A limited number of studies have 
shown that conglutinin does bind to microorganisms. Conglutinin has been shown to 
bind to viruses (bovine herpes virus 1, influenza A virus and Nebraska calf diarrhoea 
virus) and can aggregate, enhance attachment and enhance phagocytosis and killing 
(Reading et al., 1998; Hartshorn et al., 1993). Conglutinin has also been shown to bind 
with yeast cells such as S. cerevisiae and C. albicans in the presence of Ca2+ ions (Dec 
et al., 2012). It has been shown that native conglutinin and rfBC binds to LPS 
(lipopolysaccharides) of Gram-negative bacteria, such as Klebsiella pneumoniae, 
Pseudomonas aeruginosa and Escherichia coli (Wang et al., 1995). However, a 
detailed evaluation of the role of conglutinin in bovine infection and immunity is yet to 
be carried out. 
The collectins trimer structure plays a vital part in the strong interaction to the 
carbohydrate-containing microorganism and present them to immune cells (Hakansson 
and Reid 2000). Conglutinin is composed of 4 trimeric units (Hansen et al., 2002).  
Conglutinin has the ability to bind with N-acetyl glucosamine, mannose, and fucose 
residues (Loveless et al., 1995), and can also bind with zymosan (Andersen et al., 
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1992). It has also been reported that conglutinin binds to zymosan and iC3b 
(complement fragment) in a calcium dependent manner (Dec and Wernicki, 2006). In 
this study, conglutinin binding to M. smegmatis was investigated. In this study we 
show for the first time that rfBC can bind to the surface of M. smegmatis and this 
binding is dependent on Ca2+, as it is C-type lectins (Figure 3.9). In contrast, binding in 
the presence of EDTA was observed 3 to 4-fold less, while almost no binding was 
observed with maltose-binding protein (MBP) (Figure 3.9). This shows that 
conglutinin is a calcium dependent lectin confirming previous findings (Friis et al., 
1991). A concentration of 20 µg/ml of rfBC was enough to reach saturation of binding, 
which is almost similar to the approximate in vivo serum levels of rfBC in cattle of 12 
µg/ml (Holmskov et al., 1998).	 The binding of rfBC with mycobacteria has not been 
reported before. However, it has been shown that SP-D two important ligands present 
on the outer surface of M.tb those are LAM and mannose capped LAM (ManLAM) 
(Ferguson et al., 1999). 
We also investigated the direct effect of rfBC on M. smegmatis growth. We observed 
the growth inhibition of M. smegmatis by rfBC in a dose dependent manner and the 
same trend of growth inhibition was observed in all the experiments performed. There 
is 13% reduction in growth observed for 10 µg/ml, 24% for 20 µg/ml and 44% for 40 
µg/ml of rfBC. The growth inhibitory effect at 40µg/ml of rfBC was statistically 
significant (Figure 3.10). The direct effect of rfBC on mycobacteria has not been 
studied previously. It has been reported that mice injected with conglutinin prolonged 
the survival of the mice after infection with Salmonella typhimurium (Friis et al., 
1991).  
M. smegmatis was incubated with rfBC for 2 hours prior to treat with THP-1 cells. The 
infection with THP-1 cells after 3 and 6 hours shown to reduce the uptake of M. 
smegmatis coated with rfBC (Figure 3.11). There is 11% reduction in growth observed 
for 10 µg/ml, 17% for 20 µg/ml and 26 % for 40 µg/ml of rfBC. This reduction in 
uptake of M. smegmatis by THP-1 cells was significant at 40µg/ml of rfBC (Figure 
3.14). The reason for M. smegmatis minimal uptake could be rfBC is masking 
mycobacterial ligands and preventing uptake, possibly through mannose receptors 
present on macrophages. In one of the study it has been reported that SP-D most 
similar member of collectin family to the conglutinin also shown the less uptake of the 
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M. tb by macrophages by masking the mannose receptors those play a significant role 








Chapter 4- The role of conglutinin (rfBC) in mycobacterial 





Bovine conglutinin is structurally very identicals to Surfactant Protein D (SP-D). It has 
been known that SP-D interacts with Mycobacterium tuberculosis. Mycobacterium 
tuberculosis is very similar to M. bovis, the causative agent of bovine tuberculosis. We 
assume that due to the overall relevance between conglutinin and SP-D, conglutinin is 
likely to have a protective impact in bovine tuberculosis. This has never been studied 
before. Conglutinin mediates bactericidal activity toward Gram-negative bacteria in a 
system containing adherent leukocytes and complement (Friis-Christiansen et al., 
1990).  
In this chapter, we investigated the potential of the host bovine protein (rfBC) for its 
role in mycobacterial infection. The aim was to investigate the immunological 
properties of the rfBC in vitro. In the previous chapter we established that rfBC binds 
with M. smegmatis, study model for mycobacterial species. In this study we used M. 
bovis BCG as a model organism for M. bovis and THP-1 macrophages as a model cell 
line for phagocytes. The first aim in this study was to to establish the rfBC is a calcium 
dependent lectin to bind M. bovis BCG in presence of calcium. The second aim was to 
study the role of rfBC in host-pathogen interactions in bovine tuberculosis infection 
and investigating its potential as a therapeutic. For this study, we investigated 
following roles of rfBC on M. bovis BCG: 1. Direct effect of rfBC on M. bovis BCG. 
2. To study whether rfBC bound to the surface of M. bovis BCG inhibits the 
phagocytosis of M. bovis BCG by THP-1 cells. 3. To investigate if rfBC regulates 
cytokine responses during phagocytosis of and how these may play a role in adaptive 




4.2. Results  
4.2.1:  Binding of rfBC to M. bovis BCG  
ELISA was performed to show the binding of different concentration of rfBC to M. 
bovis BCG as described in the material and method section (2.2). M. bovis BCG only 
and MBP used as a controls. Proteins were diluted in two different buffers (5 mM Ca2+ 
and 5 mM EDTA), to study the calcium dependent property of rfBC in binding. 
Binding increased with increase concentration until 20 µg/ml of rfBC (Figure 4.1). It 
was observed that there is maximum binding at 20 µg/ml of rfBC and the rise in 
binding was dose-dependant. Significant binding was also observed only in the 
presence of Ca2+ and was inhibited in the presence of EDTA. Binding in the presence 
of 5 mM EDTA was reduced 3 to 4-fold, whilst negligible binding was seen with 
MBP.  
 
Figure 4.1:  Serial dilution of rfBC with M. bovis BCG in the presence of 5mM Ca2+ and 5mM 
EDTA buffers. rfBC binding to M. bovis BCG cells in the presence of Ca2+ with EDTA and maltose-
binding protein used as negative controls. Two-fold serial dilutions of rfBC were performed in 40mM 
Tris-HCl, 200mM NaCl, pH 7.4 containing 5 mM CaCl2 or 10 mM EDTA and added to the 
mycobacteria and allowed to incubate for 2 h. This was followed by incubation with rabbit anti-rfBC 
antibody or mouse anti-MBP monoclonal antibody. Then, protein A-HRP was added and developed 
with the substrate 3, 3’,5,5’-Tetramethylbenzidine (TMB) and the colour read at 450 nm. All assays 
were conducted in triplicate. There is a significance difference established between M. bovis BCG 
binding with rfBC in EDTA buffer and M. bovis BCG binding with rfBC in Ca2+ buffer. Error bars 
represent the standard error of the mean (SEM). P value analyse by applying unpaired one-way ANOVA 
test (*p<0.05).  
























4.2.2   Binding of rfBC with M. bovis BCG by immunofluorescence microscopy 
Immunofluorescence microscopy was performed to detect the binding of rfBC. In the 
previous binding experiment (Figure 4.1), we observed maximum binding on M. bovis 
BCG at 20 µg/ml of rfBC (Figure 4.1). Therefore this concentration was chosen to 
perform an immunofluorescence-binding assay for rfBC. Binding of rfBC was 
confirmed on M. bovis BCG. rfBC bound to M. bovis BCG in a calcium dependent 
manner (Figures 4.2, panels E and F),  whilst no binding was observed with MBP, used 




Figure 4.2: Binding of rfBC with M. bovis BCG by immunofluorescence microscopy. M. bovis BCG 
was incubated with 20 µg/ml of  rfBC or 20 µg/ml of maltose binding protein (MBP) (used as a negative 
control). Rabbit anti-rfBC IgG (1:100 dilution) was used as the primary antibody and goat anti-Rabbit 
IgG (H+L) secondary antibody, FITC (1:500) was used for detection of bovine rfBC bindings with M. 
bovis BCG cells. rfBC-treated M. bovis BCG is shown by green fluorescence (panels E and F). 
  

















4.2.3  Direct effect of rfBC on M. bovis BCG growth 
Here, it was demonstrated that surface-bound rfBC inhibited the growth of M. bovis 
BCG. Three concentrations of rfBC were investigated (10 µg, 20 µg and 40 µg/ml of 
rfBC) were incubated with mycobacteria for 2 hours (1 hour at 37oC and 1 hour at 4oC)  
and then cultured on agar plates for two weeks. The results revealed a dose-dependant 
trend that rfBC inhibited the grwoth of M. bovis BCG. Growth was inhibited by 26% 
with 10 µg/ml rfBC, 44 %  with 20 µg/ml rfBC and  89% with 40 µg/ml rfBC,  
compared to M. bovis BCG only (control) (Figure 4.3).	
 
 
Figure 4.3 : Direct Effect of rfBC to M. bovis BCG . Different  concentration of rfBC (10 µg, 20 µg 
and 40 µg/ml) were incubated with M. bovis BCG for 2 hours. Untreated M. bovis BCG was used as a 
negative control. Each bar represents the average of 3 experiments. There is a significance difference 
established between un-treated samples (M. bovis BCG only) and treated (M. bovis	BCG + rfBC). Error 
bars represent the standard error of the mean (SEM). P value analyse by applying unpaired one-way 
ANOVA test (*p<0.05, **p<0.01) (n=3). 
  


























4.2.4 Fluorescence microscopy to study the direct effect of rfBC on the M. bovis 
BCG. 
This experiment was performed to see whether rfBC lysed the cell membrane of the 
mycobacteria, which resulted in M. bovis BCG growth inhibition. We have not 
observed bacterial cell lyses in untreated M. bovis BCG (Figure 4.4, panel A) and 
rfBC- treated M. bovis BCG (Figure 4.4, panel C), as determined by propidium iodide 
(PI) staining. Heat-treated M. bovis BCG were used as a positive control for cell lysis 
(Figure 4.4,panel B). These results appear to suggest that rfBC may be of importance 
in the control of systemic mycobacterial infection. 
	
Figure 4.4: Fluorescence microscopy of M. bovis BCG stained with propidium iodide. Experiment 
was performed to observe the bacterial cell Lysis as a result of rfBC treatment. Impact of rfBC on the M. 
bovis BCG growth. M. bovis BCG cells were incubated for 2 h with 20 µg/ml of rfBC M. bovis BCG 
cells were stained with 1 µg /ml Propidium Iodide. Untreated M. bovis BCG were used as a negative 
control (panel A); Heat-treated M. bovis BCG was used as a positive control for cell lysis (panel B); M. 
bovis BCG treated with 20 µg/ml rfBC (panel C). 
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4.2.5 M. bovis BCG cells stained by Propidium Iodide (PI) after direct effect of 
rfBC. 
In this study we showed the quantitative data of direct effect of rfBC on the M. bovis 
BCG cell membrane permeability and lysis (Figure 4.5). This data confirmed the 
qualitative data (Figure 4.4), that rfBC does not damage the mycobacterial cell 
membrane and that inhibition is not due to cell lysis. Here, we treated M. bovis BCG 
with different concentration (10 µg, 20 µg and 40 µg/ml) of rfBC, to see whether 
differing concentrations would affect the above observation. Heat-treated M. bovis 
BCG was used as a positive control and untreated M. bovis BCG was used as a 
negative control. The data is an analysis of an average of 6 microscopic fields of view. 
 
	
Figure 4.5: Propidium iodide (PI) assay to assess bacterial cell lysis as a result of incubation with 
rfBC. M. bovis BCG cells were incubated for 2 h with 0 µg/ml, 10, 20 and 40µg/ml of rfBC. PI was 
added, and cells spotted onto glass slides and analysed using fluorescence microscopy. Fluorescent M. 
bovis BCG cells were counted from each sample and the total percentage of PI stained cells calculated 
for each rfBC concentration. Error bars represent ± 2 standard deviations. The assay was performed in 
triplicate. A one-way ANOVA test was performed to determine significant differences in PI staining 
from heated-treated M. bovis BCG versus treatment with rfBC at the different concentrations. All 
comparisons were significant (p≤0.05), unless where shown (ns: not significant, p>0.05).   






















4.2.6 Effect of rfBC on uptake of M. bovis BCG by THP-1 cells 
THP-1 cells were incubated with M. bovis BCG treated with three concentration (10 
µg, 20 µg, 40 µg) of rfBC for 3 and 6 hours (Figure 4.6). It was observed that uptake of 
M. bovis BCG treated with rfBC was decreased by THP-1 cells after 3 and 6 hours of 
incubation. Three independent experiments were performed to study the effect of rfBC 
on uptake of M. bovis BCG by THP-1 cells. All the experiments showed the same 
trend with a decrease of M. bovis BCG uptake by THP-1 cells in the presence of 10µg, 
20µg, and 40µg/ml rfBC after 3 hours of the incubation. The following reduction of 
uptake of M. bovis BCG was observed: 19% at 10 µg /ml rfBC, 37 %  at 20 µg /ml 
rfBC and 64% at 40µg/ml by THP-1 cells as compared to untreated M. bovis BCG 
(100%).  
Six hours of treatment with rfBC showed a similar effect as three hours. After six 
hours,  a reduction in M. bovis BCG uptake by THP-1 cells was observed at 15% for 
10 µg/ml, 33% for 20 µg/ml and 70% for 40-µg/ml rfBC as compared to untreated M. 








Figure 4.6: Effect of recombinant rfBC on the uptake of M. bovis BCG by THP-1 cells. Three 
concentrations (10 µg, 20 µg, 40 µg) of rfBC were used to treat M. bovis BCG. rfBC-treated 
mycobacteria were incubated with THP-1 cells for 3 and 6 hours to study the effect on phagocytosis. M. 
bovis BCG cells released after lysis  of THP-1 cells were plated on Middlebrook 7H10 agar and CFUs 
counted. Each histogram represents the average of 3 experiments. There is a significance difference in 
uptake between untreated (THP-1 + M. bovis	BCG – 0 µg/ml) and treated (THP-1 + M. bovis	BCG + 10, 
20 and 40 µg/ml of rfBC). (*p<0.05, **p<0.01). Assays were performed in triplicate. 
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4.2.7 Effect of rfBC on uptake of M. bovis BCG by THP-1 cell by fluorescence 
microscopy  
Fluorescence microscopy was performed to observe the effect of rfBC on uptake of M. 
bovis BCG by THP-1 cells after three hours of treatment. Fluorescence microscopy 
data validated the inhibitory effect of rfBC on the uptake of M. bovis BCG by THP-1 







Figure 4.7: Microscopic representation of effect of rfBC on the phagocytosis of M. bovis BCG by 
THP-1 cells. Fluorescence microscopy was performed to see the uptake of M. bovis BCG incubated 
with different concentration (10, 20 and 40 µg/ml) of rfBC by THP-1 cells. M. bovis BCG without rfBC 
was used as a negative control. GFP-expressing M. bovis BCG was incubated with rfBC for 1 hour at 
370C and 1 hour at 4oC and these rfBC treated bacteria were incubated with THP-1 cells for three hours 
to examine the effect on phagocytosis. Alexafluor546-conjugated wheat germ agglutinin (WGA) was 
used to reveal plasma membrane (red), and the nucleus was stained with Hoechst 33342 (Blue), GFP-
expressing M. bovis BCG (green). 
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4.2.8 The pro-inflammatory response of THP-1 macrophages during phagocytosis 
of M. bovis BCG treated with and without rfBC.  
Quantitative real-time PCR (qPCR) was used to study the mRNA expression of pro-
inflammatory (TNF-α, IL-1β, IL-6 and IL-12) cytokines (Figure 4.8). In this study we 
observed that rfBC-treated M. bovis BCG shows a down-regulation of the pro-
inflammatory cytokines TNFα, IL-1β, IL-6 and IL-12, at both 3 and 6 h of incubation 
with THP-1 macrophages. The effect on TNF-α is particularly significant. These levels 
in cytokine expression were compared to THP-1 only cells with no treatment with 







Figure 4.8:  Expression of pro-inflammatory cytokines by THP-1 cells treated with M. bovis BCG 
and different concentrations of rfBC. qPCR analysis of the expression of pro-inflammatory cytokines 
(TNF-α, IL-1β, IL-6 and IL-12) at 3 and 6 hours incubation  of M. bovis BCG and 10 µg, 20 µg and 40 
µg of rfBC. The calibrator sample used was THP-1 cells only. The data was normalized to 18S rRNA 
gene expression which was used as an endogenous control. The data are expressed as a mean of three 
independent experiments carried out in triplicates (SEM). The log RQ value were plotted to show the 
gene expression.  There is a significance difference established between un-treated samples (THP-1 + M. 
bovis	BCG) and treated (THP1 + M. bovis	BCG + rfBC). The significance was revealed using the 1-way 




































































  *   















































































4.2.9 The anti-inflammatory response of THP-1 macrophages during phagocytosis of M. 
bovis BCG treated with and without rfBC.  
In this study we investigated the anti-inflammatory cytokine TGF-β and IL10 gene 
expressons (Figure 4.9).  We found TGF-β showed an increase in expression in the 
presence of rfBC-treated M. bovis BCG. The graph shows that TGF-β upregulated after 
3 hours of the infection in the presence of rfBC and down regulated after 6 hours as 
compared to untreated M. bovis BCG. However, the other anti-inflammatory cytokine, 
IL-10, was also down-regulated during these initial hours of interaction. THP-1 cells 




Figure 4.9:  Expression of anti-inflammatory cytokines by THP-1 cells treated with M. bovis BCG 
and different concentrations of rfBC. qPCR analysis of the expression of anti-inflammatory cytokines 
(TGF-β and IL-10) at 3 and 6 hours incubation  of M. bovis BCG and 10 µg, 20 µg and 40 µg of rfBC. 
The calibrator sample used was THP-1 cells only. The data was normalized to 18S rRNA gene 
expression which was used as an endogenous control. The data are expressed as a mean of three 
independent experiments carried out in triplicates (SEM). The log RQ value were plotted to show the 
gene expression.  There is a significance difference established between un-treated samples (THP-1 + M. 
bovis	BCG) and treated (THP1 + M. bovis	BCG + rfBC). The significance was revealed using the 1-way 
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4.2.10 Multiplex Array Analysis to study the cytokines, chemokines and growth 
factors production by THP-1 cells after phagocytosis M. bovis BCG treated with 
and without rfBC. 
In this study we investigated the immune response after 24h of phagocytosis using 
multiplex cytokine array analysis to measure the protein levels of cytokines and 
chemokines produced by THP-1 cells in the supernatant. This study is carried out to 
investigate the role of conglutinin further in mycobacterial infection, we examined the 
subsequent immune response by THP-1 macrophages during phagocytosis. We found 
that rfBC-treated M. bovis BCG shown the decrease in the levels of pro-inflammatory 
cytokines TNF-α, IL-1α, IL-1β, IL-6, IL-12p40, as compared to untreated M. bovis 
BCG (Figure 4.10). A same patteren of decrease in levels was also observed for the 
chemokines MCP-3, MDC, Eotaxin, Fractalkine, GRO, growth factors IL-2, FGF-2, 
G-CSF, GM-CSF, IL-3, IL-7, VEGF and related ligands and receptors IFN-γ, FLT-3 
and IL-1RA. We observed that M. bovis BCG, treated with rfBC, dampened pro-
inflammatory response after 24 h of phagocytosis, compared to M. bovis BCG only, 
after a significant inhibition of bacterial uptake by the macrophages. The pro-
infammatory cytokine/chemokines levels at 48 h were similar to levels observed for M. 
bovis BCG only. The dampening of the pro-inflammatory response by conglutinin may 
also supress the production of important cytokines and chemoattractants (TNF-α, IL-
1β, IL-6, IL-12p40) that recuit inflammatory cells and discourage inflammation and 
tissue remodeling necessary for granuloma formation. 
This study also suggested that as rfBC has an anti-inflammatory effect that may 
suppress anti-mycobacterial immunity and promote the extracellular persistence of the 
M. bovis pathogen in B. taurus. A one-way ANOVA was performed to determine 
significance differences in expression between M. bovis BCG (untreated) and M. bovis 





4.2.10.1 Multiplex Array Analysis to study the cytokines production by THP-1 
cells after phagocytosis M. bovis BCG treated with and without rfBC. 
Multiplex analysis revealed that THP-1 cells infected with rfBC treated M. bovis BCG 
down regulated the level of cytokines	 TNF-α, IL-1α, IL-1β, IL-6, IL-12p40 as 
compared to THP-1 cells infected with untreated M. bovis BCG after 24 and 48 hours.  
Further suggesting a dampening of pro-inflammatory responses. The decrease in levels 
of IL-12p40 by rfBC also points to a possible suppression of Th1 cytokines that can be 
produced by CD4+ T-cells, leading to a reduction in IFN-γ which is also critical for 
sustained intracellular killing by macrophages and granuloma formation. The decrease 
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Figure 4.10: Multiplex cytokine analysis of supernatants collected at 24 h after phagocytosis of M. 
bovis BCG by THP-1 macrophages treated with rfBC. Supernatant from late time points (24 and 48 
h) (X-axis) were used for the measurement of the levels of cytokines (TNF-α, IL-1β, IL-6, IL-12 
(p40,p70), IL-1α, IL-17, TNF-β, IL-10, IL-4, IL-13 and IL-15 ) inside the THP-1 by MagPix Milliplex 
kit (EMD Millipore). Assays were performed in duplicate Bars represents ± 2 standard deviations. A 
one-way ANOVA was performed to determine significance differences in expression between M. bovis 
BCG (untreated) and M. bovis BCG incubated with rfBC of 24 and 48 hours. All these comparisons 
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4.2.10.2 Multiplex Array Analysis to study the chemokines production by THP-1 
cells after phagocytosis M. bovis BCG treated with and without rfBC. 
Multiplex analysis revealed that THP-1 cells infected with rfBC treated M. bovis BCG 
down regulated the level of chemokines MCP-3, MDC, Eotaxin, Fractalkine and GRO 





Figure 4.11: Multiplex chemokines analysis of supernatants collected at 24 h after phagocytosis of 
M. bovis BCG by THP-1 macrophages treated with rfBC. Supernatant from late time points (24 and 
48 h) (X-axis) were used for the measurement of the levels of cytokines (MCP-3, MDC, Eotaxin, 
Fractalkine, GRO and MCP-1) inside the THP-1 by MagPix Milliplex kit (EMD Millipore). Assays 
were performed in duplicate. Bars represents ± 2 standard deviations. A one-way ANOVA was 
performed to determine significance differences in expression between M. bovis BCG (untreated) and 
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4.2.10.3 Multiplex Array Analysis to study the growth factors and related ligands 
and receptors production by THP-1 cells after phagocytosis M. bovis BCG treated 
with and without rfBC. 
The supernatants were collected from phagocytosis assay of M. bovis BCG in the 
presence or absence of rfBC at 24 h and 48 h time point. In this study multiplex 
analysis shown that THP-1 cells infected with M. bovis BCG incubated with rfBC 
decreased the level of growth factors IL-2, FGF-2, G-CSF, GM-CSF, IL-3, IL-7, 
VEGF and related ligands and receptors IFN-γ, FLT-3 and IL-1RA as compared to 
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Figure 4.12: Multiplex  analysis of growth factors and related ligands and receptors supernatants 
collected at 24 and 48h after phagocytosis of M. bovis BCG by THP-1 macrophages treated with 
rfBC. Supernatant from late time points (24 and 48 h) (X-axis) were used for the measurement of the 
levels of growth factors and related ligands and receptors production. We studied the measurement of 
the levels of growth factors (IL-2, FGF-2, G-CSF, GM-CSF, VEGF, IL-3 and IL-7) and related ligands 
and receptors (IFN-γ, FLT-3 and IL-1RA) inside the THP-1 by MagPix Milliplex kit (EMD Millipore). 
Assays were performed in duplicate. Bars represents ± 2 standard deviations. A one-way ANOVA was 
performed to determine significance differences in expression between M. bovis BCG (untreated) and 
M. bovis BCG incubated with rfBC of 24 and 48 hours. All these comparisons were significant (P < 
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4.2.11 NF-κB cytoplasm to nucleus translocation during phagocytosis of M. bovis 
BCG (with and without rfBC) by THP-1 cells. 
To investigate the inflammatory response further, an experiment was conducted to 
visualise the translocation of NF-κB inTHP-1 cells infected with M. bovis BCG, with 
and without rfBC. NF-κB, is a key transcription factor that modulates the expression of 
a number of pro-inflammatory cytokines. We studied the translocation of NF-κB in 
THP-1 cells stained with an antibody against the p65 subunit of NF-κB performed 
analysis using fluorescence microscopy. We observed that NF-κB translocation was 
more pronounced in untreated M. bovis BCG as compared to THP-1 only. However, 
virtually no translocation was observed for rfBC-treated M. bovis BCG, thus 
suggesting the downregulation of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) 







Figure 4.13: NF-κB translocation in THP-1 cells after uptake of rfBC bound M. bovis BCG. 
Fluorescence microscopy was performed to investigate the cytoplasm to nucleus translocation of NF-κB 
in THP-1 cells infected with GFP-M. bovis BCG with or without 40 µg/ml of rfBC. These were 
compared with GFP-M. bovis BCG only and THP-1 cells only were used as anegative control. Bacteria 
and THP-1 cells were incubated for 3 hours for phagocytosis to occur. Cells were washed, fixed, 
permeabilised and incubated with rabbit anti-NF-κB p65 antibodies, followed by Cy3-conjugated goat 
anti-rabbit antibody (red). The nucleus was stained with DAPI (blue).  
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4.3 Discussion  
In the present study, we have studied the  bovine collectin conglutinin and its role in 
tuberculosis host-pathogen interactions. M. bovis BCG (Bacillus Calmette-Guerin) was 
used as a model for M. bovis, to study the interaction of rfBC with mycobacteria. THP-
1 (human monocyte cell line) was used as a model for the macrophages. We have 
demonstrate that a homotrimeric recombinant truncated form of rfBC, composed of the 
α-helical neck region and the CRD (Wang et al., 1995), was able to bind to M. bovis 
BCG and has a major influence on its phagocytosis by THP-1 macrophages. rfBC 
significantly inhibits the uptake of M. bovis BCG by THP-1 cells and this occurs in a 
dose dependent manner. These observations suggest that rfBC is masking 
mycobacterial ligands and inhibiting uptake, possibly through mannose receptors. 
Collectins can bind to the carbohydrate ligands on the surface of microorganisms, 
inducing aggregation and stimulating phagocytosis through specific receptors on 
phagocytes (Holmskov, 2000). There are various receptors such as C1qR/CD93, 
calreticulin, and glycoprotein-340 present on the outer surface of immune cells, those 
interacts with the collectins and helps phagocytes in the phagocytosis, killing and 
elimination of microorganisms from infected host (Tenner, 1993; Malhotra et al., 
1990; Holmskov et al., 1997).  
It has previously been shown that conglutinin-neck-CRD region is capable of binding 
to lipopolysaccharides from Gram-negative bacteria (Wang et al., 1995). It has been 
reported that conglutinin shows affinity for mannan present on the surface of 
microorganism such as zymosan (Dec et al., 2012). Zymosan (yeast cell wall 
component) is a protein and sugar molecule in which sugar is composed of many 
subunits of mannose and shows strong binding to rfBC (Dec et al., 2012). Collectins 
such as SP-D have been shown to bind to the lipoarabinomannan (LAM), important 
cell wall component of M. tuberculosis and M. bovis (Ferguson, 2002). In the previous 
chapter, we observed the rfBC binding with M. smegmatis, a non-pathogenic species of 
mycobacteria, but in this chapter, we investigated the rfBC binding with more specific 
and relevant strain of mycobacteria M. bovis BCG. The binding of rfBC with M. bovis 
BCG has not been previously investigated. In this chapter, we performed binding 
assays using different concentration of rfBC to M. bovis BCG and it was observed that 
rfBC in the presence of calcium was able to strongly bind to M. bovis BCG (Figure 
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4.1). Our result showed 3 to 4 folds less binding between rfBC and M. bovis BCG in 
the existance of EDTA and more strong binding observed in the presence of calcium, 
that confirms previous finding that rfBC is a calcium dependant lectin (Wang et al., 
1995). A concentration of 20 µg/ml of rfBC was enough to reach saturation of binding. 
This is also the first time rfBC has been shown to bind with Gram-positive bacteria. 
Immunofluorescence microscopy was also performed to visually confirm the binding 
of rfBC to M. bovis BCG (Figure 4.2). 
In this chapter, the direct effect of rfBC on the growth of M. bovis BCG was studied. 
The results showed that rfBC was able to inhibit the growth of M. bovis BCG in a dose 
dependent manner. There is 25% reduction in growth observed for 10 µg/ml, 44% for 
20 µg/ml and 90% for 40 µg/ml of rfBC. The inhibition results are statistically 
significant at all concentration observed (Figure 4.3). This direct inhibition role of 
rfBC on mycobacteria has not been studied before. It has previously been reported that 
conglutinin played a role in the survival of mice infected with pathogenic strains of 
Salmonella typhimurium, Pasteurella septica, Klebsiella pneumoniae, Listeria 
monocytogenes and Streptococcus pyogenes (Friis-Christiansen, 1990). Friis-
Christiansen in 1990 also confirmed the study, that mice injected with conglutinin 
prolonged the survival of infected mice with S. typhimurium. They suggested that 
conglutinin serve as a mediator between the bacteria and the immune cells (Friis-
Christiansen 1990). 
SP-D has been shown to inhibit the growth of E. coli, Legionella pneumophila, 
Enterobacter aerogenes and Klebsiella pneumoniae by increasing the cell membrane 
permeability (Wu et al., 2003), but not in the case of mycobacteria (Ariki, 2011). As 
we observed that rfBC have a direct inhibitory effect on the in vitro growth of M. bovis 
BCG (Figure 4.3). We performed experiments to find out whether rfBC increased the 
cell membrane permeability of the M. bovis BCG and accounting for growth inhibition.  
We found that direct effect was bacteriostatic in nature, rather than bactericidal, as 
virtually no bacterial cell lysis was observed on rfBC-treated M. bovis BCG, as 
determined by propidium iodide (PI) staining (Figures 4.4). This study show for the 
first time that rfBC has a bacteriostatic effect, which could have important finding in 
the control of mycobacterial infection in cattle. 
																																																																																																																																																					Chapter 4 
	 106 
It has been reported that collectins binds directly with the carbohydrates present on the 
microbial surface causing bacterial aggregation and virus neutralization and assists 
phagocytic cells in phagocytosis, act as an opsonin (Hansen and Holmskov, 1998). SP-
A has been shown to enhance the uptake of M. tuberculosis by phagocytic cells such as 
macrophages and this is due to the up-regulation of macrophage-mannose receptor 
(Gaynor et al., 1995). In previous studies, SP-D has shown different effects on 
phagocytosis of pathogens. M. tb treated with SP-D showed the reduction in the uptake 
by macrophages (Ferguson et al., 1999). SP-D CRD region binds to the cell wall 
components of M. tuberculosis such as mannosyl units (mannose caps) of lipoglycan 
and lipoarabinomannan (LAM) (Ferguson et al., 1999).  
The effect of rfBC on the uptake of M. bovis BCG or any other mycobacterium species 
by macrophages has not investigated before. In this chapter, we studied the effect of 
rfBC on the uptake of M. bovis BCG by THP-1 cells. For this purpose M. bovis BCG 
incubated with different concentration 10 µg, 20 µg and 40 µg/ml of rfBC for 2 hours 
to treat with THP-1 cells. We found rfBC significantly inhibit the uptake of M. bovis 
BCG by macrophages (THP-1 cells). rfBC-treated M. bovis BCG showed reduced 
uptake by THP-1 cells, compared to untreated M. bovis BCG, with up to 63% (40 
µg/ml of rfBC), 35% (20 µg/ml of rfBC) and 18% (10 µg/ml of rfBC) inhibition 
(Figure 4.6). The reasons for this significant inhibition in uptake of M. bovis BCG by 
THP-1 cells is possibly rfBC binds with surface antigens of M. bovis BCG such as 
mannose receptors on macrophages. Previously it has been reported that surfactant 
protein SP-D strongly binds to lipoglycan lipoarabinomannan (LAM) of virulent M. tb, 
strains. The complex of the M. tuberculosis–SP-D inhibited the binding of 
mycobacteria to the human macrophages (Ferguson et al., 2002). Similar to SP-D, we 
found rfBC to be able to significantly inhibit the uptake of mycobacteria by 
macrophages (THP-1 cells). One of the main route for M. tuberculosis phagocytosis by 
macrophages is via the mannose receptor (Schlesinger, 1993). It has been studied that 
conglutinin shows haemagglutination inhibition and neutralizing effect against 
influenza A virus and rota viruses (Hartshorn et al., 1993; Reading et al., 1998).  
Collectins such as SP-A and SP-D have the ability to enhance or inhibit the 
inflammatory responses against the pathogens (Kuroki et al., 2007). In this chapter, we 
investigated the effect of rfBC on the inhibition of mycobacterial growth in to the 
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THP-1 cells by engagement of pro-inflammatory and anti-inflammatory signaling 
processes. Pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6 and IL-12 
production was down regulated at 3 and 6 hours, suggesting the rfBC role in the 
adaptive immunity. Three and six hour responses of rfBC were assessed by qPCR, 
later investigated the cytokines, chemokine and growth factors levels at 24 and 48 
hours after rfBC-M. bovis BCG interaction with THP-1 cells by performing multiplex 
array analysis. Multiplex analysis showed down regulation of cytokines (TNF-α, IL-
1β, IL-12p40, IL-12p70, IL-17A and TNF-β) (Figure 4.10) for rfBC treated M. bovis 
BCG. It has been observed that mostly chemokines (MCP-3, MDC, Eotaxin, 
Fractalkine, GRO and MCP-1) (Figure 4.11) and growth factors proteins (IL-2, FGF-2, 
GM-CSF, VEGF, IFN-γ, FLT-3 and IL-1RA) (Figure 4.12) were down regulated for 
rfBC bound M. bovis BCG. TNF-α, IL-1β and IL-12 gene expression in THP-1 cells 
infected with rfBC treated M. bovis BCG was reduced in early responses (3 and 6 
hours) as well as late responses (24 and 48 hours) as compared to untreated M. bovis 
BCG (Figure 4.8). TNF-α also plays a major contribution in the formation of 
granuloma in tuberculosis infection. TNF-α mediates the recruitment of immune cells 
in the granuloma (Mohan et al., 2001).  
The mRNA level of IL-1β was down regulated in THP-1 cells treated with M. bovis 
BCG bound with rfBC after 3 and 6 hours of infection (Figure 4.8). Mutiplex analysis 
24 and 48 hours post infection revealed the same result of down regulation of IL-1β 
response was consistent with early response. In bovine tuberculosis, IL-1β is produced 
by monocytes, macrophages and dendritic cells. It has been studied that IL-1β receptor 
deficient mice are more likely infected by M. tb and also lack the ability to form 
granuloma (Juffermans et al, 2000).  
NF-κB is an important transcription factor that regulates the synthesis of pro-
inflammatory cytokines such as TNF-α and IL-1β. We studied the NF-κB translocation 
in THP-1 cells stained with an antibody against the NF-κB and analysed by 
fluorescence microscope. We observed no nuclear translocation of NF-κB in response 
to rfBC bound M. bovis BCG as compared to untreated M. bovis BCG (Figure 4.13). 
This result is further evidence of a dampening of the inflammatory response in the 
presence of rfBC and also suggested the down regulation of pro-inflammatory 
cytokines and chemokines. 
																																																																																																																																																					Chapter 4 
	 108 
IL-6 assist M. avium multiplication and survival in vitro by inhibiting TNF-α and IL-
1β secretion (Schindler et al., 1990). In this study, IL-6 mRNA expression was down 
regulated in the THP-1 cells treated with M. bovis BCG bound with rfBC after  3,6, 24 
and 48 hours of the infection (Figure 4.8, Figure 4.10). 
The expression of IL-12 was up regulated in THP-1 cells incubated with M. bovis BCG 
bound with rfBC as compared to untreated M. bovis BCG in 3 hours of infection and 
observed down regulation in 6 hours (Figure 4.8). This result suggested that 20µg and 
40µg/ml rfBC increases the expression of IL-12 in the early stage of infection but 
down regulated after 6 hours of infection. IL-12 also involved in the activation of 
antigen-specific lymphocytes, which form granuloma (Cooper et al., 1997). IL-12p 40 
and IL-12p70 were down regulated after 24 and 48 hours of the infections.   
Our result shows that TGF-β was upregulated after 3 hours of the infection in the 
presence of rfBC and down regulated after 6 hours as compared to untreated 
mycobacteria (Figure 4.9). TGF-β involved in the down regulation of pro-
inflammatory cytokines release such as TNF-α and IL-1β (Ruscetti et al., 1993). It is 
synthesised by macrophages and dendritic cells in response to tuberculosis infection. 
TGF-β helps in the mycobaterial survival by preventing the formation of reactive 
oxygen and nitrogen radicals in the macrophages (Ding et al., 1990). 
IL-10 helps in the survival of intracellular mycobacteria by deactivating macrophages 
to produce IL-12 and TNF-α, which decreases the INF-γ synthesis by CD4+. Less 
expression of INF-γ leads to decrease formation of reactive nitrogen and oxygen 
intermediates, which helps in the survival of mycobacteria (Gazzinelli et al., 1992). It 
has been shown in the mice that IL-10 stops CD4+ cell responses, which inhibit 
phagosome maturation and also stops mycobacterial antigen presentation to the 
immune cells (Bobadilla et al., 2013). In this study, the mRNA level of IL-10 in THP-
1 cells was down regulated at 3 and 6 hours (Figure 4.9) and also consistent results we 
observed after 24 and 48 hours (Figure 4.10) of infection with M. bovis BCG bound 
with c rfBC as compared to M. bovis BCG only. 
It has been studied that IL-4 is not only produced by CD4+ their primary source of 
production but also produced by CD8+ T-cells in pulmonary tuberculosis (Van et al., 
2000). Over production of IL-4 in mice promotes infection progress and reactivate 
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latent tuberculosis infection (Hernandez et al., 1996). In this study, multiplex data 
revealed the down regulation of IL-4 after 24 and 48 hours of infection in the presence 
of rfBC as compared to untreated mycobacteria (Figure 4.10). 
In this study we observed that rfBC treated M. bovis BCG down regulated the level of 
chemokines (MCP-3, MDC, Eotaxin, Fractalkine, GRO and MCP-1) expression in 
infected THP-1 cells after 24 and 48 hours as compared to untreated M. bovis BCG. It 
has also been shown that monocyte chemo-attractant protein-1 (MCP-1) increase Th2 
polarization and recruits immune cells (monocytes, memory T-cells, dendritic cells) to 
the site of infection (Rose et al., 2003). Monocyte chemo-attractant protein-3 (MCP-3) 
is secreted by macrophages and reported higher level in bronchoalveolar fluid of 
tuberculosis patient (Ruhwald et al., 2009). Growth-related oncogene-1 (GRO1) is also 
produced by macrophages, neutrophils and epithelial cells. GRO assists in the 
recruitment of neutrophils and monocytes to the infectious site (Nakagawa et al., 
1994). MDC (macrophage derived chemokine) is one of the important chemokines 
helps in the attraction of monocytes, dendritic cells and IL-2 activated natural killer 
cells to the site of infection (Godiska et al., 1997).  
We also investigated the level of growth factors and related ligands and receptors by 
THP-1 cells treated with M. bovis BCG bound with rfBC as compared to THP-1 cells 
infected with M. bovis BCG only after 24 and 48 hours. In this study multiplex 
analysis showed decreased level of growth factors (IL-2, FGF-2, G-CSF, GM-CSF and 
VEGF) and related ligands and receptors (IFN-γ, FLT-3 and IL-1RA) (Figure 4.12) by 
THP-1 cells treated with M. bovis BCG bound with rfBC as compared to THP-1 cells 
treated with M. bovis BCG only after 24 and 48 hours. Granulocytes-colony 
stimulating factor (G-CSF) is one of the important growth factor secreated by 
monocytes, fibroblasts and endothelial cells (Schneider et al., 2005). G-CSF 
encourages the proliferation and maturation of neutrophil from the precursor (Demetri 
and Griffin, 1991).  
The down regulation of the pro-inflammatory response by rfBC may also inhibit the 
production of important cytokines and chemoattractants such as TNF-α, IL-1β, IL-6, 
IL-12p40, IFN-γ those recruit inflammatory cells and prevent inflammation and 
granuloma formation (Feng et al., 2006; Smith et al., 1997). The down regulation of 
IL-12p40 by rfBC also a possible cause of suppression of the Th1 cells that results in 
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the reduction in the IFN-γ production, which is also an important component for 
intracellular killing by macrophages and helps in granuloma formation. In this study 
we also observed the down regulation of growth factors VEGF, GM-CSF and GRO in 
the THP-1 cells infected by rfBC bound M. bovis BCG as compared to untreated M. 
bovis BCG, further confirming the dampening of inflammatory responses. In vivo, 
macrophages phagocytose mycobacteria after entry in to the host but ultimately fail to 
destroy them and provide hostile environment for multiplication. rfBC inhibition of 
phagocytosis of these bacteria in to macrophages may be protective by keeping them 







Chapter 5 – Investigating the effect of complement on the 
interactions of rfBC and M. bovis BCG and its 





5.1  Introduction  
The complement system provides primary protection against pathogens. Pathogenesis 
by microorganisms depends on their ability to evade killing by host immune system. It 
is known that mycobacteria are highly adapted to living inside macrophages. To 
facilitate this, mycobacteria can activate complement, which can promote uptake into 
phagocytes via complement receptors. 
In this chapter, the binding of the bovine conglutinin fragment (rfBC) with M. bovis 
BCG with and without complement deposition has been studied, to examine the effect 
on phagocytosis by THP-1 cells and the subsequent immune response. The first aim in 
this study was to examine the complement consumption by M. bovis BCG. It has been 
previously shown, that the activation of complement system predominantly occurs via 
alternative pathway (Carroll et al., 2009). In this study, we show that the interaction 
between Mycobacterium bovis BCG and complement system in normal human serum 
was sufficient to activate the complement cascade, culminating in an average of 90% 
of complement consumption with C3b being deposited on the bacterial surface. This 
confirms that M. bovis BCG can activate complement. 
The second aim in this study was to assess the complement dependent interactions of 
rfBC with THP-1 cells on phagocytosis. We observed that rfBC inhibits phagocytosis 
of M. bovis BCG deposited with complement proteins by THP-1 cells. Conglutinin is a 
known binder of iC3b, there is a possibility of conglutinin interfere with complement 
receptor mediated uptake via CR3 and CR4 receptors by masking interaction with iC3b 
deposited on the mycobacterial surface.  
The third aim in this study was to investigate the cytokine expression of THP-1 cells 
during M. bovis BCG infection in the presence of rfBC and/or complement. We also 
observed that rfBC modulated the downstream inflammatory response, which is 






5.2  Results  
5.2.1 Complement consumption assay with M. bovis BCG 
The activation of the complement system in human serum by the alternative 
complement pathway by M. bovis BCG is shown in Figure 5.1. At different doses of 
M. bovis BCG consumed nearly 90% of complement which was activated by 
alternative pathway. To optimised and lysis in complement deposited samples were 
compared with serum only. Different amount (1mg, 2 mg, 4 mg and 8 mg) of M. bovis 
BCG were used to identify which one would present the best consumption. Figure 5.1 
shows similar consumption for all conditions that is around 90% consumption. 
 
		
Figure 5.1: Activation of alternative pathway by M. bovis BCG in normal human serum. Different 
concentrations (1mg, 2 mg, 4 mg and 8 mg) of M. bovis BCG from fresh culture OD600nm = 1 was taken. 
An M. bovis BCG bacterial pellet 10µl packed volume corresponding to 1 mg dry weight (Carrol et al., 
2009). Percentage of complement consumption was plotted with serum as a control for no consumption. 
Results are expressed as the mean of duplicates from one experiment ± S.D. 
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5.2.2 Effect of rfBC on the phagocytosis of complement deposited M. bovis BCG 
by THP-1 cells 
In this study, M. bovis BCG were deposited by complement proteins by activating 
alternative the pathway. Complement deposited M. bovis BCG was treated with three 
concentration (10µg, 20µg, 40µg) of rfBC in the presence of 5mM calcium chloride for 
3 and 6 hours (Figure 5.2). The results show that rfBC decreased complement-
deposited mycobacterial uptake by THP-1 cells at both time points.   Three 
independent experiments were carried out and all showed the same trend. The results 
are statistically significant. 
 
 
Figure 5.2: Effect of rfBC on the phagocytosis of complement coated M. bovis BCG by THP-1 
cells.1x10-2 dilution of M. bovis BCG after lysis of THP-1 cells  were plated on middle brook 7H10 agar 
plates. There is a significance difference established between un-treated samples (M. bovis BCG + 
complement) and (M. bovis	 BCG + complement + rfBC) (*p<0.05, **p<0.01). Each histogram 
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5.2.3  The effect of rfBC on the uptake of complement deposited M. bovis BCG by 
THP-1 cells after 3 hours by fluorescence microscopy  
In this study, fluorescence microscopy was performed to observe the effect of rfBC on 
uptake of complement deposited M. bovis BCG by THP-1 cells after three hours of 
phagocytosis. Fluorescence microscopy data validated the inhibitory effect of rfBC on 
the uptake of M. bovis BCG by THP-1 cells (Figure 5.2). Thus, rfBC exhibits its 
uptake inhibitory effect (Figure 5.3).  
 
Figure 5.3: Fluorescence microscopy showing the effect of rfBC on the phagocytosis of 
complement deposited M. bovis BCG by THP-1 cells. Fluorescence microscopy was performed to see 
the uptake of complement coated M. bovis BCG incubated with different concentration (10,20 and 40 
µg/ml) of rfBC in to the THP-1 cells. M. bovis without protein used as a negative control. M. bovis BCG 
coated with complement was used as a positive control. M. bovis BCG coated with complement and 
rfBC treated with THP-1 cells for three hours to examine the phagocytosis impact.  
  
 M. bovis BCG Only    THP-1 Only M. bovis BCG complement 
40µg rfBC 20µg rfBC 10µg rfBC 
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5.2.4 The pro-inflammatory response of THP-1 macrophages during phagocytosis 
of complement deposited M. bovis BCG treated with and without rfBC.  
Quantitative real-time PCR (qPCR) was used to study the mRNA expression of pro-
inflammatory (TNF-α, IL-1β, IL-6 and IL-12) cytokines (Figure 5.4). In this study we 
observed that rfBC-treated with complement deposited M. bovis BCG  shows a down-
regulation of the pro-inflammatory cytokines TNFα, IL-1β, IL-6 and IL-12, at both 3 
and 6 hours of incubation with THP-1 macrophages.  
  
	  
Figure 5.4:  Expression of pro-inflammatory cytokines by THP-1 cells treated with complement 
deposited M. bovis BCG and different concentrations of rfBC. qPCR analysis of the expression of 
pro-inflammatory cytokines (TNF-α, IL-1β, IL-6 and IL-12) at 3 and 6 hours incubation  of complement 
deposited M. bovis BCG and 10 µg, 20 µg and 40 µg of rfBC. The calibrator sample used was THP-1 
cells only. The data was normalized to 18S rRNA gene expression which was used as an endogenous 
control. The data are expressed as a mean of three independent experiments carried out in triplicates 
(SEM). The log RQ value were plotted to show the gene expression.  There is a significance difference 
established between un-treated samples (THP-1 + complement deposited M. bovis	BCG) and treated 
(THP1 + complement deposited M. bovis	BCG + rfBC). The significance was revealed using the 2-way 
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5.2.5 The anti-inflammatory response of THP-1 macrophages during phagocytosis 
of complement deposited M. bovis BCG treated with and without rfBC.  
In this study we investigated the anti-inflammatory cytokine TGF-β and IL10 gene 
expressons (Figure 5.5).  We found TGF-β showed an increase in expression in the 
presence of rfBC-treated M. bovis BCG. The graph shows that TGF-β downregulated 
after 3 and 6 hours of the infection in the presence of rfBC as compared to untreated 
complement deposited M. bovis BCG. IL-10, was also down-regulated during these 
initial hours of interaction. THP-1 cells incubated only with rfBC did not show any 
remarkable changes in cytokine expression. 
  
 
Figure 5.5:  Expression of anti-inflammatory cytokines by THP-1 cells treated with complement 
deposited M. bovis BCG and different concentrations of rfBC: qPCR analysis of the expression of 
anti-inflammatory cytokines (TGF-β and IL-10) at 3 and 6 hours incubation of M. bovis BCG and 10 µg, 
20 µg and 40 µg of rfBC. The calibrator sample used was THP-1 cells only. The data was normalized to 
18S rRNA gene expression which was used as an endogenous control. The data are expressed as a mean 
of three independent experiments carried out in triplicates (SEM). The log RQ value were plotted to 
show the gene expression.  There is a significance difference established between un-treated samples 
(THP-1 + complement deposited M. bovis	BCG) and treated (THP1 + complement deposited M. bovis	
BCG + rfBC). The significance was revealed using the 1-way ANOVA test. All comparisons are 
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5.2.6 Multiplex array analysis to study cytokine, chemokine and growth factor 
production from THP-1 cells infected by M. bovis BCG treated with rfBC and 
complement and rfBC.  
5.2.6.1 Production of pro-inflammatory and anti-inflammatory cytokines by 
THP-1 cells after 24 and 48 hours of the infection. 
Multiplex analysis revealed that THP-1 cells infected with rfBC treated complement 
deposited M. bovis BCG down regulated the level of cytokines	TNF-α, IL-1α, IL-1β, 
IL-6, IL-12p40 as compared to THP-1 cells infected with untreated complement 
deposited M. bovis BCG after 24 and 48 hours.  Further suggesting a dampening of 
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Figure 5.6: Multiplex cytokine analysis of supernatants collected at 24 h after phagocytosis of 
complement deposited M. bovis BCG by THP-1 macrophages treated with/without rfBC. M. bovis   
BCG deposited with complement coated with rfBC were incubated with THP-1 cells for 24 h and 48 h 
Supernatant from late time points (24 and 48 h) (X-axis) were used for the measurement of the levels of 
of cytokines (TNF-α, IL-1β, IL-6, IL-12 (p40,p70), IL-1α, IL-17 and TNF-β, IL-10, IL-4, IL-13 and IL-
15) inside the THP-1 by MagPix Milliplex kit (EMD Millipore). Assays were performed in duplicate 
Bars represents ± 2 standard deviations. A one-way ANOVA was performed to determine significance 
differences in expression between M. bovis BCG (untreated) and M. bovis BCG coated with rfBC; M. 
bovis BCG (untreated) to M. bovis BCG + complement; M. bovis BCG + complement to M. bovis BCG 
complement coated with rfBC of 24 and 48 hours. All these comparisons were significant (P < 0.05), 
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5.2.6.2 Production of chemokines by THP-1 cells after 24 and 48 hours of the 
infection. 
Multiplex analysis revealed that THP-1 cells infected with complement and rfBC 
treated M. bovis BCG down regulateed the level of chemokines as compared to THP-1 




Figure 5.7: Multiplex chemokines analysis of supernatants collected at 24 h after phagocytosis of 
complement deposited M. bovis BCG by THP-1 treated with rfBC.	Supernatant from late time points 
(24 and 48 h) (X-axis) were used for the measurement of the levels of chemokines (MCP-3, MDC, 
Eotaxin, Fractalkine, GRO and MCP-1) inside the THP-1 by MagPix Milliplex kit (EMD Millipore. 
Assays were performed in duplicate. Bars represents ± 2 standard deviations. A one-way ANOVA was 
performed to determine significance differences in expression between M. bovis BCG (untreated) and 
M. bovis BCG coated with rfBC; M. bovis BCG (untreated) to M. bovis BCG + complement; M. bovis 
BCG + complement to M. bovis BCG complement coated with rfBC of 24 and 48 hours. All these 
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5.2.6.3 Production of growth factors and related ligands and receptors production 
by THP-1 cells after 24 and 48 hours of the infection. 
In this study multiplex analysis shown that THP-1 cells infected with rfBC and 
complement coated M. bovis BCG down regulated the level of growth factors and 
related ligands and receptors as compared to THP-1 cells infected with untreated M. 
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Figure 5.8 : Multiplex  analysis of growth factors and related ligands and receptors supernatants 
collected at 24 and 48h after phagocytosis of complement deposited M. bovis BCG by THP-1 
macrophages treated with rfBC. Supernatant from time points (24 and 48 h) (X-axis) were used for the 
measurement of the levels of growth factors (IL-2, FGF-2, G-CSF, IL-7, IL-3, GM-CSF and VEGF) and 
related ligands and receptors (IFN-γ, FLT-3 and IL-1RA) inside the THP-1 by MagPix Milliplex kit 
(EMD Millipore). Assays were performed in duplicate. Bars represents ± 2 standard deviations. A one-
way ANOVA was performed to determine significance differences in expression between M. bovis BCG 
(untreated) and M. bovis BCG coated with rfBC; M. bovis BCG (untreated) to M. bovis BCG + 
complement; M. bovis BCG + complement to M. bovis BCG complement coated with rfBC of 24 and 48 
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5.2.7 Production of rfBC treated complement deposited M. bovis BCG on NF-κB 
cytoplasm to nucleus translocation.   
In this study we investigated the effect of rfBC on the translocation of NF-κB inTHP-1 
cells infected with complement coated M. bovis BCG. We performed this analysis by 
using fluorescence microscopy.  We observed that NF-κB translocation was more 
prominent in complement-deposited M. bovis BCG and untreated M. bovis BCG. 
However, there was no significant translocation observed in rfBC-bound complement 
deposited M. bovis BCG (Figure 5.13).  
 
Figure 5.9: NF-κB translocation in THP-1 cells after uptake of M. bovis BCG treated with rfBC 
and complement plus rfBC. Fluorescence microscopy was performed to investigate the effect of rfBC 
the translocation of Nf-kB to nucleus in THP-1 cells after the phagocytosis of complement deposited 
GFP M. bovis BCG. Complement deposited GFP M. bovis BCG used as a control. Cells were treated 
with rabbit anti Nf-κB p65 (1:200) primary antibodies followed by Cy3-conjugated goat anti-rabbit 
antibody (red). THP-1 cell nucleus is stained with Hoechst (blue) (1:10000)  
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5.3 Discussion  
Outer membrane of mycobacteria is composed of peptidoglycan layer that is 
covalently attached to the arabinogalactans, arabinomannans, glycolipids and mycolic 
acids (Daffe and Draper, 1997). In mycobacteria extra capsule layer is present on the 
top of outer membrane, this capsule contains polysaccharides, proteins and lipids. 
These lipids comprised of mostly phospholipids and glycolipids (Daffe and Etienne, 
1999). Cord factor or trehalose dimycolate is a glycolipid present in the cell wall of 
mycobacteria and is responsible to activate the complement (Ramanathan et al., 1980). 
Complement system plays an important role into the innate immunity by activating 
three different pathways. Mycobacterium is intracellular pathogen that entered and 
multiplies in to the host cells. In one of the study it has been shown that M. bovis BCG 
have ability to activate classical and alternative pathways. In the same study it has been 
demonstrated that MBL and L-ficolin binds to the mycobacterial surface result in to 
the activation of lectin pathway (Carrol et al., 2009). Complement activation by any 
pathways resulted in to the C3b deposition on the mycobacterial surface (Carrol et al., 
2009).  
By reproducing the complement assay done by Carrol et al. (2009), this study 
confirmed that M. bovis BCG is capable of activating complement through alternative 
pathway (Carrol et al., 2009) Based on what is observed in this study, with the 
consumption of different bacterial concentrations. The assay was optimised and for the 
data presented in this study, for which serum was kept on ice while the samples were 
incubated for complement consumption. Therefore, the integrity of the serum was 
preserved and assessed after the haemolytic assay performance.  
In this study when mycobacteria are coated with complement, the uptake of M. bovis 
BCG increased by THP-1 cells, but after incubation of complement coated M. bovis 
BCG with rfBC, rfBC dose dependently inhibited M. bovis BCG uptake by THP-1 
cells. It is known that C3b is an opsonin, enhancing uptake of M. tuberculosis by 
human alveolar and monocyte-derived macrophages (Schlesinger et al 1990). Due to 
genomic similarities of M. bovis BCG to M. tuberculosis, it would be likely that C3 
proteins enhanced M. bovis BCG uptake by THP-1 cells. It has been shown that 
mycobacteria could utilise complement opsonisation to be phagocytised by 
macrophages to escape from immune system and remained in the phagosome of 
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macrophages. It has been shown that the deposition of C3b on pathogen surface is the 
end result of complement activation by any pathway. Factor H is known as a main 
regulator of complement activation, which act as a cofactor for factor I to cleaves the 
α-chains of C3b to generate in active form known as iC3b (Sim et al., 1993). It has 
been known that conglutinin has the ability to agglutinate the erythrocytes those had 
been reacted with antibodies and complement in the presence of factor I (Lachmann 
and Muller, 1968). In the previous studies it has been shown that conglutinin binds 
with C3 fragment (iC3b) in the presence of calcium ions (Leon, 1957; Ross, 1986). 
It has been shown that C3b deposition on the outer surface of mycobacteria helps in 
the phagocytosis by complement receptors (CR1, CR3 or CR4) present on the 
macrophages (Ferguson et al., 2004; Hetland and Wiker, 1994; 2001; Schlesinger and 
Horwitz, 1994). C3b binding to M. tuberculosis and M. bovis BCG has been shown to 
occur via classical and alternative complement pathways and is present in the form of 
C3b and iC3b (Carroll et al., 2009, Ferguson et al., 2004).  C3b is important 
component taking part in the complement pathways to develop towards the membrane 
attack complex (MAC), but iC3b is an inactivate component of C3 does not take part 
in this reaction. C3b is known as a ligand for complement receptor 1 (CR1) but iC3b is 
ligand for complement receptor 3 and 4 (CR3 and CR4) (Ross, 1986).  However, it has 
not been demonstrated how these complement pathways are initiated by mycobacteria. 
In this study, we found that complement deposition on M. bovis BCG enhanced the 
uptake of bacterium by THP-1 cells. Although complement-deposited M. bovis BCG 
resulted in enhanced uptake by 22% as compared to untreated M. bovis BCG but rfBC 
significantly inhibits phagocytosis of mycobacterium by THP-1 cells. This inhibition 
in phagocytosis by rfBC to be dose-dependent, there is 44% reduction in uptake 
observed for 10 µg/ml, 55% for 20 µg/ml and 83% for 40 µg/ml of rfBC as compared 
to untreated complement coated M. bovis BCG. The reason for less uptake of 
complement coated mycobacteria by THP-1 cells in presence of rfBC could be as 
follows: Since rfBC is a known binder of iC3b (Ross, 1986), it may therefore bind to 
iC3b deposited on the M. bovis BCG surface, and inhibited the uptake of mycobacteria 
by complement receptors CR3 and CR4 present on the macrophages. 
In this study we observed the pro and anti-inflammatory cytokines role of rfBC and 
complement in shaping the adaptive immune response during host-pathogen 
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interaction. In our findings, rfBC and complement do seem to modulate cytokine 
responses during uptake of M. bovis BCG by THP-1 cells.  
TNF-α expression was down regulated by rfBC in the early stages of phagocytosis of 
complement coated M. bovis BCG as compared to untreated complement coated M. 
bovis BCG. The level of mRNA expression of TNF-α was down regulated after three 
hours and six hours of the infection. Mutiplex analysis of 24 and 48 hours revealed the 
down regulation of TNF-α response was consistent with early hours response. It has 
been studied that TNF-α stimulate the formation of granuloma (Flesch and Kaufmann, 
1990). TNF-α is an important cytokine produced in the early stages of infection; play 
an important role in the macrophages activation and granuloma formation (Flesch and 
Kaufmann, 1990). It has been shown that TNF-α helps in the maintaining of latent 
tuberculosis infection in the mice model by granuloma formation (Flynn et al., 1995). 
IL-1β is another important cytokine play a role against human tuberculosis infection in 
the host (Mayer-Barber et al., 2010). It is produced by immune cells, such as 
monocytes, macrophages and dendritic cells in the response to M. tuberculosis 
(Giacomini et al., 2001). We examined the down regulation of IL-1β in the presence of 
rfBC complement deposited M. bovis BCG in 3 and 6 hours of the infection as 
compared to untreated complement coated M. bovis BCG. Mutiplex analysis of 24 and 
48 hours revealed the same result of down regulation of IL-1β response in the rfBC 
treated complement deposited M. bovis BCG as compared to untreated, which was 
consistent with early responses. 
NF-κB is an important transcription factor that regulates the synthesis of pro-
inflammatory cytokines such as TNF-α and IL-1β. We studied the NF-κB translocation 
in THP-1 cells stained with an antibody against the NF-κB and analysed by 
fluorescence microscope. We observed no nuclear translocation of NF-κB in response 
to rfBC bound complement coated M. bovis BCG as compared to untreated 
complement coated M. bovis BCG. This result is further evidence of a dampening of 
the inflammatory response in the presence of rfBC and also suggested the down 
regulation of pro-inflammatory cytokines and chemokines. 
It has been shown that, IL-6 stimulates the T cell response against mycobacteria (Leal 
et al., 1999). IL-6 produced by macrophages at the site of infection during initial stages 
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of the tuberculosis infection (Hoheisel et al., 1998). In this study we observed the 
down regulation of IL-6 in the early stages after 3 and 6 hours of infection in the 
presence of rfBC. Mutiplex analysis of 24 and 48 hours revealed the down regulation 
of IL-6 response was consistent with early 3 hours response. 
IL-12 expression was down regulated in the presence of rfBC in early response of 
complement deposited M. bovis BCG as compared to untreated (M. bovis BCG + 
complement), and multiplex analysis of 24 and 48 hours revealed the same response, 
which may inhibit the Th1 response and produce INF-γ reducing inflammation. The 
down regulation of IL-12 by rfBC may be directly lead to reduce the uptake of M. 
bovis BCG by macrophages. IL-12 suppression may result in to the down regulation of 
Th1 response and activation of the CD4+ T cells, inducing INF-γ production. It has 
been shown that T-cells activation can stimulate the granuloma necrosis (Ehlers et al., 
2001) and IL-12 down regulation could be important factor to disturb the balance of 
Th1/Th2 with in the granuloma. The down regulation of the pro-inflammatory 
cytokines response by rfBC may supress the production of important cytokines and 
chemoattractants (TNF-α, IL-1β, IL-6, IL-12, IFN-γ) those are helpful in recruiting the 
immune inflammatory cell and also discourage inflammation and granuloma formation 
(Feng et al., 2006). In vivo, macrophages phagocytose mycobacteria after entry in to 
the host but ultimately fail to destroy them and provide hostile environment for 
multiplication. rfBC inhibition of phagocytosis of these bacteria in to macrophages 
may be protective by keeping them extracellular where these can be easily cleared by 
the host immune response.  
It has been studied that macrophages produced IL-10 in the early stages of tuberculosis 
infection, following the uptake of M. tb (Shaw et al., 2000). It has also been reported 
that IL-10 prevents maturation of phagosome, this helps in the Mycobacterium survival 
in the macrophages (O’Leary et al., 2011). It has been observed that IL-10 also inhibits 
dendritic cell activation (Demangel et al., 2002) result in to the inhibition of Th1 
response (Tian et al., 2005). It has been seen that IL-10 and TGF-β level was high in 
the lungs of active tuberculosis patient, which indicates the importance of these two 
cytokines in the pathogenesis of tuberculosis infection (Gong et al., 1996). TGF-β 
helps in the survival of mycobacteria by down regulating the immune cells. TGF-β 
prevents T-cells maturation and also down regulating the important cytokines (IL-1, 
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IL-6, TNF-α) those can recruit inflammatory cells for granuloma formation (Toossi 
and Ellner, 1998). We observed in this study, IL-10 and TGF-β were down regulated at 
early stages of phagocytosis in the presence of rfBC, suggesting the inhibition of anti-
inflammatory cytokines response. The down regulation of these two important 
cytokines may help in the clearance of mycobacteria in the early stages of infection 
and protect the host from further progression of infection. Mutiplex analysis of 24 and 
48 hours revealed the down regulation of IL-10 response, which is consistent with 
early response.  In this study the cytokines findings may reflects the initial 
inflammatory response in vivo, which lead to granuloma formation to prevents the 
further growth of mycobacteria and also gives a cavity to mycobacteria to stay as a 
latent infection. It has been shown that balance of inflammation is required to 
maintained the granuloma. The balance of inflammation is achieved by maintaining the 
balance in pro-inflammatory (IFN-γ, TNF-α) compared to anti-inflammatory (IL-10, 
IL4, TGF- β) cytokines with in granuloma (Ehlers and Schaible, 2013).  
We observed the down regulation of IL-4 when THP-1 cells treated with complement 
deposited M. bovis BCG bound with rfBC as compared to untreated complement 
deposited M. bovis BCG. IL-4 is an anti-inflammatory cytokines, which down regulate 
the production of INF-γ and have negative impact on the activation of macrophages 
(Lucey et al., 1996). It has been shown that mice infected with tuberculosis showed 
increased production of IL-4, which can help in the disease development and 
reactivation of latent infection (Hernandez-Pando et al., 1996).  In another study, it has 
been shown that after treatment of IL-4 by anti-IL-4 antibody reduced the M. tb 
pathogens in the lungs of the mice during the initial stages of infection as compared to 
control. In the same study IL-4 gene knock out mice showed the less number of M. tb 
in the lungs and spleen tissues (Buccheri et al., 2007).  By giving exogenous IL-4 
doses to these mice resulted in the higher number of M. tb in the host, suggested that 
IL-4 helps in the survival of mycobacteria in the host (Buccheri et al., 2007). 
We also examined the chemokines response from THP-1 cells lines treated with 
complement deposited M. bovis BCG with and without rfBC coating. In the previous 
chapter we observed the chemokines response from THP-1 cell lines without 
complement deposited M. bovis BCG bound with rfBC and M. bovis BCG  only. We 
observed that recombinant rfBC treated complement deposited M. bovis BCG down 
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regulated the level of chemokines (MCP-3, MDC, Eotaxin, Fractalkine, GRO and 
MCP-1) by infecting THP-1 cells after 24 and 48 hours as compared to untreated 
complement deposited M. bovis BCG. Monocyte chemo-attractant protein-1 (MCP-1) 
increased Th2 polarization and attracts immune cells to the site of infection (Rose et 
al., 2003). Monocyte chemo-attractant protein-3 (MCP-3) is secreted by macrophages 
and reported higher level in bronchoalveolar fluid of tuberculosis patient (Ruhwald et 
al., 2009). Growth-related oncogene-1 (GRO1) also produced by macrophages, 
neutrophils and epithelial cells. GRO assist in the recruitment of neutrophils and 
monocytes to the infectious site (Nakagawa et al., 1994). Macrophage derived 
chemokine (MDC) is also helping in the recruitment of immune cells such as 
monocytes, dendritic cells and natural killer cells to the site of infection (Godiska et 
al., 1997). The down regulation of chemo attractants response by rfBC discourage the 
inflammation and granuloma formation process and also prevent them to be 
phagocytosed by macrophages where they can multiply and survive.  
In this study we studied the level of growth factors and related ligands and receptors by 
THP-1 cells treated with complement deposited M. bovis BCG bound with rfBC as 
compared to complement deposited M. bovis BCG after 24 and 48 hours. We observed 
the down regulation of growth factors (IL-2, FGF-2, G-CSF, GM-CSF and VEGF) and 
related ligands and receptors (IFN-γ, FLT-3 and IL-1RA) by THP-1 cells treated with 
complement deposited M. bovis BCG bound with rfBC as compared to complement 
deposited M. bovis BCG after 24 and 48 hours. Granulocytes-colony stimulating factor 
(G-CSF) is one of the important growth factor produced by monocytes, fibroblasts and 
endothelial cells (Schneider et al., 2005). It encourages the immunological functions of 
neutrophil by differentiating into mature neutrophil from the precursors (Hu and Yasui, 
1997).  
In this study we studied the IFN-γ response from THP-1 cells lines treated with 
complement deposited M. bovis BCG with and without rfBC coating. We observed that 
rfBC treated complement deposited M. bovis BCG down regulated the level of IFN-γ. 
It has been shown that IFN-γ mainly produced by Natural killer (NK) cells, CD4+, 
CD8+, macrophages and mucosal epithelial cells (Munder et al., 2001). It has also been 




The pro-inflammatory response was raised significantly in complement-deposited M. 
bovis BCG and complement-deposited M. bovis BCG treated with rfBC and were at 
similar levels to M. bovis BCG only. However, for complement-deposited M. bovis 
BCG treated with rfBC, there was significant inhibition of phagocytosis, whilst for 
complement-deposited M. bovis BCG there was an enhancement of uptake. 
The dampening of the pro-inflammatory response by conglutinin may also supress the 
production of important cytokines and chemoattractants (TNF-α, IL-1β, IL-6, IL-
12p40) that recruit inflammatory cells and discourage inflammation and tissue 
remodeling necessary for granuloma formation (Feng et al., 2006; Mayer-Barber et al., 
2010). In the absence of complement in the lungs, this may be a preferred stratergy by 
the host to protect against mycobacterial infection. However, there is evidence of 
complement in the lungs that could support C3 deposition on mycobacteria (Ferguson 
et al., 2004). In this scenario, conglutinin could be acting once again to maintain the 
pathogen in the extracellular milieu, while also simultaneously tailoring the enhanced 














6.1 Conclusions and future perspectives  
In this study, bovine conglutinin was investigated for its host-pathogen interactions 
with mycobacteria in vitro. A recombinant fragment of conglutinin (rfBC) was 
expressed and purified containing the carbohydrate recognition domain (CRD) and 
neck region. The binding and direct effect of rfBC on the growth of mycobacteria was 
investigated, together with the effect of rfBC on phagocytosis of mycobacteria by 
macrophages. The effect of rfBC on the phagocytosis of complement deposited M. 
bovis BCG was also investigated. In the studies conducted, M. bovis BCG and M. 
smegmatis (non-pathogenic mycobacterial species) were used as model organisms of 
M. bovis and M. tuberculosis, respectively, to demonstrate that rfBC was able to bind 
to mycobacteria and play an important role on their uptake by macrophages. These 
studies show that rfBC interactions with mycobacteria and macrophages can modulate 
the subsequent inflammatory response, possible influencing the outcome of adaptive 
immunity. In this chapter, the possible implications from our results will be discussed 
and with respect to the understanding of rfBC role in the bovine tuberculosis and how 
it may rfBC could be used as a possible treatment, prophylactic or biomarker against 
bovine and possibly human tuberculosis. 
Conglutinin is an important member of collectin family, which is synthesized in the 
liver and is present in the serum and can be produced locally by neutrophil, dendritic 
and macrophage cells (Dec et al., 2012). Previously conglutinin has been shown to 
possess growth inhibition activity against Gram-negative bacteria and also has 
antiviral effects against influenza A virus and human immunodeficiency virus (HIV) 
(Laursen et al., 1994). Bovine tuberculosis remains an important agricultural 
economic problem in the United Kingdom and worldwide, it is not only effecting 
cattle but also found in domestic and wild animals including humans (Abernethy et 
al., 2013).  Conglutinin is found in the cattles, which makes an important collectin to 
be studied in the bovine tuberculosis (M. bovis infection). However, its role in bovine 
tuberculosis has never been studied before. The primary organ targeted by M. bovis is 
the host lung and the bacterial infection is accompanied by a localized inflammation, 
resulting in the migration of different immune cells and leakage of serum proteins on 
the site of infection. Some of the first host molecules to be involved are collectins, 
which are soluble innate immune molecules that play an important role in targeting 
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microbes by binding to oligosaccharides and lipid structures on their surface and can 
stimulate aggregation, complement activation, opsonisation, effect on phagocytosis 
and inhibit growth (Hartshorn et al., 1993; Reading et al., 1997; Wang et al., 1995).  
It is hypothesized that during inflammation conglutinin leaks from the blood vessels 
at the site of infection due to changes in vascular permeability and is likely to come in 
direct contact with M. bovis and immune cells and therefore may modulate the 
outcome of the infection. It is also possible that alveolar macrophages may also 
produce conglutinin locally. It has been studied that conglutinin binds with zymosan 
and complement fragment iC3b in the presence of calcium ions and also shows 
antimicrobial activity in vitro (Dec and Wernicki 2006).  
I observed the rfBC binds to M. bovis BCG and M. smegmatis and this binding is 
dose-dependent, reaching saturation of binding at 20µg/ml. This binding of rfBC with 
M. bovis BCG and M. smegmatis was greater in the presence of Ca2+ as compared to 
EDTA. This is the first observation of conglutinin binding to a Gram-positive 
bacterium (M. bovis BCG and M. smegmatis). We observed less binding between 
rfBC with M. smegmatis as compared to M. bovis BCG. As rfBC is a bovine protein 
and M. bovis is a causative agent of bovine TB, so there should be some relevance in 
the binding. Surfactant protein D (SP-D) has also been shown to bind to the mannose 
caps of M. tuberculosis lipoarabinomannan (LAM) and other carbohydrates present 
on the surface of M. tuberculosis (Ferguson, 2002), as SP-D is mostly structurally 
similar to conglutinin (Hansen and Holmskov, 2002) and M. bovis BCG has similar 
bacterial surface as M. tuberculosis including LAM (Jankute et al., 2014; Jungblut et 
al., 1999), so most likely the ligand for rfBC interaction with M. bovis BCG is LAM.   
We also observed that rfBC directly inhibits the growth of M. bovis BCG and M. 
smegmatis in vitro and we found this inhibition was dose-dependent. We also 
observed that rfBC inhibition is bacteriostatic in nature rather then bactericidal as our 
experiment shown that there was no cell lysis observed in rfBC treated M. bovis BCG. 
This inhibition could be through intracellular signaling in the mycobacteria to affect 
the important genes responsible for cell metabolism and bacterial survival. To the best 
of our knowledge the direct bacteriostatic inhibition role of collectin (conglutinin) on 
Gram-positive bacterium (mycobacteria) has not been studied before. In the previous 
studies it has been shown that SP-A and SP-D inhibited the growth of Gram-negative 
																																																																																																																																																					Chapter 6 
	 134 
bacteria by increasing the cell permeability but this role was also not bactericidal 
(Hogenkamp et al., 2007; Wu et al., 2003). In the previous studies, it has been shown 
that rfBC played an important role in the survival of mice infected with pathogen 
strains of Salmonella typhimurium, Pasteurella septica, Klebsiella pneumoniae, 
Listeria monocytogenes and Streptococcus pyogenes (Ingram 1959). It has been 
reported that rfBC helps in the prolonged survival of mice infected with S. 
typhimurium (Friis-Christiansen 1990).  
In this study, we found that rfBC inhibits the phagocytosis and growth of 
mycobacteria (M. bovis BCG and M. smegmatis) inside the THP-1 cells in a dose 
dependent manner. Our data showed less uptakes of M. smegmatis by THP-1 cells as 
compared to the phagocytosis of M. bovis BCG. From previous findings we observed 
less bindings of M. smegmatis with rfBC as compared to M. bovis BCG bounds to 
rfBC. This could be a reason of less uptake of M. smegmatis by THP-1 cells in the 
presence of rfBC. The inhibitory effect of rfBC was further confirmed by 
fluorescence microscopy. This reduction in uptake of mycobacteria (M. bovis BCG 
and M. smegmatis) in the presence of rfBC may stimulate intracellular signaling in the 
mycobacteria to affect the important genes function those are responsible for cell 
metabolism and bacterial survival. Other reason of the less uptake of mycobacteria by 
the THP-1 cells could be, rfBC bound with mycobacterial surface antigens, in the 
result less binding of mycobacteria to the mannose receptors on macrophages. The 
reason of reduced uptake could be rfBC bound to the bacterial cell wall component 
LAM, which are ligands for mannose receptors (Ferguson et al., 2002). Further 
studies are required to confirm this highly likely possibility by performing conglutinin 
lectin-blotting to identify the mycobacterial ligand for conglutinin. This study can be 
performed by separating the cell wall component with the help of SDS-PAGE and 
transferred to the nitrocellulose membrane. This membrane will be incubated with 
conglutinin and further treated with the specific antibody of LAM to determine the 
conglutinin-LAM interaction. It has been reported that SP-D is highly similar to the 
bovine conglutinin and strongly binds to LAM of virulent M. tuberculosis, strains 
(Ferguson et al., 2002). SP-D bound to M. tuberculosis has already been shown to be 
inhibiting binding of mycobacteria to human macrophages (Ferguson et al., 2002).  
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The effect of complement and how conglutinin may impact the M. bovis BCG 
interaction with macrophages (THP-1) was also investigated. It has been shown that 
C3b deposition on the surface of mycobacteria enhances uptake of the bacterium by 
complement receptors (CR1, CR3 or CR4) present on the macrophages (Cywes et al., 
1996; Ferguson et al., 2004; Hetland and Wiker, 1994; 2001; Schlesinger and 
Horwitz, 1994). Studies have shown C3 activation and deposition of C3 fragments 
onto M. tuberculosis and M. leprae cell surfaces via both the classical and alternative 
pathways (Ferguson et al., 2004; Ramanathan et al., 1980; Schlesinger and Horwitz, 
1994). In another study, C3 binding to M. tuberculosis and M. bovis BCG has been 
shown to occur via classical and alternative complement pathways and is present in 
the form of C3b and iC3b (Carroll et al., 2009, Ferguson et al., 2004).  C3b is 
important component taking part in the complement pathways to develop towards the 
membrane attack complex (MAC), but iC3b is an inactive component of C3 does not 
take part in this reaction. C3b is known as a ligand for complement receptor 1 (CR1) 
but iC3b is ligand for complement receptor 3 and 4 (CR3 and CR4) (Ross, 1986). In 
this study, we observed less uptake of complement deposited M. bovis BCG by THP-
1 cells when treated with rfBC. The reasons for less uptake of complement coated M. 
bovis BCG by THP-1 cells in presence of rfBC could be; as conglutinin is a known 
unique binder of iC3b (Ross, 1986) and therefore conglutinin binds with iC3b 
deposited on the M. bovis BCG surface, and inhibits the uptake of mycobacteria 
through complement receptors CR3 and CR4 present on the macrophages. In this 
study we observed that there was increase in uptake of complement deposited M. 
bovis BCG by THP-1 cells as compared to M. bovis BCG only, this increase in 
phagocytosis likely to be enhanced uptake by complement receptors such as CR1, 
CR3 and CR4.  
Overall, the summary of our findings from this thesis, show that conglutinin (rfBC) 
significantly inhibits phagocytosis of M. bovis BCG by macrophages (THP-1) in a 
complement dependent and complement independent manner by probably blocking 
the host-bacterial interaction to complement and mannose receptors. Further 
experiments need to be carried out to confirm the interaction of conglutinin with the 
mannose and complement receptors.   
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Furthermore, the role of conglutinin in shaping the macrophage pro- and anti-
inflammatory response during mycobacterial infection was also investigated. The data 
show that conglutinin and complement do seem to modulate cytokine responses 
during phagocytosis of M. bovis BCG by THP-1 cells.  We observed that conglutinin 
bound to M. bovis BCG cause the down regulation of the pro-inflammatory response 
after the initial 3 and 6 hours of phagocytosis as well as later hours 24 and 48 of the 
phagocytosis as compared to M. bovis BCG only. In this study we observed the up-
regulation of pro-inflammatory cytokines in the THP-1 cells infected with 
complement deposited M. bovis BCG and complement deposited M. bovis BCG 
treated with rfBC led down regulation of cytokines in the THP-1 cells. In vivo, 
macrophages phagocytose mycobacteria but ultimately fail to destroy them and 
provide hostile environment for multiplication. rfBC inhibition of phagocytosis of 
these bacteria into macrophages may be protective against infection by keeping them 
extracellular where these can be easily cleared by the host immune response (Feng et 
al., 2006). The dampening of the pro-inflammatory response by conglutinin may also 
supress the production of important cytokines and chemoattractants (TNF-α, IL-1β, 
IL-6, IL-12p40) that recuit inflammatory cells and discourage inflammation and tissue 
remodeling necessary for granuloma formation. In the absence of complement in the 
lungs, this may be a preferred stratergy by the host to protect against mycobacterial 
infection. However, there is evidence of complement in the lungs that could support 
C3 deposition on mycobacteria. In this scenerio, conglutinin could be acting once 
again to maintain the pathogen in the extracellular milieu, while also simultaneously 
tailoring the enhanced pro-inflammatory response to the extracellular environment for 
clearance of the pathogen. 
Conglutinin is secreted by liver and found in the serum of the bovine host. The mean 
serum concentration of the conglutinin is 12 µg/ml in the serum (Holmskov et al., 
1998), which is approximately similar to the concentration of rfBC used in this study. 
Low levels of serum concentration of conglutinin have been reported in cattle 
suffering from respiratory infection (Holmskov et al., 1998). There are very few cases 
reported of mycobacterium presence in the cattle plasma (Lepper et al., 1977; 
Srivastava et al., 2008), this is due to either underreporting of these cases, due to 
culling, or perhaps cattle are better able to to cope with disseminated infections (Swift 
et al., 2016).  
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There is no evidence of conglutinin being produced locally in the bovine lungs. One 
previous study showed its presence in the lung macrophages, but it is not clear either 
this conglutinin that this conglutinin travelled from other part of the body or if it is 
secreted in the lung macrophages (Holmskov et al., 1992). Further studies are 
required to find out whether conglutinin in present in the lungs. If the presence of the 
conglutinin is confirmed in the lungs, then it could play a significant role in the early 
stages of tuberculosis infection. In the mycobacterial infection, factors enhance the 
phagocytosis of bacterium in to the macrophages are likely to be hazardous to the host 
and can help in the pathogenesis of disease. In this study we found that rfBC inhibit 
the phagocytosis of M. bovis BCG and M. smegmatis in to the THP-1 cells, we 
anticipate that reducing macrophages uptake and multiplication of mycobacteria will 
be protective for the host. Therefore, the finding from this study suggest that 
conglutinin could be an important host defence collectin against tuberculosis 
infection.  
The finding from this study needs to be further confirmed by repeating the 
experiments using M. bovis and bovine macrophages. If we found the effective 
inhibitory effect on the growth of M. bovis in vitro then we can further carry on the 
study by using animal models to find out the effect of rfBC to control bovine 
tuberculosis.  
Over all, our finding suggested that conglutinin is involved in the host-pathogen 
interaction in tuberculosis infection by inhibiting the uptake of mycobacteria by 
macrophages by blocking the macrophage mannose and complement receptors. 
Conglutinin also help in the clearance of tuberculosis infection by preventing the 
mycobacterium immune evasion strategies. We also observed that conglutinin cause 
the down regulation of pro-inflammatory response against infection, which down 
regulate the cellular immune response against infection and prevent tissue damaging 
and also assist in the extracellular clearance of mycobacteria. 
Therefore, findings from our study suggest that conglutinin plays an important host 
defense role against bovine tuberculosis infection by inhibiting phagocytosis of 
mycobacteria by macrophages via two key known mechanisms of interaction, i.e., the 
macrophage mannose receptor and complement iC3b receptors. Conglutinin probably 
enhances the clearance of mycobacterial infection by downplaying pathogen immune 
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evasion strategies and also augmenting the pro-inflammatory response against 
infection by down-regulating the cellular immune response against infection, 
supressing tissue damage and steering toward the extracellular clearance of the 
pathogen. This study provides insights into previously unknown involvement of 
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